<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">1754</journal-id><journal-id journal-id-type="pmc-domain">frontimmu</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC9513067</article-id><article-id pub-id-type="pmcid-ver">PMC9513067.1</article-id><article-id pub-id-type="pmcaid">9513067</article-id><article-id pub-id-type="pmcaiid">9513067</article-id><article-id pub-id-type="pmid">36177012</article-id><article-id pub-id-type="doi">10.3389/fimmu.2022.905867</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>T cell responses to control fungal infection in an immunological memory lens</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Sharma</surname><given-names initials="J">Jaishree</given-names></name><xref rid="fn003" ref-type="author-notes">
<sup>&#8224;</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/903418"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mudalagiriyappa</surname><given-names initials="S">Srinivasu</given-names></name><xref rid="fn003" ref-type="author-notes">
<sup>&#8224;</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/881954"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Nanjappa</surname><given-names initials="SG">Som Gowda</given-names></name><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/212144"/></contrib></contrib-group><aff id="aff1">
<institution>Department of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaign</institution>, <addr-line>Urbana, IL</addr-line>, <country>United States</country>
</aff><author-notes><fn fn-type="edited-by"><p>Edited by: Eui Ho Kim, Institut Pasteur Korea, South Korea</p></fn><fn fn-type="edited-by"><p>Reviewed by: Fabian Salazar, University of Exeter, United Kingdom; Na Cui, Peking Union Medical College Hospital (CAMS), China</p></fn><corresp id="fn001">*Correspondence: Som Gowda Nanjappa, <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:nanjappa@illinois.edu">nanjappa@illinois.edu</email></corresp><fn fn-type="equal" id="fn003"><p>&#8224;These authors have contributed equally to this work</p></fn><fn fn-type="other" id="fn002"><p>This article was submitted to Immunological Memory, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>13</day><month>9</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>13</volume><issue-id pub-id-type="pmc-issue-id">399856</issue-id><elocation-id>905867</elocation-id><history><date date-type="received"><day>28</day><month>3</month><year>2022</year></date><date date-type="accepted"><day>22</day><month>8</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2022</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-04 14:25:13.383"><day>04</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2022 Sharma, Mudalagiriyappa and Nanjappa</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Sharma, Mudalagiriyappa and Nanjappa</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fimmu-13-905867.pdf"/><abstract><p>In recent years, fungal vaccine research emanated significant findings in the field of antifungal T-cell immunity. The generation of effector T cells is essential to combat many mucosal and systemic fungal infections. The development of antifungal memory T cells is integral for controlling or preventing fungal infections, and understanding the factors, regulators, and modifiers that dictate the generation of such T cells is necessary. Despite the deficiency in the clear understanding of antifungal memory T-cell longevity and attributes, in this review, we will compile some of the existing literature on antifungal T-cell immunity in the context of memory T-cell development against fungal infections.</p></abstract><kwd-group><kwd>CD4+ T cells</kwd><kwd>CD8+ T cells</kwd><kwd>memory</kwd><kwd>fungal</kwd><kwd>vaccination</kwd><kwd>infection</kwd><kwd>immunity</kwd></kwd-group><funding-group><award-group><funding-source id="cn001"><institution-wrap><institution>Office of Extramural Research, National Institutes of Health
</institution><institution-id institution-id-type="doi">10.13039/100006955</institution-id></institution-wrap></funding-source><award-id award-type="contract" rid="cn001">5R01AI153522</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="1"/><equation-count count="0"/><ref-count count="310"/><page-count count="21"/><word-count count="10346"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>An increasing global burden of fungal diseases due to increasing immunocompromised individuals has heightened the need for effective preventive and therapeutic strategies. Fungi are one of the large biome classes, but only a handful of them are pathogenic to humans, causing a significant case fatality of up to 90%. More than 150 million severe cases and over 1.5 million succumb to fungal infections annually, despite the use of antifungal drugs (<xref rid="B1" ref-type="bibr">1</xref>&#8211;<xref rid="B3" ref-type="bibr">3</xref>). Some existing antifungals are effective but cause serious side effects and are liable to the growing drug-resistant fungal pathogens. With expanding knowledge on host&#8211;fungal pathogen interactions, there is a tremendous leap in the thrust to develop fungal vaccines. The pan-fungal vaccine is highly desirable, but the features of different fungal pathogenesis and elicitation of distinct immune responses require a clear understanding of the fungus&#8211;immune system interface, i.e., vaccine immunity and the potential to develop immunological memory. This review gives an overview of antifungal memory T cells.</p><p>Although there is a good amount of evidence of antibody-mediated immunity (<xref rid="B4" ref-type="bibr">4</xref>), adaptive immune cell responses against pathogenic fungi are mainly mediated by T cells, and genetic or acquired T-cell deficiency leads to a higher incidence of opportunistic infections (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>). Antifungal defense mechanisms by CD4<sup>+</sup> T cells, a major class of T cells, involve the secretion of proinflammatory cytokines and cell&#8211;cell interactions to activate innate immune cells, help CD8<sup>+</sup> T cells, and provide help for the generation of antibodies from B cells (<xref rid="B7" ref-type="bibr">7</xref>). The antifungal CD4<sup>+</sup> T-cell immunity involves the expression of IFN&#947;, TNF&#945;, GM-CSF, and IL-17A cytokines, which are differentially produced in a fungus- and tissue-specific manner. For example, IFN&#947;, TNF&#945;, and GM-CSF are predominantly induced during histoplasmosis, aspergillosis, cryptococcosis, paracoccidioidomycosis, pneumocystosis, and talaromycosis, whereas type 17 cytokines, IL-17A/F, and IL-22 are mainly induced during candidiasis, coccidioidomycosis, blastomycosis, and mucormycosis (reviewed here). Nonetheless, it is common to see both types of responses with variable degrees in most fungal infections. These secreted cytokines generate an inflammatory milieu and act on other cells for innate cell recruitment, activation, secretion of antimicrobial peptides, and killing of fungi (<xref rid="B8" ref-type="bibr">8</xref>&#8211;<xref rid="B10" ref-type="bibr">10</xref>). In contrast, the antifungal T cell-mediated immunity is compromised if their cytokine signature yields regulatory or unprotective cytokines that can lead to severe disseminated infections (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>). Despite the need for CD4<sup>+</sup> T-cell help for CD8<sup>+</sup> T-cell activation and memory maintenance in viral and bacterial infection scenarios, using mouse models of fungal infections against <italic toggle="yes">Pneumocystis</italic>, <italic toggle="yes">Histoplasma</italic>, and <italic toggle="yes">Blastomyces</italic>, the studies have shown that antifungal CD8<sup>+</sup> T cells can be induced, retained as long-lasting memory, and recalled upon the challenge to provide immunity independent of the T-cell help during mouse models of <italic toggle="yes">Pneumocystis</italic>, <italic toggle="yes">Histoplasma</italic>, and <italic toggle="yes">Blastomyces</italic> infections (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B13" ref-type="bibr">13</xref>&#8211;<xref rid="B16" ref-type="bibr">16</xref>). Antifungal activity of CD8<sup>+</sup> T cells involves cell cytotoxicity (<xref rid="B17" ref-type="bibr">17</xref>) and secretion of proinflammatory cytokines; the latter often mimics CD4<sup>+</sup> T-cell antifungal cytokine functions.</p><p>The host&#8217;s first response to fungal invasion starts with innate immunity, which then engages the adaptive immune arm to mount antigen-specific responses to control or clear fungal infection (<xref rid="B18" ref-type="bibr">18</xref>). The pattern recognition receptors (PRRs) are critical for innate immune responses for initial fungal control, and their mutations are associated with higher susceptibility (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B19" ref-type="bibr">19</xref>&#8211;<xref rid="B21" ref-type="bibr">21</xref>). The activation of innate immune cells and generation of apt inflammatory milieu facilitate dendritic cell priming of na&#239;ve T cells to become effectors, which eventually differentiate to form antifungal memory T cells (<xref rid="B22" ref-type="bibr">22</xref>). Thus, the innate immunity dictated by fungal recognition shapes adaptive T-cell immunity and immunological memory.</p></sec><sec id="s2"><title>Fungal recognition by the immune system: Bridging innate to adaptive immunity</title><p>Among innate cells, dendritic cells are essential for priming na&#239;ve T cells (<xref rid="B23" ref-type="bibr">23</xref>). The activated dendritic cells process and present the antigens to CD4<sup>+</sup> and CD8<sup>+</sup> T cells through MHC-II and MHC-I molecules, respectively. Along with antigen presentation, dendritic cells provide costimulatory signals for T-cell responses (<xref rid="B24" ref-type="bibr">24</xref>). Thus, the functions of dendritic cell maturation and activation are a critical step toward bridging innate with adaptive immunity, and such events are mainly mediated by PRR signals. PRRs are a category of host cell receptors that sense specific molecules/patterns, the pathogen-associated molecular patterns (PAMPs) such as &#946;-glucans and mannans of pathogenic fungi, and this recognition is key for innate immune cell activation to provide a primary antifungal defense. The PRRs are mainly classified as Toll-like receptors (TLRs), C-type lectin receptors (CLRs), retinoic acid-inducible gene I-like receptors (RLRs), and NOD-like receptors (NLRs), which can directly bind to the PAMPs of fungi, whereas damage-associated molecular patterns (DAMPs) can bind to PRRs and their canonical DAMP-sensing receptors such as P2X purinoceptor 7 (P2XR7), triggering receptor expressed on myeloid cells 1/2 (TREM1/2), and receptor for advanced glycation end products (RAGE) (<xref rid="B25" ref-type="bibr">25</xref>&#8211;<xref rid="B28" ref-type="bibr">28</xref>). Several of PAMPs of fungi, including &#946;-glucans, mannans, glycoprotein A, and glyceroglycolipids, have been identified for their functions using their PRRs in the host (<xref rid="B29" ref-type="bibr">29</xref>&#8211;<xref rid="B32" ref-type="bibr">32</xref>). There are excellent reviews on PRRs and fungal immunity elsewhere. Here, we highlight how PRRs can influence the innate immune cells to guide adaptive T-cell immunity.</p><p>Although negative signaling is noted with few PRRs, many are associated with their positive signaling to promote activation, phagocytosis, and antigen presentation by dendritic cells to T cells. The activated innate immune cells generate an inflammatory micro milieu conducive to the recruitment, activation, differentiation, and expansion of fungal-specific T cells by secreting cytokines and chemokines. Among PRRs, fungal-recognizing CLRs are instrumental in driving innate immune cell responses. Due to structural differences, different fungi show differential CLR binding properties leading to diverse host cell responses. The prototypic member of this family, the Dectin-1 receptor, expressed on innate immune cells including macrophages, neutrophils, and dendritic cells (DCs), recognizes &#946;1-3-glucans of the fungal cell wall. The interference of Dectin-1 interaction with &#946;-glucans by a soluble dectin-Fc fusion protein dampened the expression of inflammatory cytokines, TNF&#945;, IL-1, IL-6, MIP-2, CCL3, G-CSF, and GM-CSF, expression <italic toggle="yes">in vivo</italic>, and increased fungal burden during aspergillosis (<xref rid="B33" ref-type="bibr">33</xref>). Ablation of Dectin-1 resulted in decreased reactive oxygen species (ROS) production by neutrophils and the ability to kill <italic toggle="yes">Aspergillus in vitro.</italic> Additionally, alveolar macrophages of Dectin-1<sup>&#8722;/&#8722;</sup> mice had defective production of proinflammatory cytokines and chemokines, including IL-1&#945;, IL-1&#946;, and TNF&#945;. The Dectin-1 recognition of <italic toggle="yes">Aspergillus</italic> seems important for IL-17A production, and neutralization of IL-17A led to impaired <italic toggle="yes">Aspergillus fumigatus</italic> clearance and higher mortality of infected mice (<xref rid="B34" ref-type="bibr">34</xref>). Dectin-1 promoted the survival of antigen-specific CD4<sup>+</sup> T cells, not the CD8<sup>+</sup> T cells, specifically in GI-associated lymphoid tissues following systemic <italic toggle="yes">Candida</italic> infection, and ablation of Dectin-1 reduced the tissue-specific dendritic cells and increased activation of CD4<sup>+</sup> T cells leading to higher susceptibility to <italic toggle="yes">Candida</italic>-induced colitis (<xref rid="B35" ref-type="bibr">35</xref>). During systemic <italic toggle="yes">Candida</italic> infection, the protective role of Dectin-1 was fungal strain-specific, possibly due to variable adaptation of <italic toggle="yes">Candida albicans</italic> strains <italic toggle="yes">in vivo</italic>, including the changes in the microbiota of mice due to different mouse facilities, with changes in the cell wall components and high chitin in the cell wall masks the dependability on Dectin-1 recognition (<xref rid="B36" ref-type="bibr">36</xref>). Further, pathogenic fungi can avoid host Dectin-1 recognition of &#946;-(1,3)-glucan by masking with &#945;-(1,3)-glucan, phosphatidylserine, capsule, rodlet layer/melanin, and mannans or trimming to reduce the exposure in the cell wall, thus increasing immune evasion <italic toggle="yes">in vivo</italic> (<xref rid="B37" ref-type="bibr">37</xref>&#8211;<xref rid="B40" ref-type="bibr">40</xref>). However, Dectin-1 was dispensable for controlling infections from <italic toggle="yes">Blastomyces</italic>, <italic toggle="yes">Cryptococcus</italic>, certain strains or species of <italic toggle="yes">Candida</italic>, or <italic toggle="yes">Candida</italic> colonization (<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B41" ref-type="bibr">41</xref>&#8211;<xref rid="B45" ref-type="bibr">45</xref>), suggesting the differential requirement of CLRs for fungal immunity.</p><p>Unlike the Dectin-1 receptor, cytoplasmic domains of Dectin-2 and Mincle receptors lack their own ITAM motifs and associate with FcR&#947; immunoreceptor harboring cytoplasmic ITAM motif for signaling (<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>). Dectin-2 and Mincle have been shown to be important for immunity against blastomycosis (<xref rid="B48" ref-type="bibr">48</xref>), aspergillosis (<xref rid="B49" ref-type="bibr">49</xref>), histoplasmosis (<xref rid="B44" ref-type="bibr">44</xref>), chromoblastomycosis (<xref rid="B50" ref-type="bibr">50</xref>), disseminated candidiasis (<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B52" ref-type="bibr">52</xref>), and species-specific candidiasis (<xref rid="B45" ref-type="bibr">45</xref>). Dectin-2 signals through the Syk-CARD9 pathway and promote Th17 cell responses (<xref rid="B51" ref-type="bibr">51</xref>) by inducing the expression of IL-1 and IL-23 cytokines (<xref rid="B53" ref-type="bibr">53</xref>). Despite that Dectin-2 and Mincle share their signaling through FcR&#947; immunoreceptors, their role in activation, expansion, and differentiation of antigen-specific CD4<sup>+</sup> T-cell responses may differ. While Dectin-2 was essential for enhancing Th17 cell differentiation, Mincle recognition suppressed Th17 polarization during chromoblastomycosis (<xref rid="B50" ref-type="bibr">50</xref>).</p><p>In addition to CLRs, TLRs expressed by innate cells are involved in the control of fungal infection. Myeloid differentiation primary response protein 88 (MyD88), an adaptor molecule for many TLRs signaling, has been shown to play a role in antifungal immunity against <italic toggle="yes">Blastomyces dermatitidis</italic>, <italic toggle="yes">Paracoccidioides brasiliensis</italic>, <italic toggle="yes">A. fumigatus</italic>, <italic toggle="yes">Cryptococcus neoformans</italic>, and <italic toggle="yes">C. albicans</italic> (<xref rid="B54" ref-type="bibr">54</xref>&#8211;<xref rid="B56" ref-type="bibr">56</xref>). TLR2 plays a significant role in conferring protective immunity against <italic toggle="yes">Candida</italic> infection at mucosal sites, including gastrointestinal and reproductive tracts by inducing Th17 differentiation through MyD88 signaling (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>). However, the role of TLR2 in controlling systemic candidiasis seems to be fungal strain specific (<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B60" ref-type="bibr">60</xref>). Additionally, IL-1R/MyD88 signaling pathway is necessary for host resistance against <italic toggle="yes">Candida</italic>, and TLR4/MyD88 pathways mediate protection against <italic toggle="yes">Aspergillus</italic> infection by regulating Th1 and Th2 response (<xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B61" ref-type="bibr">61</xref>). TLR3 in DCs senses fungal RNA derived from dying cells and potentiates the cross-presentation to activate CD8<sup>+</sup> T cells during aspergillosis (<xref rid="B62" ref-type="bibr">62</xref>). Nevertheless, compared to those of CLRs, the functions of many TLRs in the context of antifungal immunity seem to be modest or redundant.</p><p>NLRs function against fungal defense mainly involved the activation of inflammasomes, which leads to caspase-dependent production of functional IL-1&#946; and IL-18 cytokines. Both of these cytokines have been shown to exert antifungal host defense in an NLRP3-dependent manner (<xref rid="B63" ref-type="bibr">63</xref>). NLRC4 negatively regulates NLRP3 inflammasome activity, suppressing early IL-1&#946; and late IL-18-mediated antifungal CD8<sup>+</sup> T-cell responses during pneumocystosis (<xref rid="B64" ref-type="bibr">64</xref>). Thus, some PRRs of the non-CLR class play a role in immunity against fungal infections (<xref rid="B26" ref-type="bibr">26</xref>).</p><p>Genetic polymorphisms are associated with susceptibility or resistance to infections. The genetic TLR polymorphisms related to fungal disease susceptibility in humans undergoing allogenic stem cell transplants seem to be modest or minimal (<xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B66" ref-type="bibr">66</xref>). The genetic predisposition due to PRR polymorphisms to fungal infections is variable and depends on the pathogen or the degree of inflammation. For example, TLR4 polymorphism D299G is associated with increased susceptibility to <italic toggle="yes">Candida</italic> bloodstream infection, possibly due to higher immunosuppressive cytokine IL-10 production. However, such susceptibility was not seen in urogenital <italic toggle="yes">Candida</italic> infection (<xref rid="B67" ref-type="bibr">67</xref>). Similarly, the TLR4 polymorphisms (D299G/T399I), despite the normal colonization of the fungus, are associated with mitigating the hyperinflammation and tissue damage during aspergillosis (<xref rid="B66" ref-type="bibr">66</xref>). Similarly, genetic polymorphisms of CLRs have been associated with susceptibility to fungal infections. Dectin-1 single-nucleotide polymorphisms (SNPs), rs3901533 and rs7309123, enhanced the susceptibility to invasive pulmonary aspergillosis (<xref rid="B68" ref-type="bibr">68</xref>). Dectin-1 polymorphism of Y238X led to decreased receptor signaling and increased susceptibility to invasive aspergillosis and recurrent vulvovaginitis caused by <italic toggle="yes">Candida</italic> (<xref rid="B69" ref-type="bibr">69</xref>, <xref rid="B70" ref-type="bibr">70</xref>). Alternative splicing leading to truncated Dectin-1 seen in the C57BL/6 strain, compared to the DBA/2 mouse strain, increased the susceptibility to coccidioidomycosis (<xref rid="B71" ref-type="bibr">71</xref>). Thus, it is essential to decipher gene polymorphisms in humans to understand the susceptibility to fungal infections.</p><p>T cells can also express several PRRs to respond to PAMPs during fungal infections. Engagement of the cell-intrinsic PRR pathway is one of the non-classical T-cell signaling routes to enhance the activation, effector function, and memory formation of T cells as proposed originally by Janeway (<xref rid="B72" ref-type="bibr">72</xref>). Important PRRs on T cells that detect fungal PAMPs are TLRs, NLRs, and damage-associated molecular pattern-sensing receptors. TLRs can function as co-stimulatory receptors that complement TCR-induced signals to enhance effector T-cell proliferation, survival, and cytokine production (<xref rid="B73" ref-type="bibr">73</xref>). T cells expressing TLRs, including TLR2 and TLR4, can directly sense pathogens and modulate T-cell responses. Na&#239;ve CD4<sup>+</sup> T cells do not express significant levels of TLR2/TLR4 mRNA and proteins, but activated and memory T cells express high levels of membrane-bound TLR2 and TLR4 (<xref rid="B74" ref-type="bibr">74</xref>, <xref rid="B75" ref-type="bibr">75</xref>). TLR2 signaling in T cells can be modulated by TCR and IL-2-induced mTOR signals (<xref rid="B76" ref-type="bibr">76</xref>). Intrinsic MyD88 signaling can modulate the T-cell functions during fungal infections. MyD88 signaling, both extrinsic, non-CD4<sup>+</sup> T cell-mediated (<xref rid="B77" ref-type="bibr">77</xref>) and intrinsic, CD8<sup>+</sup> T cell-mediated (<xref rid="B78" ref-type="bibr">78</xref>), fosters fungal vaccine immunity by T cells by regulating the survival and proliferation of effector T cells. MyD88 promoted the sustained Tc17 cell proliferation by activating mTOR <italic toggle="yes">via</italic> Akt1, and cell-intrinsic IL-1R and TLR2 signaling, but not IL-18R, were required for MyD88-dependent Tc17 responses (<xref rid="B78" ref-type="bibr">78</xref>). MyD88 deletion in FoxP3<sup>+</sup> regulatory T cells increased the fungal burden and immunopathology during oral <italic toggle="yes">C. albicans</italic> infection in mice, coinciding with reduced IL-17A expressing FoxP3<sup>+</sup> T cells (T<sub>reg</sub>17) and increased dysfunctional IFN&#947;<sup>+</sup>/FoxP3<sup>+</sup> cells (IFN&#947;<sup>+</sup> T<sub>reg</sub>). This dysregulated IL-1&#946;-mTOR-Treg17 axis contributes to overt inflammation during mucosal infections in elderly individuals in a model of oral candidiasis (<xref rid="B79" ref-type="bibr">79</xref>). NLRP3, a member of the NLR family, can indirectly sense danger signals. In a murine model of disseminated talaromycosis, compared to wild-type mice, Casp-1 and Nlrp3 global KO mice displayed higher mortality rates and fungal load, which correlated with impaired CD4<sup>+</sup> T-cell recruitment into granulomas (<xref rid="B80" ref-type="bibr">80</xref>). Although this study did not look into T-cell intrinsic effect, NLRP3 signaling in CD4<sup>+</sup> T cells has been shown to augment Th1 immunity (<xref rid="B81" ref-type="bibr">81</xref>). Further studies are needed to dissect the T-cell intrinsic PRR functions against fungal infections. Interestingly, PRR has been used to generate modified TCR of T cells. Dectin-1-chimeric antigen receptor (D-CAR) was bioengineered using the extracellular domain of Dectin-1 to redirect T-cell specificity toward fungal &#946;-glucan moieties for immunity (<xref rid="B82" ref-type="bibr">82</xref>). D-CAR+ T cells could inhibit <italic toggle="yes">A. fumigatus</italic> hyphae formation <italic toggle="yes">in vitro</italic> and reduce pulmonary fungal burden <italic toggle="yes">in vivo.</italic> In this study, chimeric CD8<sup>+</sup> T cells kill the fungi directly by pumping out cytolysins onto yeast/hyphae of <italic toggle="yes">Aspergillus</italic> and indirectly by secreting IFN&#947; that can potentiate the killing of yeasts by neutrophils (<xref rid="B83" ref-type="bibr">83</xref>).</p></sec><sec id="s3"><title>Antifungal T cells</title><p>CD4<sup>+</sup> T cells, also called helper T cells, are instrumental in controlling fungal infections, and their deficiency leads to severe disseminated infections by opportunistic fungal pathogens. As the name suggests, the helper cells bolster innate immune cell functions, aid in the generation of productive B-cell responses, help CD8<sup>+</sup> T-cell responses, and control autoimmunity. Based on their cytokine secretion and functions during fungal infections (<xref rid="B84" ref-type="bibr">84</xref>, <xref rid="B85" ref-type="bibr">85</xref>), T cells are classified into Th1 (IFN&#947;, GM-CSF, and TNF&#945;), Th17 (IL-17A/F), Th22 (IL-22), Th2 (IL-4 and IL-13), Th9 (IL-9 and IL-10), Treg (IL-10 and TGF&#946;), and Tr1 (IL-10). The cytokines produced by T cells have a multifaceted role in controlling or regulating the pathogenesis during infections, including fungal infections (<xref rid="B86" ref-type="bibr">86</xref>). Although a mixture of different cytokine-producing T cells is often found during fungal infections, the predominant subset of T-cell responses is associated with the type of pathogen, infection, or tissue location (<xref rid="T1" ref-type="table">
<bold>Table 1</bold>
</xref>). Here, we will highlight some of the roles of these T cells for immunity against different pathogenic fungi with a focus on memory phenotypic cells.</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table&#160;1</label><caption><p>Major T-cell subsets elicited and shown to be protective against fungal pathogens.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Pathogenic fungi</th><th valign="top" colspan="3" align="center" rowspan="1">Mechanism(s) of protection</th><th valign="top" align="center" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Aspergillus</italic> spp.</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">Th1 (circulation), Th17 (lungs)</td><td valign="top" align="left" rowspan="1" colspan="1">Tc1</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B87" ref-type="bibr">87</xref>&#8211;<xref rid="B89" ref-type="bibr">89</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Blastomyces</italic> spp.</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">Th1, Th17</td><td valign="top" align="left" rowspan="1" colspan="1">Tc1, Tc17</td><td valign="top" align="left" rowspan="1" colspan="1">Tc1 (<sub>EM/CM</sub>)<break/>Tc17 (<sub>EM</sub>)</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B90" ref-type="bibr">90</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Candida</italic> spp.</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">Th1, Th17</td><td valign="top" align="left" rowspan="1" colspan="1">Tc1, Tc17</td><td valign="top" align="left" rowspan="1" colspan="1">T<sub>RM</sub>
</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B91" ref-type="bibr">91</xref>&#8211;<xref rid="B94" ref-type="bibr">94</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Cryptococcus</italic> spp.</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">Th1, Th17?</td><td valign="top" align="left" rowspan="1" colspan="1">Tc1</td><td valign="top" align="left" rowspan="1" colspan="1">T<sub>RM</sub>
</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B95" ref-type="bibr">95</xref>, <xref rid="B96" ref-type="bibr">96</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Coccidioides</italic> spp.</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">Th1, Th17, Th2</td><td valign="top" align="left" rowspan="1" colspan="1">Tc1</td><td valign="top" align="left" rowspan="1" colspan="1">T<sub>EM</sub>
</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B97" ref-type="bibr">97</xref>&#8211;<xref rid="B99" ref-type="bibr">99</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Histoplasma</italic> spp.</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">Th1, Th17</td><td valign="top" align="left" rowspan="1" colspan="1">Tc1</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B100" ref-type="bibr">100</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Paracoccidioides</italic> spp.</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">Th1, Th17</td><td valign="top" align="left" rowspan="1" colspan="1">Tc1</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B101" ref-type="bibr">101</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Pneumocystis</italic> spp.</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">Th1?</td><td valign="top" align="left" rowspan="1" colspan="1">Tc1</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B102" ref-type="bibr">102</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Talaromyces</italic> spp.</bold>
</td><td valign="top" rowspan="1" colspan="1">Th1, Th17</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B103" ref-type="bibr">103</xref>, <xref rid="B104" ref-type="bibr">104</xref>)</td></tr></tbody></table><table-wrap-foot><fn><p>Different subsets of CD4<sup>+</sup> T helper cells and CD8<sup>+</sup> T cells have been shown to participate in immunity against different pathogenic fungi. In some of the pathogenic fungi, different types of memory T-cell development have been documented.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s4"><title>Pathogen-specific antifungal T cells</title><sec id="s4_1"><title>
Candida
</title><p>Anti-<italic toggle="yes">Candida</italic> memory T-cell responses are studied in the context of mucosal infections, vaccine-induced responses, and commensal-specific/pre-exposed T cells in healthy donors. <italic toggle="yes">Candida</italic> is a commensal but opportunistic fungal pathogen that causes disseminated infection under compromised immunity. In a mouse model of oropharyngeal candidiasis (OPC), after resting for 6 weeks following primary infection, the memory CD4<sup>+</sup> conferred immunity to secondary infection by producing antigen-specific IL-17A responses (<xref rid="B91" ref-type="bibr">91</xref>). However, depletion of CD4<sup>+</sup> T cells did not cause OPC, possibly compensated by developed residual IL-17A expressing memory CD8<sup>+</sup> T cells and CD3<sup>+</sup>CD4<sup>&#8722;</sup>CD8<sup>&#8722;</sup> cells. In a mouse model of <italic toggle="yes">C. albicans</italic> skin infection, IL-17<sup>+</sup> CD4<sup>+</sup> T cells were enriched in the skin, which transitioned into sessile CD69<sup>+</sup>/CD103<sup>+</sup> tissue-resident memory T cells (T<sub>RM</sub>) within 90 days. This suggests that the long-lasting antifungal memory Th17 cells are generated in the non-lymphoid organ, such as the skin (<xref rid="B105" ref-type="bibr">105</xref>). Importantly, these T<sub>RM</sub> cells provided better immunity than migratory Th17 cells following infectious challenges. In a mouse model of vulvovaginal candidiasis, Th17 cells persisted even after the clearance of the yeast but in low numbers by day 30 (<xref rid="B106" ref-type="bibr">106</xref>). The vaginal washes showed the presence of IL-17A, IL-23, and &#946;-defensins. Nevertheless, this study did not examine the long-term maintenance of effector/memory CD4<sup>+</sup> T cells.</p><p>The <italic toggle="yes">C. albicans</italic> hypha-specific surface protein antigen, agglutinin-like sequence (Als3)-based NDV-3A vaccine was used for active immunization in a mouse model that prevented <italic toggle="yes">Candida</italic> colonization at vein catheterization site (<xref rid="B107" ref-type="bibr">107</xref>), and the mechanisms involve the induction of high levels of anti-rAls3p-N antibodies. Here, the antibody titers persisted 15 days post-boost, interfered with <italic toggle="yes">Candida</italic> colonization at the catheter site, and reduced the fungal burdens in the kidneys. Although the elicitation of CD4<sup>+</sup> T-cell responses or their persistence was not evaluated in this study, the blocking/inhibitory ability of the antibodies may suggest their potential. In another study, where the NDV-3 vaccine was used in a mouse model of vaccine immunity to vulvovaginal candidiasis, robust antibody responses and immunity were dependent on both T and B cells (<xref rid="B108" ref-type="bibr">108</xref>). However, the immunity was assessed 2 weeks following the boost, which may not give a clear understanding of long-lasting memory CD4<sup>+</sup> T-cell development. Nevertheless, in a human study, intramuscular NDV-3 vaccination of the volunteers induced the durable serum and cervicovaginal antibody titer (anti-Als3) for up to 1 year and provided significant immunity against recurrent vulvovaginal candidiasis (<xref rid="B109" ref-type="bibr">109</xref>). This study found significantly higher numbers of Als3-specific cytokine (IFN&#947; and IL-17A) secreting peripheral blood mononuclear cells (PBMCs) even after day 90 of vaccination. Although this trial evaluated an immunotherapeutic vaccine, whether the vaccination induces the antigen-free (<italic toggle="yes">Candida</italic> reexposure-free) persistence of long-lasting &#8220;memory adaptive (T and B) cells&#8221; needs to be assessed.</p><p>
<italic toggle="yes">Candida</italic>-specific memory CD4<sup>+</sup> T cells in healthy blood donors produced IL-17A and IFN&#947;, but not IL-10, following restimulation (<xref rid="B110" ref-type="bibr">110</xref>). The human <italic toggle="yes">Candida-</italic>specific memory Th17 cells preferentially expressed phenotypic markers, CCR6 and CCR4 (<xref rid="B92" ref-type="bibr">92</xref>), which suggests the generation of long-lived anti-<italic toggle="yes">Candida</italic> memory T cells in humans, possibly due to stimulations from commensal microorganisms. Notably, human <italic toggle="yes">Candida</italic>-specific memory CD4<sup>+</sup> T cells are heterogeneous, produce multiple cytokines, and have unique and shared clonotypes among memory subsets (<xref rid="B111" ref-type="bibr">111</xref>). <italic toggle="yes">C. albicans</italic>-specific T<sub>RM</sub> cells prevented the fungal overgrowth in human skin and oral mucosa by producing IL-17A (<xref rid="B105" ref-type="bibr">105</xref>, <xref rid="B112" ref-type="bibr">112</xref>). Similarly, <italic toggle="yes">Candida-</italic>specific IL-9-producing CD4<sup>+</sup> T cells, Th9, were found enriched in the skin of healthy donors (suggesting their memory phenotype) and have the ability to amplify IFN&#947;, IL-9, IL-13, and IL-17 by skin-tropic T cells (<xref rid="B113" ref-type="bibr">113</xref>). However, gut Th9 cells protect against <italic toggle="yes">Candida</italic> reinfection and mitigate associated pathology (<xref rid="B114" ref-type="bibr">114</xref>). Another <italic toggle="yes">Candida-</italic>specific subset of CD4<sup>+</sup> T cells expressing IL-22 (Th22) is found in humans as memory cells and is increased following infection (<xref rid="B115" ref-type="bibr">115</xref>). Further, Th22 seems to provide defense against recurrent vulvovaginitis caused by <italic toggle="yes">Candida</italic> in humans (<xref rid="B116" ref-type="bibr">116</xref>), suggesting the formation of mucosal memory Th22 cells. In this line, defective Th22 responses are associated with chronic mucocutaneous candidiasis (<xref rid="B117" ref-type="bibr">117</xref>). Although little is known about the fate of pre-existing antifungal memory T cells during co-infection, a recent study suggests the impaired T-cell responses to <italic toggle="yes">Candida</italic> following COVID-19 infection that was associated with diminished inflammatory cytokines release (<xref rid="B118" ref-type="bibr">118</xref>).</p><p>In the mouse models of mucosal candidiasis, studies have shown that Tc17 cells play a role in both oral and vaginal infections (<xref rid="B91" ref-type="bibr">91</xref>, <xref rid="B119" ref-type="bibr">119</xref>). Oral immunization of mice with <italic toggle="yes">C. albicans</italic> under B-cell deficiency induced systemic memory of CD8<sup>+</sup> T cells and provided protection following the challenge (<xref rid="B120" ref-type="bibr">120</xref>). The screening of <italic toggle="yes">Candida</italic>-specific memory CD8<sup>+</sup> T cells in healthy human blood donors showed a non-classical cytotoxic molecules expression profile, i.e., secretion of granulysin and granzyme K rather than perforin/granzyme B (<xref rid="B121" ref-type="bibr">121</xref>). The CD8<sup>+</sup> T cells were reactive to <italic toggle="yes">C. albicans</italic>, <italic toggle="yes">Candida glabrata</italic>, and <italic toggle="yes">Sporothrix</italic> and expressed lysosomal degranulation markers, CD107a/b, and secreted IFN&#947; and TNF&#945;, following <italic toggle="yes">ex vivo</italic> stimulation with yeast-loaded dendritic cells.</p><p>In one study, the various phylogenetically closer and distant yeast-specific T-cell responses were assessed using PBMCs of humans and found a predominant presence of IFN&#947;-expressing effector memory CD8<sup>+</sup> T cells (<xref rid="B122" ref-type="bibr">122</xref>). Interestingly, in this study, enriched CD8<sup>+</sup> T cells were more reactive to filamentous form than the unicellular form of <italic toggle="yes">Candida</italic>. In HIV<sup>+</sup> patients, the <italic toggle="yes">Candida</italic>-specific activated memory CD8<sup>+</sup> T cells were accumulated within the oropharyngeal candidiasis (OPC) lesions at the lamina propria&#8211;epithelium interface (<xref rid="B123" ref-type="bibr">123</xref>). Similarly, <italic toggle="yes">C. albicans</italic>-specific CD8<sup>+</sup> T cells were found in the blood and nasal mucosa of chronic rhinosinusitis patients, suggesting a possible persistent T cell-mediated mucosal inflammation (<xref rid="B124" ref-type="bibr">124</xref>), which may be due to repeated exposure to the antigen.</p></sec><sec id="s4_2"><title>
Aspergillus
</title><p>
<italic toggle="yes">Aspergillus</italic>, a globally prevalent opportunistic fungal pathogen, causes pulmonary and invasive mycoses following inhalation of spores. Immunity to aspergillosis is primarily associated with the development of memory Th1 cells, while biased Th2 or regulatory responses are linked to exacerbated disease (<xref rid="B125" ref-type="bibr">125</xref>&#8211;<xref rid="B127" ref-type="bibr">127</xref>). Experimental vaccination of mice with conidia, hyphae, crude culture filtrate antigens, or adjuvanted (CpG ODN1862) cell wall glucanase Crf1 protein strongly induced Th1 (IFN&#947; and IL-2) responses, formed effector or memory T cells, and conferred immunity following the challenge (<xref rid="B87" ref-type="bibr">87</xref>, <xref rid="B128" ref-type="bibr">128</xref>&#8211;<xref rid="B131" ref-type="bibr">131</xref>). In line with the protective role of Th1 responses, IL-4 seems to play a negative role following <italic toggle="yes">A. fumigatus</italic> challenge (<xref rid="B127" ref-type="bibr">127</xref>). In chronic rhinosinusitis with nasal polyposis patients, the mycology culture showed the presence of <italic toggle="yes">Aspergillus flavus</italic>, and PBMCs stimulated with aspergillus antigens showed an increased ratio of aspergillus-specific Th17 cells over Tregs, suggesting prior sensitization (<xref rid="B132" ref-type="bibr">132</xref>). Further, stimulated PBMC culture supernatant showed elevated levels of IL-17 and IL-10 with reduced TGF&#946; levels, suggesting the possible associated pathology in these patients. Prior work has shown the negative effect of IL-10 for control of experimental lethal systemic aspergillosis (<xref rid="B133" ref-type="bibr">133</xref>), and its overexpression, due to genetic polymorphisms, predisposes to invasive aspergillosis possibly by inhibiting TNF&#945; secretion in hematopoietic stem cell recipients or hematological patients (<xref rid="B134" ref-type="bibr">134</xref>, <xref rid="B135" ref-type="bibr">135</xref>). However, IL-10 seems to be protective in regulating exaggerated immune responses and inflammation in allergic bronchopulmonary aspergillosis (<xref rid="B136" ref-type="bibr">136</xref>), suggesting that the regulatory role of IL-10 depends on the disease context. In many healthy individuals (10%&#8211;30%), multi-<italic toggle="yes">Aspergillus-</italic>specific T cells were found, suggesting their memory potential and feasibility to expand, store, and be used for self-adoptive transfers following hematopoietic stem cell transplantation (<xref rid="B137" ref-type="bibr">137</xref>&#8211;<xref rid="B139" ref-type="bibr">139</xref>). Hematopoietic stem cell transplant patients undergo a period of immunocompromised state, enhancing vulnerability to many opportunistic fungal infections, including aspergillosis. Thus, rapid preventive or therapeutic reconstitution of the functional adaptive immune system is beneficial. Adoptive immunotherapy using either donor-derived (<xref rid="B139" ref-type="bibr">139</xref>) or partially HLA-matched antigen-specific T cells can be used to prevent or treat opportunistic fungal infections (<xref rid="B140" ref-type="bibr">140</xref>). In a preclinical study, <italic toggle="yes">in vitro</italic> expanded yeast-specific cytokine-producing Th cells have been used to reduce the severity of pulmonary and cerebral forms of aspergillus infections in mice (<xref rid="B141" ref-type="bibr">141</xref>).</p><p>Although the role of Th17 cells in pulmonary aspergillosis is debated, a recent study suggests the presence of aspergillus-specific Th17 cells that correlated with protective immunity (<xref rid="B88" ref-type="bibr">88</xref>), and possible mechanisms may include the formation of inducible bronchus-associated lymphoid tissue (iBALT) structures and development of T<sub>RM</sub> cells (<xref rid="B142" ref-type="bibr">142</xref>). With the use of recombinant aspergillus proteins (Asp f proteins), a study investigated the presence of yeast-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cells in healthy non-atopic donors (<xref rid="B143" ref-type="bibr">143</xref>). In these individuals, the cytokine production signature suggested the presence of aspergillus-specific memory T cells expressing IFN&#947;, IL-17A, and to some extent IL-4, possibly due to prior exposure. Importantly, this study showed the presence of <italic toggle="yes">Aspergillus</italic>-reactive IFN&#947;<sup>+</sup> T cells for up to 6 months of follow-up observations. However, the persistence of diverse cytokine-expressing T cells as memory in humans needs to be evaluated for their role in immunity or immunopathology following infection.</p></sec><sec id="s4_3"><title>
Pneumocystis
</title><p>
<italic toggle="yes">Pneumocystis</italic> is another opportunistic fungus that causes infection under immunodeficiency, especially of CD4<sup>+</sup> T cells and B cells. It is believed that <italic toggle="yes">Pneumocystis</italic> may persist in individuals upon early age exposure without any apparent symptoms, akin to toxoplasma. The reactivation occurs when an individual becomes immunodeficient or severely immunosuppressed, suggesting an active role of memory or effector adaptive immunity to keep the fungus at bay. However, recent studies suggest the possibility of reinfection in immunocompromised individuals (<xref rid="B144" ref-type="bibr">144</xref>). Murine models have been valuable in understanding the host&#8211;<italic toggle="yes">Pneumocystis</italic> interface for adaptive immunity and recapitulating human primary immune disorders (<xref rid="B145" ref-type="bibr">145</xref>). Increasing evidence suggests that B-cell responses are important in the control of <italic toggle="yes">Pneumocystis</italic>. Anti-CD20 mAb therapy in humans enhanced the susceptibility to pneumocystosis, suggesting a critical role of B cells (<xref rid="B146" ref-type="bibr">146</xref>). Of note, the CD20 mAb therapy does not deplete mature plasma cells (<xref rid="B147" ref-type="bibr">147</xref>), raising questions on mature long-lived plasma cell generation against <italic toggle="yes">Pneumocystis</italic>. It is possible that anti-CD20 mAb therapy leads to functional impairment of antibody-secreting cells. However, in a murine model of pneumocystosis, neither the memory CD4<sup>+</sup> T cells nor B cells are required for clearance of infection (<xref rid="B146" ref-type="bibr">146</xref>). Here, convalescent <italic toggle="yes">Pneumocystis</italic>-specific IgGs were enough to provide immunity. Interestingly, B cells are required for elicitation of antigen-specific CD4<sup>+</sup> T-cell responses to <italic toggle="yes">Pneumocystis</italic> (<xref rid="B148" ref-type="bibr">148</xref>, <xref rid="B149" ref-type="bibr">149</xref>), suggesting a potential cross-talk between these two subsets for immunity against pneumocystosis. Notably, in the simian model of vaccination with <italic toggle="yes">Pneumocystis jirovecii</italic> protease kexin (KEX1), once the B cells are primed, induction of CD4<sup>+</sup> T-cell deficiency with SHIV infection did not prevent antibody-dependent control of infection, suggesting the persistence of &#8220;memory&#8221; plasma cells or threshold levels of Ab titers (<xref rid="B150" ref-type="bibr">150</xref>). In a murine model, memory CD4<sup>+</sup> T cells were dispensable for pneumocystosis control, whereas memory CD8<sup>+</sup> T cells, alveolar macrophages, and <italic toggle="yes">Pneumocystis</italic>-specific IgG contributed to secondary immunity (<xref rid="B102" ref-type="bibr">102</xref>). Here, the IgG antibody enhanced the macrophage killing of yeast, while macrophages helped CD8<sup>+</sup> T-cell recall responses in IFN&#947; production. IFN&#947;-stimulated CD8<sup>+</sup> T cells, in turn, can be potent antifungal cytotoxic cells (<xref rid="B13" ref-type="bibr">13</xref>). However, interestingly, CD8<sup>+</sup> T cells seem to help CD4<sup>+</sup> T cells with their IFN&#947; responses. Memory CD4<sup>+</sup> T cells can indirectly potentiate NK cell functions against infection caused by <italic toggle="yes">Pneumocystis murina</italic>, and depletion of CD4<sup>+</sup> T cells significantly reduced the accumulation of NK cells and NK-cell mediated immunity (<xref rid="B151" ref-type="bibr">151</xref>). In a mouse model of vaccine immunity, immunization with a recombinant fusion protein containing N-terminal 544-aa <italic toggle="yes">Pneumocystis</italic> cross-reactive antigen-1 and trigger factor (TF) induced protective and cross-reactive antibody responses that provided immunity even after memory CD4<sup>+</sup> T cells were depleted at the time of challenge infection (<xref rid="B152" ref-type="bibr">152</xref>). Thus, CD4<sup>+</sup> T cells seem to have functional duality against <italic toggle="yes">Pneumocystis</italic> infection, first by helping B cells and CD8<sup>+</sup> T cells to become protective differentiated memory cells and second by secreting proinflammatory cytokines to control the primary infection.</p></sec><sec id="s4_4"><title>
Cryptococcus
</title><p>
<italic toggle="yes">C. neoformans</italic> is a facultative intracellular opportunistic pathogen commonly associated with AIDS patients due to severe CD4<sup>+</sup> T-cell deficiency. The CD4<sup>+</sup> T-cell immunity to cryptococcosis is mainly dependent on Th1 cytokines. Models of vaccination and infection suggested the role of CD4<sup>+</sup> T cells and their Th1 cytokine profile. <italic toggle="yes">Cryptococcus</italic>-activated CD4<sup>+</sup> T cells recruited other immune cells, enhanced the phagocytosis, and killed infected cells by CD8<sup>+</sup> T cells, akin to intracellular bacterial infections (<xref rid="B153" ref-type="bibr">153</xref>). Striking effects of Th1-derived cytokines for immunity against cryptococcosis are noticed when genetically engineered <italic toggle="yes">C. neoformans</italic> strain H99 expressing IFN&#947; (H99-&#947;) was experimentally used in mice (<xref rid="B154" ref-type="bibr">154</xref>). Here, the &#8220;vaccinated&#8221; mice cleared the infection that was associated with a large influx of leukocytes, enhanced T-cell recruitment, and increased Th1 and decreased Th2-type cytokines following challenge infection. The use of a recombinant strain of <italic toggle="yes">C. neoformans</italic> (H99-&#947;) as a vaccine strain induced memory CD8<sup>+</sup> T cells to mediate immunity under CD4<sup>+</sup> T-cell deficiency, suggesting that antifungal CD8<sup>+</sup> T cells can compensate CD4<sup>+</sup> T cells (<xref rid="B155" ref-type="bibr">155</xref>). Notably, there was the development of memory T cells and enhanced secondary responses following the challenge. <italic toggle="yes">C. neoformans</italic> chitin deacetylase 2 peptide (Cda2-Pep1) delivered in glucan particle (GP)-based vaccination robustly protected the mice following the challenge, and the immunity was correlated with their MHC-II binding affinity (<xref rid="B156" ref-type="bibr">156</xref>). Similarly, multi-epitope vaccine/s may be useful in controlling cryptococcosis (<xref rid="B157" ref-type="bibr">157</xref>). In an experimental model, immunization with either cell wall or cytoplasmic protein preparation from <italic toggle="yes">Cryptococcus gattii</italic> induced vaccine immunity after challenge and protection that was associated with enhanced Th1 responses and antigen-specific serum IgG (<xref rid="B158" ref-type="bibr">158</xref>). Nevertheless, in such vaccination platforms, the development of memory T cells is not clear. However, <italic toggle="yes">Cryptococcus</italic> antigen-pulsed dendritic cell-based systemic vaccination elicited long-lived memory Th17 cells in the lungs (<xref rid="B95" ref-type="bibr">95</xref>). Interestingly, these cells were lung resident T<sub>RM</sub> cells, produced IL-17A but not IFN&#947;, and mediated protection against <italic toggle="yes">C. gattii</italic> challenge. Pulmonary infection with <italic toggle="yes">C. neoformans</italic> elicited strong CD8<sup>+</sup> T-cell responses to control the infection independent of CD4<sup>+</sup> T cells (<xref rid="B15" ref-type="bibr">15</xref>). In this line, immunization with the genetically mutant <italic toggle="yes">Cryptococcus</italic> strain (&#916;sgl1) that accumulates steryl glucosides led to induction of protective immunity that required either CD8<sup>+</sup> or CD4<sup>+</sup> T cells (<xref rid="B159" ref-type="bibr">159</xref>). However, these studies did not show memory T-cell development or persistence. In HIV-associated <italic toggle="yes">Cryptococcus</italic> meningitis patients, the clearance of infection was strongly correlated with Th1, not Th2 or Th17, cytokines (IFN&#947; or TNF&#945;). In contrast, their defective expression led to higher mortality (<xref rid="B160" ref-type="bibr">160</xref>), suggesting an importance of type I immunity. Lower frequency of cytokine-producing memory CD8<sup>+</sup> and CD4<sup>+</sup> T cells was found in HIV-infected patients with <italic toggle="yes">Cryptococcus</italic> meningitis (CM), but their numbers were increased with more polyfunctional IL-2<sup>+</sup>/IL-17<sup>+</sup> CD4<sup>+</sup> T cells and IL-2<sup>+</sup> CD8<sup>+</sup> T cells following antiretroviral therapy (ART) in CM-associated immune reconstitution inflammatory syndrome (CM-IRIS) (<xref rid="B161" ref-type="bibr">161</xref>) patients, suggesting the pathological role of cryptococcal memory T cells under certain conditions.</p></sec><sec id="s4_5"><title>
Blastomyces
</title><p>Mouse models of immunity to blastomycosis suggest that CD4<sup>+</sup> T cells are essential for controlling primary pulmonary infections. An experimental mouse model of vaccination suggested that Th17 cells expressing IL-17A are the main driver for immunity against pulmonary blastomycosis by activating macrophages and neutrophils (<xref rid="B56" ref-type="bibr">56</xref>). A <italic toggle="yes">Blastomyces</italic>-specific fungal antigen, Calnexin, was found to be conserved among multiple fungal pathogens, and vaccination with Adjuplex adjuvant or encapsulated glucan mannan particles seems to induce robust CD4<sup>+</sup> T-cell responses and immunity (<xref rid="B162" ref-type="bibr">162</xref>, <xref rid="B163" ref-type="bibr">163</xref>). Identification of such conserved antigens may help the design of pan-fungal vaccines (<xref rid="B164" ref-type="bibr">164</xref>). Although homeostasis of memory CD4<sup>+</sup> T cells was not studied, the fungal-specific CD4<sup>+</sup> T cells persisted for 8 weeks and the adoptive transfer of vaccine-induced effector CD4<sup>+</sup> T cells mediated the immunity following the lethal challenge even after 10 weeks of rest (<xref rid="B162" ref-type="bibr">162</xref>), suggesting their potential to become memory. Interestingly, intranasal delivery of vaccine-candidate <italic toggle="yes">Blastomyces</italic> endonuclease-2 (Bl-Eng2) induced T<sub>RM</sub> cells in the lungs but failed to provide proactive immunity, unlike systemic vaccine-induced migratory CD4<sup>+</sup> T cells (<xref rid="B165" ref-type="bibr">165</xref>). Importantly, Bl-Eng2 is a glycoprotein antigen that has mannose residues that bind to Dectin-2 and a protein backbone with protective CD4 T-cell epitope/peptide (<xref rid="B165" ref-type="bibr">165</xref>, <xref rid="B166" ref-type="bibr">166</xref>), thus a vaccine candidate with intrinsic adjuvanticity property. Admixing adjuvants, especially TLR9 (CpG55.2) and Aldeltin (formulation with alum OH) with fungal antigen (Bl-Eng2 peptide) potentiated the vaccine immunity against blastomycosis, which was dependent on type 1 and type 17 cytokine-producing migratory and lung-resident T cells (<xref rid="B167" ref-type="bibr">167</xref>). In the mouse model of vaccination under CD4<sup>+</sup> T-cell deficiency, CD8<sup>+</sup> T cells could mount sterilizing immunity to lethal pulmonary infection. Immunity was predominantly mediated by IL-17A<sup>+</sup> CD8<sup>+</sup> (Tc17) cells (<xref rid="B90" ref-type="bibr">90</xref>) with disparate dependency on the type I cytokines (by Tc1 cells), IFN&#947;, TNF&#945;, and GM-CSF (<xref rid="B168" ref-type="bibr">168</xref>); i.e., deficiency of one Tc1 cytokine was compensated by other Tc1 cytokines. Notably, antifungal memory CD8<sup>+</sup> T cells were long-lasting and persisted stably without plasticity in the absence of vaccine antigen or CD4<sup>+</sup> T-cell help (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B169" ref-type="bibr">169</xref>). These memory CD8<sup>+</sup> T-cell precursors portrayed stem cell-like phenotype and can be fine-tuned by MyD88-Akt-mTOR signaling (<xref rid="B78" ref-type="bibr">78</xref>). Additionally, targeting the negative regulator of the TCR signaling molecule, Cblb, could enhance memory CD8<sup>+</sup> T-cell responses of both Tc1 and Tc17 responses to inactivated vaccine and potentiate immunity following lethal pulmonary challenge (<xref rid="B170" ref-type="bibr">170</xref>). Memory Tc17 cells predominantly expressed GM-CSF, and these co-expressing cells potentiated the fungal vaccine immunity without precipitating pathology (<xref rid="B171" ref-type="bibr">171</xref>).</p></sec><sec id="s4_6"><title>
Histoplasma
</title><p>
<italic toggle="yes">Histoplasma</italic> is an opportunistic fungal pathogen and causes disseminated infection in severely immunocompromised patients. Incidentally, most people living in the Ohio-Mississippi river valley endemic regions were reactive to <italic toggle="yes">Histoplasma</italic> (<xref rid="B172" ref-type="bibr">172</xref>), suggesting memory T-cell persistence. Memory CD4<sup>+</sup> T cells contributed to immunity following the secondary infection, and depletion of both CD4<sup>+</sup> and CD8<sup>+</sup> T-cell subsets enhanced the infection and decreased survivability (<xref rid="B173" ref-type="bibr">173</xref>). The deficiency of IL-10 conferred salutary effects on memory T cell-mediated protection to secondary histoplasmosis (<xref rid="B174" ref-type="bibr">174</xref>). The immunity was dependent on T cell-derived TNF&#945; or IFN&#947;, and the protection conferred by T cells generated under IL-10 deficiency was robust. Although memory responses of IL-17<sup>+</sup> T cells are not clear, induction of their effector type and immunity has been noticed following vaccination or infection with <italic toggle="yes">Histoplasma</italic> (<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B170" ref-type="bibr">170</xref>, <xref rid="B175" ref-type="bibr">175</xref>). In a model of histoplasmosis, CD8<sup>+</sup> T cells could compensate for the loss of CD4<sup>+</sup> T cells for vaccine immunity (<xref rid="B176" ref-type="bibr">176</xref>), and the depletion of CD8<sup>+</sup> T cells compromised the primary immune responses (<xref rid="B177" ref-type="bibr">177</xref>). Immunity to histoplasmosis was perforin-dependent and perforin-independent, which included cytokine-mediated (IFN&#947; or TN&#945;) mechanisms (<xref rid="B178" ref-type="bibr">178</xref>). The antigen cross-presentation by dendritic cells seems to be critical for the elicitation of protective antifungal CD8<sup>+</sup> T-cell responses (<xref rid="B14" ref-type="bibr">14</xref>). Although the above studies do not evaluate memory homeostasis, memory responses to histoplasmosis were bolstered by IL-10 neutralization, where fewer CD8<sup>+</sup> T cells were enough to mediate immunity (<xref rid="B174" ref-type="bibr">174</xref>).</p></sec><sec id="s4_7"><title>
Coccidioides
</title><p>Coccidioidomycosis or Valley Fever is caused by species of dimorphic fungus, <italic toggle="yes">Coccidioides</italic>, a major cause of mycosis endemic to the southwestern United States. Immunity to Valley Fever is primarily associated with T cells expressing both type 1 and type 17 cytokines (Th1/Th17) (<xref rid="B179" ref-type="bibr">179</xref>, <xref rid="B180" ref-type="bibr">180</xref>). The regulatory T cells were associated with persistent coccidioidomycosis in the pediatric population that was recapitulated in resistant vs. susceptible mice (<xref rid="B181" ref-type="bibr">181</xref>, <xref rid="B182" ref-type="bibr">182</xref>). Cytokine IL-10 plays a negative role in memory Th1 and Th17 recall responses and immunity following <italic toggle="yes">Coccidioides</italic> infection, but not for the development of memory T cells. Coccidioidomycosis immune donors had polyfunctional T cells composed of both effector and central memory phenotypic cells (<xref rid="B183" ref-type="bibr">183</xref>), suggesting their long-term immune role. In a human vaccine study using formaldehyde-killed sperules of <italic toggle="yes">Coccidioides immitis</italic>, no statistical differences in susceptibility to infection were found between placebo and vaccination groups (<xref rid="B184" ref-type="bibr">184</xref>). However, the memory T-cell development or their functions between these groups were not clear. Nevertheless, there is an active attempt to improve the vaccine efficacy using a multivalent vaccine against <italic toggle="yes">Coccidioides</italic> infection that required mixed Th1 and Th17 cell-mediated immunity (<xref rid="B185" ref-type="bibr">185</xref>, <xref rid="B186" ref-type="bibr">186</xref>). In a mouse model of vaccine immunity using a temperature-sensitive, auxotrophic mutant of <italic toggle="yes">C. immitis</italic>, the adoptive transfers of either CD4<sup>+</sup> or CD8<sup>+</sup> T cells from vaccinated mice to recipient mice infected with lethal strain conferred protection, and the immunity was mediated through TNF&#945; (<xref rid="B97" ref-type="bibr">97</xref>). In this study, although effector CD8<sup>+</sup> T cells (2 weeks post-immunization) were used to show protective immunity, the mice were monitored for 50 days following the challenge, suggesting the effector cells&#8217; persistence and possible conversion into memory cells.</p></sec><sec id="s4_8"><title>
Paracoccidioides
</title><p>Immunity to paracoccidioidomycosis depends on the CD4<sup>+</sup> T cells expressing Th1 cytokines, IFN&#947;, TNF&#945;, and IL-2 (<xref rid="B187" ref-type="bibr">187</xref>). The type of T-cell response determines the nature of the disease or the susceptibility, with Th2-dominant responses being non-protective and a mix of Th17/Th22 and Th1/Th2 providing the intermediate protection (<xref rid="B188" ref-type="bibr">188</xref>). Experimental vaccination with P10 antigen (of gp43 protein) in Montanide ISA 720, CFA, flagellin, and DODAB adjuvants induced Th1 response and protected against intratracheal challenge infection (<xref rid="B189" ref-type="bibr">189</xref>, <xref rid="B190" ref-type="bibr">190</xref>). Here, both effector and central memory phenotypic cells were found to be successfully recalled into the lungs after infection. Similarly, fungal-specific memory CD4<sup>+</sup> and CD8<sup>+</sup> T cells were seen in the patients, and low numbers of memory CD4<sup>+</sup> T cells were associated with relapse of the disease (<xref rid="B191" ref-type="bibr">191</xref>). In the model of pulmonary paracoccidioidomycosis, CD8<sup>+</sup> T cells were induced to control the fungi in the absence of CD4<sup>+</sup> T cells by secretion of type 1 cytokines (IFN&#947; and IL-2), and the depletion of CD8<sup>+</sup> T cells increased the fungal burden with a concomitant increase of non-protective IL-4 and IL-5 cytokines (<xref rid="B101" ref-type="bibr">101</xref>). Nitric oxide helps control <italic toggle="yes">Paracoccidioides</italic> infection, and deficiency of NO and CD8<sup>+</sup> T cells seems to be detrimental to immunity. Interestingly, CD8<sup>+</sup> T cells enhance the recruitment of TNF&#945;/IFN&#947;-producing CD4<sup>+</sup> T cells and the influx of inflammatory cells (<xref rid="B192" ref-type="bibr">192</xref>). However, the maintenance of such a response as memory is unclear.</p></sec></sec><sec id="s5"><title>Cross-reactive antifungal T cells</title><p>Cross-reactivity, the recognition of two or more peptides by the same TCR, of T cells has been documented. Cross-reactive antifungal T cells are useful, and identifying the antigens helps in the generation of a pan-fungal T-cell vaccine (<xref rid="B193" ref-type="bibr">193</xref>). <italic toggle="yes">C. albicans</italic> existence as a commensal microbe induces memory CD4<sup>+</sup> T cells. Incidentally, these <italic toggle="yes">C. albicans</italic>-specific cells can cross-react with airborne fungi, like <italic toggle="yes">Aspergillus</italic>, and exacerbate acute inflammatory lung pathologies (<xref rid="B194" ref-type="bibr">194</xref>, <xref rid="B195" ref-type="bibr">195</xref>). Similarly, <italic toggle="yes">A.&#160;fumigatus</italic> antigen-induced memory Th1 cells were cross-reactive to <italic toggle="yes">C. albicans</italic> (<xref rid="B130" ref-type="bibr">130</xref>). T cells specific to <italic toggle="yes">A. fumigatus</italic> were cross-reacted to induce protective immune responses against <italic toggle="yes">Aspergillus</italic> and <italic toggle="yes">Mucorales</italic> sp. infections (<xref rid="B138" ref-type="bibr">138</xref>). <italic toggle="yes">A. fumigatus</italic>-specific T cells, in culture, exhibited cross-reactivity with lysates derived from other fungi, including non-fumigatus <italic toggle="yes">Aspergillus</italic>, <italic toggle="yes">C. albicans</italic>, <italic toggle="yes">Penicillium</italic> spp., and <italic toggle="yes">Scedosporium apiospermum</italic> but not with <italic toggle="yes">Aspergillus terreus</italic>, <italic toggle="yes">C. glabrata</italic>, <italic toggle="yes">Fusarium</italic> spp., and <italic toggle="yes">Mucor</italic> spp. (<xref rid="B196" ref-type="bibr">196</xref>). Although such distantly related fungi have cross-reactive T cells, high cross-reactivity of T cells was noticed between phylogenetically related <italic toggle="yes">Scedosporium</italic> and <italic toggle="yes">Lomentospora</italic> species, but not with <italic toggle="yes">A. fumigatus</italic> (<xref rid="B197" ref-type="bibr">197</xref>). The cross-reactivity by adaptive immunity across kingdoms, i.e., fungus and bacteria, is noticed and exploited for vaccination against <italic toggle="yes">Candida</italic> and <italic toggle="yes">Staphylococcus aureus</italic> (<xref rid="B198" ref-type="bibr">198</xref>), including emerging multidrug-resistant <italic toggle="yes">Candida auris</italic> infection (<xref rid="B199" ref-type="bibr">199</xref>). Similarly, pan-fungal vaccines can be developed and used against different pathogenic fungi if the shared antigen is identified (<xref rid="B163" ref-type="bibr">163</xref>). Although the mechanism of cross-reactivity of fungal T cells is mainly due to shared epitope sequence (<xref rid="B163" ref-type="bibr">163</xref>), the broad cross-reactivity of the CD4<sup>+</sup> T cells may be due to the nature of TCR binding with peptide-MHC class II that allows multiple anchor residues with greater flexibility of amino acid variation (<xref rid="B200" ref-type="bibr">200</xref>, <xref rid="B201" ref-type="bibr">201</xref>). The bystander activation <italic toggle="yes">via</italic> TCR-independent mechanisms (<xref rid="B202" ref-type="bibr">202</xref>) may also be involved.</p></sec><sec id="s6"><title>Mechanisms of T cell-mediated fungal control</title><p>T cell-mediated control of fungal infections involves mechanisms that are chiefly mediated through the effectual functions of the cytokines they secrete. Additionally, cytotoxic functions, independent of cytokines, of CD8<sup>+</sup> T have been documented during fungal infections. Here we highlight some of the actions of cytokines/cytotoxic molecules for fungal control.</p><p>IL-17A and GM-CSF cytokines at the site of infection protected against fungal pathogens in part by enhancing the neutrophil recruitment to the site of infection (<xref rid="B9" ref-type="bibr">9</xref>). Further, these cytokines can activate recruited neutrophils and macrophages to bolster their ability to kill fungal cells. Activated neutrophils and macrophages may exert direct fungicidal activity <italic toggle="yes">via</italic> phagocytosis, degranulation, ROS production, and neutrophil extracellular trap (NET) formation (<xref rid="B203" ref-type="bibr">203</xref>). Different granules (primary azurophilic, secondary specific, and tertiary gelatinase) in neutrophils contain different cytolytic molecules (<xref rid="B17" ref-type="bibr">17</xref>). The role of the IL-17 axis and neutrophils during dimorphic fungal infections has been reviewed elsewhere (<xref rid="B204" ref-type="bibr">204</xref>). IL-17 and IL-22 act on cells to promote STAT3 activation, upregulate Reg proteins, and secrete antimicrobial peptides (AMPs), S100 proteins, and &#946;-defensins from epithelial cells and keratinocytes that destroy the fungal pathogen (<xref rid="B205" ref-type="bibr">205</xref>). Further, IL-22 signaling helps in the regeneration of oral epithelial cells and &#8220;licenses&#8221; IL-17 signaling for resistance against oral mucosal candidiasis (<xref rid="B206" ref-type="bibr">206</xref>). AMPs secreted by epithelial cells induce cell wall permeabilization, mitochondrial dysfunction, and osmotic dysregulation in fungi to elicit fungicidal and fungistatic activity (<xref rid="B207" ref-type="bibr">207</xref>). Conversely, IL-17A may drive allergic outcomes by enhancing eosinophil recruitment following repeated exposure to <italic toggle="yes">A. fumigatus</italic> conidia (<xref rid="B208" ref-type="bibr">208</xref>).</p><p>IFN&#947;, GM-CSF, and TNF&#945; enhance macrophage functions by promoting phagocyte maturation, polarization of macrophages to M1 type, and fungus-killing ability. IFN&#947; is known to strongly activate phagocytes and their functions against fungi (<xref rid="B209" ref-type="bibr">209</xref>). Both IFN&#947; and TNF induce ROS production from macrophages, which is fungistatic to intracellular fungal pathogens <italic toggle="yes">Histoplasma capsulatum</italic> and <italic toggle="yes">C. immitis</italic> (<xref rid="B210" ref-type="bibr">210</xref>, <xref rid="B211" ref-type="bibr">211</xref>). Furthermore, IFN&#947; promotes rapid acidification of phagolysosomes in macrophages (<xref rid="B212" ref-type="bibr">212</xref>), upregulation of MHC-II molecules, and antigen presentation by APCs to elicit T-cell immunity (<xref rid="B213" ref-type="bibr">213</xref>). GM-CSF enhances macrophage ROS production and limits intracellular yeast growth by sequestration of zinc (<xref rid="B214" ref-type="bibr">214</xref>). GM-CSF deficiency impairs the production of TNF&#945; and IFN&#947; (<xref rid="B215" ref-type="bibr">215</xref>), which are important for the control of intracellular fungal infections. Similarly, TNF&#945; signaling enhances the activation, phagocytosis, and ROS-producing ability of innate immune cells for antifungal functions. Interestingly, early TNF&#945; expression during <italic toggle="yes">C. neoformans</italic> infection increased the fungal burden, reduced mature dendritic cells, and increased Th2 responses (<xref rid="B216" ref-type="bibr">216</xref>). TNF&#945; was needed for the maturation and recruitment of DC and the production of IL-12 and IFN&#947;. However, TNF&#945; prevented biofilm development by <italic toggle="yes">C. albicans</italic> (<xref rid="B217" ref-type="bibr">217</xref>), and TNF blockade can enhance opportunistic infections.</p><p>Cytotoxic functions of T cells are well documented for CD8<sup>+</sup> T cells. Antifungal CD8<sup>+</sup> T cells deploy several antimicrobial granules (mainly granulysin and granzyme K) (<xref rid="B121" ref-type="bibr">121</xref>) for direct cytotoxic activity against the fungal pathogen or fungus-infected cells (<xref rid="B218" ref-type="bibr">218</xref>, <xref rid="B219" ref-type="bibr">219</xref>). Granzymes can mediate cell death by induction of active caspases, generation of ROS, and mitochondrial damage, while perforin may facilitate their release from the endosomes (<xref rid="B220" ref-type="bibr">220</xref>). Although this review focuses on T cells and their memory, antifungal NK cell development is not well documented. NK cells, like CD8<sup>+</sup> T cells, can produce cytotoxic molecules to kill fungi. The binding of NK cell receptors NKp46 and NCR1 to surface glycans of <italic toggle="yes">Candida</italic> led to degranulation and death of the yeast (<xref rid="B221" ref-type="bibr">221</xref>). Similar observations were made with human NK activating receptor NKp30 for the direct killing of <italic toggle="yes">Cryptococcus</italic> and <italic toggle="yes">Candida</italic> (<xref rid="B222" ref-type="bibr">222</xref>). Interestingly, &#8220;cytotoxic&#8221; CD4<sup>+</sup> T cells can also produce granulysin to mediate the killing of <italic toggle="yes">C. neoformans</italic> (<xref rid="B223" ref-type="bibr">223</xref>), and this function was dysregulated in HIV-infected patients.</p></sec><sec id="s7"><title>CD4<sup>+</sup> T-cell help for antifungal CD8<sup>+</sup> T cells</title><p>Most fungal infections are caused by opportunistic fungal pathogens under compromised CD4<sup>+</sup> T cells or their functions. Unlike viral or bacterial models, effector and memory CD8<sup>+</sup> T-cell homeostasis in fungal infections is poorly understood, and the studies have been done using animal models of fungal vaccine immunity. Attempts have been made to understand the role of antifungal CD8<sup>+</sup> T cells in the absence of CD4<sup>+</sup> T cells, a potential avenue to exploit residual immunity for preventive and therapeutic purposes for individuals with CD4<sup>+</sup> T-cell lymphopenia. Because optimal programming leads to the generation of long-lasting memory CD8<sup>+</sup> T cells (<xref rid="B224" ref-type="bibr">224</xref>, <xref rid="B225" ref-type="bibr">225</xref>) and contributes to fungal vaccine immunity (<xref rid="B8" ref-type="bibr">8</xref>), we reason that a potent fungal vaccination can &#8220;license&#8221; dendritic cells for CD8<sup>+</sup> T-cell priming independent of CD4<sup>+</sup> T-cell help. Fungi are decorated, including some secretory, with several potential PAMPs that can bolster the dendritic cell activation and functions (<xref rid="B226" ref-type="bibr">226</xref>&#8211;<xref rid="B228" ref-type="bibr">228</xref>). Therefore, the CD8<sup>+</sup> T-cell memory imprinting and memory homeostasis following fungal vaccination can be independent of CD4<sup>+</sup> T-cell help (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B169" ref-type="bibr">169</xref>). However, evidence from viral and bacterial infections suggests that CD4<sup>+</sup> T-cell help is essential for eliciting CD8<sup>+</sup> T-cell responses (<xref rid="B229" ref-type="bibr">229</xref>). The mechanisms of CD4<sup>+</sup> T cells help CD8<sup>+</sup> T cells involve optimal activation of dendritic cells, enhancement of their phagocytosis, potentiation of antigen processing and presentation, upregulation of costimulatory ligands, and generation of an apt inflammatory <italic toggle="yes">micro milieu</italic> by dendritic cells for na&#239;ve CD8<sup>+</sup> T-cell priming and programming (<xref rid="B230" ref-type="bibr">230</xref>, <xref rid="B231" ref-type="bibr">231</xref>). The direct mechanisms of CD4<sup>+</sup> T cells help involve providing IL-2 for the proliferation of differentiating CD8<sup>+</sup> T cells and lending co-stimulation through CD40L-CD40 (<xref rid="B7" ref-type="bibr">7</xref>). Further, CD4<sup>+</sup> T cells may help recruit memory CD8<sup>+</sup> T cells into mucosal surfaces (<xref rid="B232" ref-type="bibr">232</xref>). Well-primed CD8<sup>+</sup> T cells can produce IL-2 (<xref rid="B169" ref-type="bibr">169</xref>) and get help in an autocrine manner (<xref rid="B233" ref-type="bibr">233</xref>). We also found chemokine receptor-mediated recruitment of effector CD8<sup>+</sup> T cells into the lungs, which was independent of CD4<sup>+</sup> T cells following pulmonary challenge in a mouse model of vaccine immunity to pulmonary blastomycosis (<xref rid="B90" ref-type="bibr">90</xref>). Recent evidence suggests that the requirement of help from CD4<sup>+</sup> T cells to CD8<sup>+</sup> T cells largely depends on their distinct interactions with the dendritic cells during their activation (<xref rid="B230" ref-type="bibr">230</xref>, <xref rid="B234" ref-type="bibr">234</xref>). Thus, well-programmed CD8<sup>+</sup> T cells, endowed with intrinsic memory capacity, can independently bestow their recall responses and immunity (<xref rid="B235" ref-type="bibr">235</xref>, <xref rid="B236" ref-type="bibr">236</xref>). Further studies are needed to understand the fungal antigens and the role of dendritic cells in CD8<sup>+</sup> T-cell priming.</p></sec><sec id="s8"><title>Memory T cells: An overview</title><p>The development of immunological memory is the hallmark of vaccination. Following infection or vaccination, the first responders, innate immune cells, exert broadly specific immunity to limit pathogen growth and initiate adaptive T-cell immunity. T-cell recognition is highly antigen-specific and binds to processed antigens/epitopes loaded onto MHC molecules, resulting in their activation, differentiation, and proliferation during the first phase of T-cell response, which is the expansion phase (<xref rid="B237" ref-type="bibr">237</xref>). In the ensuing contraction phase, mostly coinciding with the elimination of pathogen or antigen, ~90%&#8211;95% of effector T cells [short-lived effector cells (SLECs)] undergo attrition by apoptosis, and the remaining 5%&#8211;10% of cells [memory precursor effector cells (MPECs)] differentiate to become long-lived, quickly and robustly responding, memory cells (<xref rid="B238" ref-type="bibr">238</xref>) in the memory phase (<xref rid="f1" ref-type="fig">
<bold>Figure 1</bold>
</xref>). The central paradigm of vaccination is to generate qualitatively superior threshold numbers of memory T cells (<xref rid="B237" ref-type="bibr">237</xref>, <xref rid="B239" ref-type="bibr">239</xref>, <xref rid="B240" ref-type="bibr">240</xref>).</p><fig position="float" id="f1" orientation="portrait"><label>Figure&#160;1</label><caption><p>Differentiation and generation of memory T-cell subsets. Following recognition of fungal PAMPs by PRRs, activated antigen-presenting cells (APCs) process the antigen from phagocytosed fungus to load onto MHC molecule. MHC&#8211;peptide complex is recognized by cognate TCR of na&#239;ve T cells leading to TCR signaling, activation, and differentiation of T cells into different subsets directed by different cytokine milieus. The differentiated T cells accompanied by proliferation during expansion phase secrete inflammatory cytokines to aid in fungal killing. Fungal clearance usually coincides with initiation of T-cell contraction phase where 90% of effector cells die by apoptosis. The remaining cells differentiate to become long-lived memory cells. Memory T cells express unique phenotypic attributes and transcription factors, some of which dictate homing to lymphoid organs (CCR7/CD62L). Tissue-resident memory T cells (T<sub>RM</sub>) continue to reside in tissue of responses. The effector memory T cells (T<sub>EM</sub>) continue to invigilate the pathogen by recirculation between peripheral tissues and blood. Self-renewing central memory (T<sub>CM</sub>) and central memory stem T cells (T<sub>SCM</sub>) are preferentially home to secondary lymphoid organs and serve as &#8220;seeders&#8221; of secondary effector and memory T cells when needed. PAMPs, pathogen-associated molecular patterns; PRR, pattern recognition receptors; Th, helper T cell; Tc, cytotoxic T cell (CD8<sup>+</sup> T cell); T<sub>SCM</sub>, stem memory T cells; T<sub>CM</sub>, central memory T cell; T<sub>EM</sub>, effector memory T cell.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-13-905867-g001.jpg"/></fig><p>Memory T cells are unique and often behave like stem cells in their homeostasis and longevity. Many models of memory T-cell generation are proposed, and one of them suggests that memory programming or imprinting can happen as early as the first antigen encounter (<xref rid="B241" ref-type="bibr">241</xref>, <xref rid="B242" ref-type="bibr">242</xref>). Others suggested dynamic and progressive imprinting of memory from a subset of effector cells. In the absence of cognate antigen, memory T cells are quiescent and slow dividing and share many features with na&#239;ve T cells (<xref rid="B243" ref-type="bibr">243</xref>, <xref rid="B244" ref-type="bibr">244</xref>). However, they are uniquely programmed for stem cell potential and balanced cell apoptosis and proliferation for their steady homeostasis (<xref rid="B240" ref-type="bibr">240</xref>, <xref rid="B245" ref-type="bibr">245</xref>), chiefly controlled by cytokines IL-7 and IL-15 (<xref rid="B246" ref-type="bibr">246</xref>). Na&#239;ve, effector, and memory T cells are differentiated based on their expression of surface and intracellular markers (<xref rid="B241" ref-type="bibr">241</xref>, <xref rid="B247" ref-type="bibr">247</xref>&#8211;<xref rid="B249" ref-type="bibr">249</xref>), which endorse their homing and functional attributes. Memory T cells are a heterogeneous pool of cells derived from multiple clones and fates of polarization and differentiation based on the &#8220;one cell multiple fate theory&#8221; (<xref rid="B250" ref-type="bibr">250</xref>, <xref rid="B251" ref-type="bibr">251</xref>). Hence, these features are imprinted in memory T-cell heterogeneity in homeostatic turnover, effector function, location, and trafficking properties (<xref rid="B111" ref-type="bibr">111</xref>, <xref rid="B248" ref-type="bibr">248</xref>, <xref rid="B252" ref-type="bibr">252</xref>).</p><p>Classically, memory T cells were divided into two groups, T<sub>EM</sub> and T<sub>CM</sub>, based on their lymph node homing properties with distinct proliferative renewal and functional properties (<xref rid="B240" ref-type="bibr">240</xref>, <xref rid="B241" ref-type="bibr">241</xref>). With the advancement of our understanding and discovery of new markers, memory cells are classified into many groups in both humans and mice. Based on the markers, memory cells are broadly classified as central memory T (T<sub>CM</sub>), effector memory T (T<sub>EM</sub>), tissue-resident memory T (T<sub>RM</sub>), and stem cell memory T (T<sub>SCM</sub>) cells (<xref rid="B241" ref-type="bibr">241</xref>, <xref rid="B253" ref-type="bibr">253</xref>&#8211;<xref rid="B255" ref-type="bibr">255</xref>). Effector memory T cells (T<sub>EM</sub>), CD45RA<sup>&#8722;</sup>CD127<sup>+</sup>CD122<sup>+</sup>CD27<sup>&#8722;/+</sup>CD62L<sup>&#8722;</sup>/CCR7<sup>&#8722;</sup>, can migrate into peripheral tissues and exhibit immediate higher effector function with limited proliferation potential during the reinfection. T<sub>CM</sub> cells, CD45RA<sup>&#8722;</sup>CD127<sup>+</sup>CD122<sup>+</sup>CD27<sup>+</sup>CD62L<sup>+</sup>/CCR7<sup>+</sup>, are housed in secondary lymphoid organs with high proliferative potential but weaker effector properties as compared to T<sub>EM</sub> cells (<xref rid="B255" ref-type="bibr">255</xref>, <xref rid="B256" ref-type="bibr">256</xref>). The dogma is that T<sub>CM</sub> cells are reservoirs or seeders of T<sub>EM</sub> cells in need. The property of CD62L<sup>lo</sup>/CCR7<sup>lo</sup> defines the T<sub>EM</sub> cell exclusion from lymph nodes and migration to peripheral tissues to rapidly exude effector molecules upon antigen encounter. In contrast, T<sub>CM</sub> cells are CD62L<sup>hi</sup>/CCR7<sup>hi</sup>, allowing them to be preferentially home to lymph nodes (<xref rid="B257" ref-type="bibr">257</xref>). Both types of memory cells endow memory homeostasis properties where T<sub>CM</sub> mediates secondary immune responses for long-term protection and T<sub>EM</sub> offers instant protection (<xref rid="B258" ref-type="bibr">258</xref>). Nevertheless, as alluded earlier, the homeostatic proliferative potential of T<sub>EM</sub> and T<sub>CM</sub> cells varies (<xref rid="B259" ref-type="bibr">259</xref>).</p><p>A newly emerging T-cell memory subset, tissue-resident memory (T<sub>RM</sub>), is restricted to a particular tissue and is identified based on the expression of CD103<sup>+/&#8722;</sup>, CD49a, and CD69 (<xref rid="B260" ref-type="bibr">260</xref>). The main feature of T<sub>RM</sub> is their restriction to the tissue (<xref rid="B261" ref-type="bibr">261</xref>), possibly due to the expression of CD69 that suppresses the S1P receptor function for lymph node homing (<xref rid="B262" ref-type="bibr">262</xref>). Further, TGF&#946; signaling in these T cells augments the CD103 expression that facilitates latching onto epithelial cells (<xref rid="B263" ref-type="bibr">263</xref>, <xref rid="B264" ref-type="bibr">264</xref>). Given the strategic position, T<sub>RM</sub> cells offer immediate local tissue immunity against invading pathogens (<xref rid="B265" ref-type="bibr">265</xref>).</p><p>The memory stem T cell (T<sub>SCM</sub>) subset, unique and often considered closest to na&#239;ve T cells, exhibits stem cell-like properties with higher self-renewal capacity. Unlike conventional memory T-cell subsets, the T<sub>SCM</sub> subset maintains a na&#239;ve cell phenotype with <italic toggle="yes">multipotency</italic> and serves as a reservoir of memory T cells for a lifetime (<xref rid="B266" ref-type="bibr">266</xref>, <xref rid="B267" ref-type="bibr">267</xref>). However, the identity of such unique memory T cells that are fungal-specific is lacking despite the description of antifungal memory cells in humans (<xref rid="B111" ref-type="bibr">111</xref>). Further studies are required to reveal the existence of antifungal T<sub>SCM</sub> in mice and humans.</p><p>With our understanding of memory T-cell differentiation and function, the memory cells can be classified in many ways, may depend on the infection or model system, and may be largely due to graded responses during the early programming of effector cells (<xref rid="B254" ref-type="bibr">254</xref>, <xref rid="B268" ref-type="bibr">268</xref>&#8211;<xref rid="B270" ref-type="bibr">270</xref>). Unlike an acute viral infection, in chronic viral infection, the central memory phenotypic T cells poorly develop (<xref rid="B271" ref-type="bibr">271</xref>), and high antigen levels induce an exhausted phenotype (<xref rid="B272" ref-type="bibr">272</xref>). It should be noted that antifungal memory T-cell homeostasis is poorly defined and not well understood.</p></sec><sec id="s9"><title>Factors influencing generation of antifungal memory T cells</title><p>Our understanding of memory T-cell generation suggests that their attributes are bestowed by early programming during the expansion phase. However, the inflammatory milieu and the antigen persistence can affect their fate. The graded imprinting and epigenetic changes during the effector phase determine the memory T cell fate and the type. Na&#239;ve T cells must recognize cognate antigens portrayed on MHC molecules (Signal 1) of dendritic cells. Studies have shown that degree of antigen recognition by na&#239;ve or effector cells and antigen persistence (chronic and persistent infections) has a greater impact (<xref rid="B273" ref-type="bibr">273</xref>&#8211;<xref rid="B275" ref-type="bibr">275</xref>). However, this feature can be valuable during vaccine formulations where the antigen is delivered to the site of T-cell activation gradually to enhance the magnitude of their differentiation and expansion. Not surprisingly, booster doses are often given to augment adaptive immune responses, especially with subunit or inactivated vaccines. The costimulatory signal/s (Signal 2) is essential to break the TCR signaling threshold or tolerance to activate the T cells. The role of the classical costimulatory molecule, CD28, in recognizing B7 ligands on antigen-presenting cells is well defined, including during fungal vaccine immunity (<xref rid="B276" ref-type="bibr">276</xref>). However, other costimulatory molecules may influence memory T cells&#8217; qualitative and quantitative traits (<xref rid="B277" ref-type="bibr">277</xref>), including fungal immunity (<xref rid="B278" ref-type="bibr">278</xref>&#8211;<xref rid="B282" ref-type="bibr">282</xref>). Interestingly, CD28 may play a negative role in Th17 subset differentiation (<xref rid="B283" ref-type="bibr">283</xref>), but in the absence of CD28, the differentiation required proinflammatory cytokine signaling (<xref rid="B284" ref-type="bibr">284</xref>). Nevertheless, for subunit or less potent vaccine antigen formulations, engaging multiple costimulatory molecules may help potentiate the T-cell responses and eventual memory formation (<xref rid="B167" ref-type="bibr">167</xref>, <xref rid="B226" ref-type="bibr">226</xref>). The inflammatory milieu generated by proinflammatory cytokines (Signal 3) is instrumental for effector T-cell differentiation and memory feature imprinting (<xref rid="B285" ref-type="bibr">285</xref>). Immunity to different fungal infections needs distinct cytokines produced by T-cell subsets (<xref rid="B4" ref-type="bibr">4</xref>), and the deviation from protective T-cell subsets may lead to enhanced pathology and disseminated infections (<xref rid="B286" ref-type="bibr">286</xref>&#8211;<xref rid="B289" ref-type="bibr">289</xref>). Immunity to different fungal pathogens predominantly requires either T cell-derived type I cytokines (IFN&#947;, GM-CSF, and TNF&#945;) or type 17 (IL-17A/F) responses (<xref rid="B80" ref-type="bibr">80</xref>, <xref rid="B290" ref-type="bibr">290</xref>) mainly at systemic and mucosal surfaces, respectively. Nevertheless, following fungal vaccination or infections, both types of subsets are induced at different magnitudes and found to contribute to immunity at variable degrees (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B168" ref-type="bibr">168</xref>, <xref rid="B291" ref-type="bibr">291</xref>&#8211;<xref rid="B294" ref-type="bibr">294</xref>). Future studies are necessary to understand the elements of memory T-cell differentiation, homeostasis, and their recall responses for immunity following infection or vaccination.</p></sec><sec id="s10"><title>Co-stimulatory and coinhibitory molecules influencing antifungal potential memory T cells</title><p>Co-stimulatory and coinhibitory receptor molecules present in T cells can fine-tune immune responses to fungal vaccines and infections. While co-stimulation leads to the potentiation of cell signaling, inhibitory signals deliver opposite effects during T-cell activation, thus inhibiting T-cell responses (<xref rid="B295" ref-type="bibr">295</xref>). Similarly, coinhibitory receptors present on memory T cells restrict recall responses but preserve memory cells by inhibiting terminal differentiation (<xref rid="B296" ref-type="bibr">296</xref>). Interestingly, the expression of coinhibitory molecules on resident memory CD8<sup>+</sup> T cells (Trm) is an intrinsic property present in their core gene signature (<xref rid="B297" ref-type="bibr">297</xref>, <xref rid="B298" ref-type="bibr">298</xref>). Compared to circulatory memory T cells, resident memory T cells expressing high amounts of coinhibitory receptors (2B4, CTLA-4, LAG3, PD-1, and Tim-3) were able to undergo local proliferation following secondary rechallenge (<xref rid="B299" ref-type="bibr">299</xref>). Here, we highlight a few studies where the co-stimulatory or inhibitory molecules modulate antifungal T-cell responses.</p><p>PD-1 is a coinhibitory molecule expressed in T cells associated with dysfunction, and blocking PD-1 enhances the T-cell functions. Hence, anti-PD-1 mAb administration improved the fungal clearance in a model of persistent cryptococcosis (<xref rid="B297" ref-type="bibr">297</xref>). Interestingly, the effect was independent of effector cell numbers and myeloid cell activation, but reduced expression of IL-5 and IL-10 by lung leukocytes and enhanced sustained expression of OX40, a costimulatory molecule, on T cells. Similarly, the blockade of PD-1 and CTLA-4 improves survival during primary and secondary fungal sepsis (<xref rid="B300" ref-type="bibr">300</xref>) associated with improved T-cell functions. Signaling lymphocyte activation molecule (SLAM) family members act as co-receptors for T cells fine-tuning immune homeostasis during infections (<xref rid="B301" ref-type="bibr">301</xref>). Mutation in SLAM-associated protein (SAP), required for SLAM signaling, results in X-linked lymphoproliferative disease (XLP). A recent study showed that SLAMF1, a member of the SLAM family, was dispensable for T-cell activation and expansion following fungal vaccination, but the fungal immunity was severely compromised (<xref rid="B302" ref-type="bibr">302</xref>). This study of vaccine immunity against lethal fungal pneumonia implied that SLAMF1 is mainly important for innate host control of lung fungal overgrowth as well as inflammation, recruitment, or expansion of fungal-specific effector CD4<sup>+</sup> T cells. Another molecule, CD43, also called sialophorin, is a membrane-bound receptor that exists in two forms with one highly glycosylated on T cells (<xref rid="B303" ref-type="bibr">303</xref>, <xref rid="B304" ref-type="bibr">304</xref>). CD43 can be co-stimulatory and inhibitory, and depending on the context, it is known to promote T-cell contraction and reduced memory (<xref rid="B305" ref-type="bibr">305</xref>). In the context of cell-to-cell interactions, studies showed that CD43 deficiency led to enhanced homotypic binding of T cells through ligands such as ICAM-1 and fibronectin while augmenting the T-cell proliferation (<xref rid="B306" ref-type="bibr">306</xref>, <xref rid="B307" ref-type="bibr">307</xref>). In other studies, pre-activation of CD43 with a mAb reduced the TCR signaling threshold, enhanced the degradation of Cbl, prolonged the TCR signaling, and augmented the T-cell response (<xref rid="B308" ref-type="bibr">308</xref>). Our recent study showed the indispensable role of CD43 for Tc17 responses and vaccine immunity to pulmonary fungal infection (<xref rid="B309" ref-type="bibr">309</xref>).</p><p>T cells typically express one or more co-stimulatory receptors. Thus, understanding the role of their signaling helps design vaccines to bolster qualitatively superior antifungal memory T cells and potentiate their functions for immunotherapeutics. Further, formulations of vaccines for fungal infections should account for the type of T-cell responses desired. Nevertheless, additional studies are warranted to delineate the role of co-stimulatory molecules during fungal infections. Adjuvants in vaccines act to enhance the T-cell stimulatory signals and proinflammatory cytokine production that polarize the T-cell responses (<xref rid="B310" ref-type="bibr">310</xref>). Different adjuvants have different characteristics in biasing T-cell response/s. For example, Alum potentiates Th2 responses, while Monophosphoryl lipid A (MPL)/CpG1018 bolsters Th1 responses. For controlling some fungal infections, especially those that are dependent on IL-17 responses, novel adjuvants are necessary.</p></sec><sec sec-type="conclusions" id="s11"><title>Conclusions and future directions</title><p>Immunological memory of fungal infections is poorly defined, but their existence and longevity are documented in preclinical and clinical studies. Most studies on T-cell memory came from preclinical model systems of fungal vaccine immunity. It is increasingly evident that T cells play a dominant role in fungal immunity, although other immune elements, including B cells and antibodies, cannot be overlooked. Although the innate cell inflammatory <italic toggle="yes">micro milieu</italic> is key for defining T-cell lineages and their functions for fungal immunity, the direct costimulatory signals or blockade of inhibitory signals delivered to T cells can regulate their effectors and memory cells. Non-canonical T cells such as natural T helper, MAIT, and NKT cell&#8217;s role in some fungal infections have been documented, but their persistence as memory cells is not clear (<xref rid="B32" ref-type="bibr">32</xref>). Harnessing non-canonical T cells for vaccine immunity can be a new avenue for controlling fungal infections.</p><p>The mechanisms of the generation of antifungal memory T cells are not well understood and need in-depth investigations. The studies will be particularly relevant for the development and application of vaccine platforms. As with many different bacterial and viral defense mechanisms, the protective T-cell effectors vary depending on the pathogenic fungi, so the memory T-cell development mechanisms. Further, fungal co-infections and the disease outcomes need thorough studies, such as mucormycosis in COVID-19 patients. Novel findings on the use of fungal PAMPs as adjuvants for vaccines call for an understanding of adjuvanticity properties and their role in the programming of immunological memory. The new concept-based emergence of chimeric antigen receptor T (CAR-T) cells for immunotherapy to treat fungal infections is attractive, and its efficiency or utility needs attention. The plasticity of antifungal T cells has not been clearly understood, and its bases for immunopathology during recall responses and immunity need further evaluation. Further, the identification of phenotypic and functional markers of protective immunological memory T cells would be useful in designing and assessing the potency and efficacy of fungal vaccines.</p></sec><sec sec-type="author-contributions" id="s12"><title>Author contributions</title><p>JS, SM, and SN conceived, wrote, and edited the manuscript. All authors contributed to the article and approved the submitted version.</p></sec><sec sec-type="funding-information" id="s13"><title>Funding</title><p>This study was funded by NIAID-NIH 5R01AI153522 (SN).</p></sec><sec sec-type="acknowledgment" id="s14"><title>Acknowledgment</title><p>Wee used biorender 2022 for genereation of a figure.</p></sec><sec sec-type="COI-statement" id="s15"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="s16"><title>Publisher&#8217;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec></body><back><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>GD</given-names></name><name name-style="western"><surname>Denning</surname><given-names>DW</given-names></name><name name-style="western"><surname>Gow</surname><given-names>N</given-names></name><name name-style="western"><surname>Levitz</surname><given-names>SM</given-names></name><name name-style="western"><surname>Netea</surname><given-names>MG</given-names></name><name name-style="western"><surname>White</surname><given-names>TC</given-names></name></person-group>. <article-title>Hidden killers: Human fungal infections</article-title>. <source>Sci Transl Med</source> (<year>2012</year>) <volume>4</volume>:<fpage>165rv113</fpage>&#8211;<lpage>165rv113</lpage>. doi: <pub-id pub-id-type="doi">10.1126/scitranslmed.3004404</pub-id><pub-id pub-id-type="pmid">23253612</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bongomin</surname><given-names>F</given-names></name><name name-style="western"><surname>Gago</surname><given-names>S</given-names></name><name name-style="western"><surname>Oladele</surname><given-names>RO</given-names></name><name name-style="western"><surname>Denning</surname><given-names>DW</given-names></name></person-group>. <article-title>Global and multi-national prevalence of fungal diseases-estimate precision</article-title>. <source>J Fungi (Basel)</source> (<year>2017</year>) <volume>3</volume>(<issue>4</issue>):<page-range>57</page-range>. doi: <pub-id pub-id-type="doi">10.3390/jof3040057</pub-id><pub-id pub-id-type="pmcid">PMC5753159</pub-id><pub-id pub-id-type="pmid">29371573</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kainz</surname><given-names>K</given-names></name><name name-style="western"><surname>Bauer</surname><given-names>MA</given-names></name><name name-style="western"><surname>Madeo</surname><given-names>F</given-names></name><name name-style="western"><surname>Carmona-Gutierrez</surname><given-names>D</given-names></name></person-group>. <article-title>Fungal infections in humans: the silent crisis</article-title>. <source>Microb Cell</source> (<year>2020</year>) <volume>7</volume>:<page-range>143&#8211;5</page-range>. doi: <pub-id pub-id-type="doi">10.15698/mic2020.06.718</pub-id><pub-id pub-id-type="pmcid">PMC7278517</pub-id><pub-id pub-id-type="pmid">32548176</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verma</surname><given-names>A</given-names></name><name name-style="western"><surname>Wuthrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Deepe</surname><given-names>G</given-names></name><name name-style="western"><surname>Klein</surname><given-names>B</given-names></name></person-group>. <article-title>Adaptive immunity to fungi</article-title>. <source>Cold Spring Harb Perspect Med</source> (<year>2014</year>) <volume>5</volume>:<fpage>a019612</fpage>. doi: <pub-id pub-id-type="doi">10.1101/cshperspect.a019612</pub-id>.<pub-id pub-id-type="pmid">25377140</pub-id><pub-id pub-id-type="pmcid">PMC4355251</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wuthrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Deepe</surname><given-names>GS</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Klein</surname><given-names>B</given-names></name></person-group>. <article-title>Adaptive immunity to fungi</article-title>. <source>Annu Rev Immunol</source> (<year>2012</year>) <volume>30</volume>:<page-range>115&#8211;48</page-range>. doi: <pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-074958</pub-id><pub-id pub-id-type="pmcid">PMC3584681</pub-id><pub-id pub-id-type="pmid">22224780</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lionakis</surname><given-names>MS</given-names></name><name name-style="western"><surname>Netea</surname><given-names>MG</given-names></name><name name-style="western"><surname>Holland</surname><given-names>SM</given-names></name></person-group>. <article-title>Mendelian genetics of human susceptibility to fungal infection</article-title>. <source>Cold Spring Harb Perspect Med</source> (<year>2014</year>) <volume>4</volume>(<issue>6</issue>):<elocation-id>a019638</elocation-id>. doi: <pub-id pub-id-type="doi">10.1101/cshperspect.a019638</pub-id>.<pub-id pub-id-type="pmid">24890837</pub-id><pub-id pub-id-type="pmcid">PMC4031953</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Castellino</surname><given-names>F</given-names></name><name name-style="western"><surname>Germain</surname><given-names>RN</given-names></name></person-group>. <article-title>Cooperation between CD4+ and CD8+ T cells: When, where, and how</article-title>. <source>Annu Rev Immunol</source> (<year>2006</year>) <volume>24</volume>:<page-range>519&#8211;40</page-range>. doi: <pub-id pub-id-type="doi">10.1146/annurev.immunol.23.021704.115825</pub-id><pub-id pub-id-type="pmid">16551258</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nanjappa</surname><given-names>SG</given-names></name><name name-style="western"><surname>Klein</surname><given-names>BS</given-names></name></person-group>. <article-title>Vaccine immunity against fungal infections</article-title>. <source>Curr Opin Immunol</source> (<year>2014</year>) <volume>28</volume>:<fpage>27</fpage>&#8211;<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.coi.2014.01.014</pub-id><pub-id pub-id-type="pmid">24583636</pub-id><pub-id pub-id-type="pmcid">PMC4037332</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Conti</surname><given-names>HR</given-names></name><name name-style="western"><surname>Gaffen</surname><given-names>SL</given-names></name></person-group>. <article-title>IL-17-Mediated immunity to the opportunistic fungal pathogen candida albicans</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>195</volume>:<page-range>780&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1500909</pub-id><pub-id pub-id-type="pmcid">PMC4507294</pub-id><pub-id pub-id-type="pmid">26188072</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lionakis</surname><given-names>MS</given-names></name><name name-style="western"><surname>Iliev</surname><given-names>ID</given-names></name><name name-style="western"><surname>Hohl</surname><given-names>TM</given-names></name></person-group>. <article-title>Immunity against fungi</article-title>. <source>JCI Insight</source> (<year>2017</year>) <volume>2</volume>(<issue>11</issue>):<elocation-id>e93156</elocation-id>. doi: <pub-id pub-id-type="doi">10.1172/jci.insight.93156</pub-id><pub-id pub-id-type="pmcid">PMC5453709</pub-id><pub-id pub-id-type="pmid">28570272</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van De Veerdonk</surname><given-names>FL</given-names></name><name name-style="western"><surname>Netea</surname><given-names>MG</given-names></name></person-group>. <article-title>T-Cell subsets and antifungal host defenses</article-title>. <source>Curr Fungal Infect Rep</source> (<year>2010</year>) <volume>4</volume>:<page-range>238&#8211;43</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s12281-010-0034-6</pub-id><pub-id pub-id-type="pmcid">PMC2949562</pub-id><pub-id pub-id-type="pmid">20976286</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bacher</surname><given-names>P</given-names></name><name name-style="western"><surname>Kniemeyer</surname><given-names>O</given-names></name><name name-style="western"><surname>Schonbrunn</surname><given-names>A</given-names></name><name name-style="western"><surname>Sawitzki</surname><given-names>B</given-names></name><name name-style="western"><surname>Assenmacher</surname><given-names>M</given-names></name><name name-style="western"><surname>Rietschel</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Antigen-specific expansion of human regulatory T cells as a major tolerance mechanism against mucosal fungi</article-title>. <source>Mucosal Immunol</source> (<year>2014</year>) <volume>7</volume>:<page-range>916&#8211;28</page-range>. doi: <pub-id pub-id-type="doi">10.1038/mi.2013.107</pub-id><pub-id pub-id-type="pmid">24301658</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mcallister</surname><given-names>F</given-names></name><name name-style="western"><surname>Steele</surname><given-names>C</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>M</given-names></name><name name-style="western"><surname>Young</surname><given-names>E</given-names></name><name name-style="western"><surname>Shellito</surname><given-names>JE</given-names></name><name name-style="western"><surname>Marrero</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>T Cytotoxic-1 CD8+ T cells are effector cells against pneumocystis in mice</article-title>. <source>J Immunol</source> (<year>2004</year>) <volume>172</volume>:<page-range>1132&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.172.2.1132</pub-id><pub-id pub-id-type="pmid">14707088</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>JS</given-names></name><name name-style="western"><surname>Yang</surname><given-names>CW</given-names></name><name name-style="western"><surname>Wang</surname><given-names>DW</given-names></name><name name-style="western"><surname>Wu-Hsieh</surname><given-names>BA</given-names></name></person-group>. <article-title>Dendritic cells cross-present exogenous fungal antigens to stimulate a protective CD8 T cell response in infection by histoplasma capsulatum</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>174</volume>:<page-range>6282&#8211;91</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.174.10.6282</pub-id><pub-id pub-id-type="pmid">15879127</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindell</surname><given-names>DM</given-names></name><name name-style="western"><surname>Moore</surname><given-names>TA</given-names></name><name name-style="western"><surname>Mcdonald</surname><given-names>RA</given-names></name><name name-style="western"><surname>Toews</surname><given-names>GB</given-names></name><name name-style="western"><surname>Huffnagle</surname><given-names>GB</given-names></name></person-group>. <article-title>Generation of antifungal effector CD8+ T cells in the absence of CD4+ T cells during cryptococcus neoformans infection</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>174</volume>:<page-range>7920&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.174.12.7920</pub-id><pub-id pub-id-type="pmid">15944298</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nanjappa</surname><given-names>SG</given-names></name><name name-style="western"><surname>Mcdermott</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Fites</surname><given-names>JS</given-names></name><name name-style="western"><surname>Galles</surname><given-names>K</given-names></name><name name-style="western"><surname>Wuthrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Deepe</surname><given-names>GS</given-names><suffix>Jr.</suffix></name><etal/></person-group>. <article-title>Antifungal Tc17 cells are durable and stable, persisting as long-lasting vaccine memory without plasticity towards IFNgamma cells</article-title>. <source>PloS Pathog</source> (<year>2017</year>) <volume>13</volume>:<fpage>e1006356</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1006356</pub-id><pub-id pub-id-type="pmid">28542595</pub-id><pub-id pub-id-type="pmcid">PMC5456400</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mok</surname><given-names>AC</given-names></name><name name-style="western"><surname>Mody</surname><given-names>CH</given-names></name><name name-style="western"><surname>Li</surname><given-names>SS</given-names></name></person-group>. <article-title>Immune cell degranulation in fungal host defence</article-title>. <source>J Fungi</source> (<year>2021</year>) <volume>7</volume>:<fpage>484</fpage>. doi: <pub-id pub-id-type="doi">10.3390/jof7060484</pub-id><pub-id pub-id-type="pmcid">PMC8234259</pub-id><pub-id pub-id-type="pmid">34208679</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cutler</surname><given-names>JE</given-names></name><name name-style="western"><surname>Deepe</surname><given-names>GS</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Klein</surname><given-names>BS</given-names></name></person-group>. <article-title>Advances in combating fungal diseases: Vaccines on the threshold</article-title>. <source>Nat Rev Microbiol</source> (<year>2007</year>) <volume>5</volume>:<fpage>13</fpage>&#8211;<lpage>28</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro1537</pub-id><pub-id pub-id-type="pmid">17160002</pub-id><pub-id pub-id-type="pmcid">PMC2214303</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jaeger</surname><given-names>M</given-names></name><name name-style="western"><surname>Stappers</surname><given-names>MH</given-names></name><name name-style="western"><surname>Joosten</surname><given-names>LA</given-names></name><name name-style="western"><surname>Gyssens</surname><given-names>IC</given-names></name><name name-style="western"><surname>Netea</surname><given-names>MG</given-names></name></person-group>. <article-title>Genetic variation in pattern recognition receptors: Functional consequences and susceptibility to infectious disease</article-title>. <source>Future Microbiol</source> (<year>2015</year>) <volume>10</volume>:<fpage>989</fpage>&#8211;<lpage>1008</lpage>. doi: <pub-id pub-id-type="doi">10.2217/fmb.15.37</pub-id><pub-id pub-id-type="pmid">26059622</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Merkhofer</surname><given-names>RM</given-names></name><name name-style="western"><surname>Klein</surname><given-names>BS</given-names></name></person-group>. <article-title>Advances in understanding human genetic variations that influence innate immunity to fungi</article-title>. <source>Front Cell Infect Microbiol</source> (<year>2020</year>) <volume>10</volume>:<elocation-id>69</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2020.00069</pub-id><pub-id pub-id-type="pmid">32185141</pub-id><pub-id pub-id-type="pmcid">PMC7058545</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naik</surname><given-names>B</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>SMQ</given-names></name><name name-style="western"><surname>Laha</surname><given-names>S</given-names></name><name name-style="western"><surname>Das</surname><given-names>SP</given-names></name></person-group>. <article-title>Genetic susceptibility to fungal infections and links to human ancestry</article-title>. <source>Front Genet</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>709315</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fgene.2021.709315</pub-id><pub-id pub-id-type="pmid">34490039</pub-id><pub-id pub-id-type="pmcid">PMC8417537</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verma</surname><given-names>A</given-names></name><name name-style="western"><surname>W&#252;thrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Deepe</surname><given-names>G</given-names></name><name name-style="western"><surname>Klein</surname><given-names>B</given-names></name></person-group>. <article-title>Adaptive immunity to fungi</article-title><source>Cold Spring Harb Perspect Med</source> (<year>2015</year>) <volume>5</volume>(<issue>3</issue>):<elocation-id>a019612</elocation-id>. doi: <pub-id pub-id-type="doi">10.1101/cshperspect.a019612</pub-id><pub-id pub-id-type="pmcid">PMC4355251</pub-id><pub-id pub-id-type="pmid">25377140</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banchereau</surname><given-names>J</given-names></name><name name-style="western"><surname>Steinman</surname><given-names>RM</given-names></name></person-group>. <article-title>Dendritic cells and the control of immunity</article-title>. <source>Nature</source> (<year>1998</year>) <volume>392</volume>:<page-range>245&#8211;52</page-range>. doi: <pub-id pub-id-type="doi">10.1038/32588</pub-id><pub-id pub-id-type="pmid">9521319</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steinman</surname><given-names>RM</given-names></name></person-group>. <article-title>Dendritic cells and the control of immunity: Enhancing the efficiency of antigen presentation</article-title>. <source>Mt Sinai J Med</source> (<year>2001</year>) <volume>68</volume>:<page-range>160&#8211;6</page-range>.<pub-id pub-id-type="pmid">11373688</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeuchi</surname><given-names>O</given-names></name><name name-style="western"><surname>Akira</surname><given-names>S</given-names></name></person-group>. <article-title>Pattern recognition receptors and inflammation</article-title>. <source>Cell</source> (<year>2010</year>) <volume>140</volume>:<page-range>805&#8211;20</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2010.01.022</pub-id><pub-id pub-id-type="pmid">20303872</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plato</surname><given-names>A</given-names></name><name name-style="western"><surname>Hardison</surname><given-names>SE</given-names></name><name name-style="western"><surname>Brown</surname><given-names>GD</given-names></name></person-group>. <article-title>Pattern recognition receptors in antifungal immunity</article-title>. <source>Semin Immunopathol</source> (<year>2015</year>) <volume>37</volume>:<fpage>97</fpage>&#8211;<lpage>106</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00281-014-0462-4</pub-id><pub-id pub-id-type="pmid">25420452</pub-id><pub-id pub-id-type="pmcid">PMC4326652</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patin</surname><given-names>EC</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>A</given-names></name><name name-style="western"><surname>Orr</surname><given-names>SJ</given-names></name></person-group>. <article-title>Pattern recognition receptors in fungal immunity</article-title>. <source>Semin Cell Dev Biol</source> (<year>2019</year>) <volume>89</volume>:<fpage>24</fpage>&#8211;<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.semcdb.2018.03.003</pub-id><pub-id pub-id-type="pmid">29522806</pub-id><pub-id pub-id-type="pmcid">PMC6461132</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>T</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>R</given-names></name></person-group>. <article-title>DAMP-sensing receptors in sterile inflammation and inflammatory diseases</article-title>. <source>Nat Rev Immunol</source> (<year>2020</year>) <volume>20</volume>:<fpage>95</fpage>&#8211;<lpage>112</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41577-019-0215-7</pub-id><pub-id pub-id-type="pmid">31558839</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>GD</given-names></name></person-group>. <article-title>Innate antifungal immunity: The key role of phagocytes</article-title>. <source>Annu Rev Immunol</source> (<year>2011</year>) <volume>29</volume>:<fpage>1</fpage>&#8211;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev-immunol-030409-101229</pub-id><pub-id pub-id-type="pmid">20936972</pub-id><pub-id pub-id-type="pmcid">PMC3434799</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lionakis</surname><given-names>MS</given-names></name><name name-style="western"><surname>Levitz</surname><given-names>SM</given-names></name></person-group>. <article-title>Host control of fungal infections: Lessons from basic studies and human cohorts</article-title>. <source>Annu Rev Immunol</source> (<year>2018</year>) <volume>36</volume>:<page-range>157&#8211;91</page-range>. doi: <pub-id pub-id-type="doi">10.1146/annurev-immunol-042617-053318</pub-id><pub-id pub-id-type="pmid">29237128</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salazar</surname><given-names>F</given-names></name><name name-style="western"><surname>Brown</surname><given-names>GD</given-names></name></person-group>. <article-title>Antifungal innate immunity: A perspective from the last 10 years</article-title>. <source>J Innate Immun</source> (<year>2018</year>) <volume>10</volume>:<page-range>373&#8211;97</page-range>. doi: <pub-id pub-id-type="doi">10.1159/000488539</pub-id><pub-id pub-id-type="pmcid">PMC6784043</pub-id><pub-id pub-id-type="pmid">29768268</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dunne</surname><given-names>MR</given-names></name><name name-style="western"><surname>Wagener</surname><given-names>J</given-names></name><name name-style="western"><surname>Loeffler</surname><given-names>J</given-names></name><name name-style="western"><surname>Doherty</surname><given-names>DG</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>TR</given-names></name></person-group>. <article-title>Unconventional T cells - new players in antifungal immunity</article-title>. <source>Clin Immunol</source> (<year>2021</year>) <volume>227</volume>:<fpage>108734</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clim.2021.108734</pub-id><pub-id pub-id-type="pmid">33895356</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steele</surname><given-names>C</given-names></name><name name-style="western"><surname>Rapaka</surname><given-names>RR</given-names></name><name name-style="western"><surname>Metz</surname><given-names>A</given-names></name><name name-style="western"><surname>Pop</surname><given-names>SM</given-names></name><name name-style="western"><surname>Williams</surname><given-names>DL</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>The beta-glucan receptor dectin-1 recognizes specific morphologies of aspergillus fumigatus</article-title>. <source>PloS Pathog</source> (<year>2005</year>) <volume>1</volume>:<page-range>0323&#8211;34</page-range>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.0010042</pub-id><pub-id pub-id-type="pmcid">PMC1311140</pub-id><pub-id pub-id-type="pmid">16344862</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Werner</surname><given-names>JL</given-names></name><name name-style="western"><surname>Metz</surname><given-names>AE</given-names></name><name name-style="western"><surname>Horn</surname><given-names>D</given-names></name><name name-style="western"><surname>Schoeb</surname><given-names>TR</given-names></name><name name-style="western"><surname>Hewitt</surname><given-names>MM</given-names></name><name name-style="western"><surname>Schwiebert</surname><given-names>LM</given-names></name><etal/></person-group>. <article-title>Requisite role for the dectin-1 &#946;-glucan receptor in pulmonary defense against aspergillus fumigatus</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>182</volume>:<page-range>4938&#8211;46</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.0804250</pub-id><pub-id pub-id-type="pmcid">PMC3434356</pub-id><pub-id pub-id-type="pmid">19342673</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Drummond</surname><given-names>RA</given-names></name><name name-style="western"><surname>Dambuza</surname><given-names>IM</given-names></name><name name-style="western"><surname>Vautier</surname><given-names>S</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>JA</given-names></name><name name-style="western"><surname>Reid</surname><given-names>DM</given-names></name><name name-style="western"><surname>Bain</surname><given-names>CC</given-names></name><etal/></person-group>. <article-title>CD4+ T-cell survival in the GI tract requires dectin-1 during fungal infection</article-title>. <source>Mucosal Immunol</source> (<year>2015</year>) <volume>9</volume>:<fpage>492</fpage>&#8211;<lpage>502</lpage>. doi: <pub-id pub-id-type="doi">10.1038/mi.2015.79</pub-id><pub-id pub-id-type="pmid">26349660</pub-id><pub-id pub-id-type="pmcid">PMC4677461</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marakalala</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Vautier</surname><given-names>S</given-names></name><name name-style="western"><surname>Potrykus</surname><given-names>J</given-names></name><name name-style="western"><surname>Walker</surname><given-names>LA</given-names></name><name name-style="western"><surname>Shepardson</surname><given-names>KM</given-names></name><name name-style="western"><surname>Hopke</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Differential adaptation of candida albicans <italic toggle="yes">in vivo</italic> modulates immune recognition by dectin-1</article-title>. <source>PloS Pathog</source> (<year>2013</year>) <volume>9</volume>:<fpage>e1003315</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1003315</pub-id><pub-id pub-id-type="pmid">23637604</pub-id><pub-id pub-id-type="pmcid">PMC3630191</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rappleye</surname><given-names>CA</given-names></name><name name-style="western"><surname>Eissenberg</surname><given-names>LG</given-names></name><name name-style="western"><surname>Goldman</surname><given-names>WE</given-names></name></person-group>. <article-title>Histoplasma capsulatum alpha-(1,3)-glucan blocks innate immune recognition by the beta-glucan receptor</article-title>. <source>Proc Natl Acad Sci U.S.A.</source> (<year>2007</year>) <volume>104</volume>:<page-range>1366&#8211;70</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0609848104</pub-id><pub-id pub-id-type="pmcid">PMC1783108</pub-id><pub-id pub-id-type="pmid">17227865</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davis</surname><given-names>SE</given-names></name><name name-style="western"><surname>Hopke</surname><given-names>A</given-names></name><name name-style="western"><surname>Minkin</surname><given-names>SC</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Montedonico</surname><given-names>AE</given-names></name><name name-style="western"><surname>Wheeler</surname><given-names>RT</given-names></name><name name-style="western"><surname>Reynolds</surname><given-names>TB</given-names></name></person-group>. <article-title>Masking of beta(1-3)-glucan in the cell wall of candida albicans from detection by innate immune cells depends on phosphatidylserine</article-title>. <source>Infect Immun</source> (<year>2014</year>) <volume>82</volume>:<page-range>4405&#8211;13</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.01612-14</pub-id><pub-id pub-id-type="pmcid">PMC4187869</pub-id><pub-id pub-id-type="pmid">25114110</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hopke</surname><given-names>A</given-names></name><name name-style="western"><surname>Brown</surname><given-names>AJP</given-names></name><name name-style="western"><surname>Hall</surname><given-names>RA</given-names></name><name name-style="western"><surname>Wheeler</surname><given-names>RT</given-names></name></person-group>. <article-title>Dynamic fungal cell wall architecture in stress adaptation and immune evasion</article-title>. <source>Trends Microbiol</source> (<year>2018</year>) <volume>26</volume>:<page-range>284&#8211;95</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.tim.2018.01.007</pub-id><pub-id pub-id-type="pmcid">PMC5869159</pub-id><pub-id pub-id-type="pmid">29452950</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>M</given-names></name><name name-style="western"><surname>Solis</surname><given-names>NV</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>M</given-names></name><name name-style="western"><surname>Garleb</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>T</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Control of beta-glucan exposure by the endo-1,3-glucanase Eng1 in candida albicans modulates virulence</article-title>. <source>PloS Pathog</source> (<year>2022</year>) <volume>18</volume>:<fpage>e1010192</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1010192</pub-id><pub-id pub-id-type="pmid">34995333</pub-id><pub-id pub-id-type="pmcid">PMC8775328</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakamura</surname><given-names>K</given-names></name><name name-style="western"><surname>Kinjo</surname><given-names>T</given-names></name><name name-style="western"><surname>Saijo</surname><given-names>S</given-names></name><name name-style="western"><surname>Miyazato</surname><given-names>A</given-names></name><name name-style="western"><surname>Adachi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ohno</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Dectin-1 is not required for the host defense to cryptococcus neoformans</article-title>. <source>Microbiol Immunol</source> (<year>2007</year>) <volume>51</volume>:<page-range>1115&#8211;9</page-range>. doi: <pub-id pub-id-type="doi">10.1111/j.1348-0421.2007.tb04007.x</pub-id><pub-id pub-id-type="pmid">18037789</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saijo</surname><given-names>S</given-names></name><name name-style="western"><surname>Fujikado</surname><given-names>N</given-names></name><name name-style="western"><surname>Furuta</surname><given-names>T</given-names></name><name name-style="western"><surname>Chung</surname><given-names>S-H</given-names></name><name name-style="western"><surname>Kotaki</surname><given-names>H</given-names></name><name name-style="western"><surname>Seki</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Dectin-1 is required for host defense against pneumocystis carinii but not against candida albicans</article-title>. <source>Nat Immunol</source> (<year>2007</year>) <volume>8</volume>:<fpage>39</fpage>&#8211;<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ni1425</pub-id><pub-id pub-id-type="pmid">17159982</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vautier</surname><given-names>S</given-names></name><name name-style="western"><surname>Drummond</surname><given-names>RA</given-names></name><name name-style="western"><surname>Redelinghuys</surname><given-names>P</given-names></name><name name-style="western"><surname>Murray</surname><given-names>GI</given-names></name><name name-style="western"><surname>Maccallum</surname><given-names>DM</given-names></name><name name-style="western"><surname>Brown</surname><given-names>GD</given-names></name></person-group>. <article-title>Dectin-1 is not required for controlling candida albicans colonization of the gastrointestinal tract</article-title>. <source>Infect Immun</source> (<year>2012</year>) <volume>80</volume>:<page-range>4216&#8211;22</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.00559-12</pub-id><pub-id pub-id-type="pmcid">PMC3497410</pub-id><pub-id pub-id-type="pmid">22988015</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Lebert</surname><given-names>V</given-names></name><name name-style="western"><surname>Hung</surname><given-names>CY</given-names></name><name name-style="western"><surname>Galles</surname><given-names>K</given-names></name><name name-style="western"><surname>Saijo</surname><given-names>S</given-names></name><name name-style="western"><surname>Lin</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>C-type lectin receptors differentially induce th17 cells and vaccine immunity to the endemic mycosis of north America</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>192</volume>:<page-range>1107&#8211;19</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1302314</pub-id><pub-id pub-id-type="pmcid">PMC3910401</pub-id><pub-id pub-id-type="pmid">24391211</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thompson</surname><given-names>A</given-names></name><name name-style="western"><surname>Da Fonseca</surname><given-names>DM</given-names></name><name name-style="western"><surname>Walker</surname><given-names>L</given-names></name><name name-style="western"><surname>Griffiths</surname><given-names>JS</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>PR</given-names></name><name name-style="western"><surname>Gow</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Dependence on mincle and dectin-2 varies with multiple candida species during systemic infection</article-title>. <source>Front Microbiol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>633229</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2021.633229</pub-id><pub-id pub-id-type="pmid">33717025</pub-id><pub-id pub-id-type="pmcid">PMC7951061</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sato</surname><given-names>K</given-names></name><name name-style="western"><surname>Yang</surname><given-names>XL</given-names></name><name name-style="western"><surname>Yudate</surname><given-names>T</given-names></name><name name-style="western"><surname>Chung</surname><given-names>JS</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Luby-Phelps</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Dectin-2 is a pattern recognition receptor for fungi that couples with the fc receptor gamma chain to induce innate immune responses</article-title>. <source>J Biol Chem</source> (<year>2006</year>) <volume>281</volume>:<page-range>38854&#8211;66</page-range>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M606542200</pub-id><pub-id pub-id-type="pmid">17050534</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graham</surname><given-names>LM</given-names></name><name name-style="western"><surname>Brown</surname><given-names>GD</given-names></name></person-group>. <article-title>The dectin-2 family of c-type lectins in immunity and homeostasis</article-title>. <source>Cytokine</source> (<year>2009</year>) <volume>48</volume>:<page-range>148&#8211;55</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.cyto.2009.07.010</pub-id><pub-id pub-id-type="pmcid">PMC2756403</pub-id><pub-id pub-id-type="pmid">19665392</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Lee</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Fites</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Merkhofer</surname><given-names>R</given-names></name><name name-style="western"><surname>Zarnowski</surname><given-names>R</given-names></name><name name-style="western"><surname>Brandhorst</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Ligation of dectin-2 with a novel microbial ligand promotes adjuvant activity for vaccination</article-title>. <source>PloS Pathog</source> (<year>2017</year>) <volume>13</volume>:<fpage>e1006568</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1006568</pub-id><pub-id pub-id-type="pmid">28793349</pub-id><pub-id pub-id-type="pmcid">PMC5565193</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loures</surname><given-names>FV</given-names></name><name name-style="western"><surname>Rohm</surname><given-names>M</given-names></name><name name-style="western"><surname>Lee</surname><given-names>CK</given-names></name><name name-style="western"><surname>Santos</surname><given-names>E</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JP</given-names></name><name name-style="western"><surname>Specht</surname><given-names>CA</given-names></name><etal/></person-group>. <article-title>Recognition of aspergillus fumigatus hyphae by human plasmacytoid dendritic cells is mediated by dectin-2 and results in formation of extracellular traps</article-title>. <source>PloS Pathog</source> (<year>2015</year>) <volume>11</volume>:<fpage>e1004643</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1004643</pub-id><pub-id pub-id-type="pmid">25659141</pub-id><pub-id pub-id-type="pmcid">PMC4450068</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wuthrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Lerksuthirat</surname><given-names>T</given-names></name><name name-style="western"><surname>Hardison</surname><given-names>SE</given-names></name><name name-style="western"><surname>Brown</surname><given-names>GD</given-names></name><etal/></person-group>. <article-title>Fonsecaea pedrosoi-induced Th17-cell differentiation in mice is fostered by dectin-2 and suppressed by mincle recognition</article-title>. <source>Eur J Immunol</source> (<year>2015</year>) <volume>45</volume>:<page-range>2542&#8211;52</page-range>. doi: <pub-id pub-id-type="doi">10.1002/eji.201545591</pub-id><pub-id pub-id-type="pmcid">PMC4562893</pub-id><pub-id pub-id-type="pmid">26140582</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saijo</surname><given-names>S</given-names></name><name name-style="western"><surname>Ikeda</surname><given-names>S</given-names></name><name name-style="western"><surname>Yamabe</surname><given-names>K</given-names></name><name name-style="western"><surname>Kakuta</surname><given-names>S</given-names></name><name name-style="western"><surname>Ishigame</surname><given-names>H</given-names></name><name name-style="western"><surname>Akitsu</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against candida albicans</article-title>. <source>Immunity</source> (<year>2010</year>) <volume>32</volume>:<page-range>681&#8211;91</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2010.05.001</pub-id><pub-id pub-id-type="pmid">20493731</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ifrim</surname><given-names>DC</given-names></name><name name-style="western"><surname>Quintin</surname><given-names>J</given-names></name><name name-style="western"><surname>Courjol</surname><given-names>F</given-names></name><name name-style="western"><surname>Verschueren</surname><given-names>I</given-names></name><name name-style="western"><surname>Van Krieken</surname><given-names>JH</given-names></name><name name-style="western"><surname>Koentgen</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>The role of dectin-2 for host defense against disseminated candidiasis</article-title>. <source>J Interferon Cytokine Res</source> (<year>2016</year>) <volume>36</volume>:<page-range>267&#8211;76</page-range>. doi: <pub-id pub-id-type="doi">10.1089/jir.2015.0040</pub-id><pub-id pub-id-type="pmcid">PMC4827303</pub-id><pub-id pub-id-type="pmid">27046240</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saijo</surname><given-names>S</given-names></name><name name-style="western"><surname>Iwakura</surname><given-names>Y</given-names></name></person-group>. <article-title>Dectin-1 and dectin-2 in innate immunity against fungi</article-title>. <source>Int Immunol</source> (<year>2011</year>) <volume>23</volume>:<page-range>467&#8211;72</page-range>. doi: <pub-id pub-id-type="doi">10.1093/intimm/dxr046</pub-id><pub-id pub-id-type="pmid">21677049</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bellocchio</surname><given-names>S</given-names></name><name name-style="western"><surname>Montagnoli</surname><given-names>C</given-names></name><name name-style="western"><surname>Bozza</surname><given-names>S</given-names></name><name name-style="western"><surname>Gaziano</surname><given-names>R</given-names></name><name name-style="western"><surname>Rossi</surname><given-names>G</given-names></name><name name-style="western"><surname>Mambula</surname><given-names>SS</given-names></name><etal/></person-group>. <article-title>The contribution of the toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens <italic toggle="yes">in vivo</italic>
</article-title>. <source>J Immunol</source> (<year>2004</year>) <volume>172</volume>:<page-range>3059&#8211;69</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.172.5.3059</pub-id><pub-id pub-id-type="pmid">14978111</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calich</surname><given-names>VLG</given-names></name><name name-style="western"><surname>Pina</surname><given-names>A</given-names></name><name name-style="western"><surname>Felonato</surname><given-names>M</given-names></name><name name-style="western"><surname>Bernardino</surname><given-names>S</given-names></name><name name-style="western"><surname>Costa</surname><given-names>TA</given-names></name><name name-style="western"><surname>Loures</surname><given-names>FV</given-names></name></person-group>. <article-title>Toll-like receptors and fungal infections: the role of TLR2, TLR4 and MyD88 in paracoccidioidomycosis</article-title>. <source>FEMS Immunol Med Microbiol</source> (<year>2008</year>) <volume>53</volume>:<fpage>1</fpage>&#8211;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1574-695X.2008.00378.x</pub-id><pub-id pub-id-type="pmid">18384366</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wuthrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Gern</surname><given-names>B</given-names></name><name name-style="western"><surname>Hung</surname><given-names>CY</given-names></name><name name-style="western"><surname>Ersland</surname><given-names>K</given-names></name><name name-style="western"><surname>Rocco</surname><given-names>N</given-names></name><name name-style="western"><surname>Pick-Jacobs</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Vaccine-induced protection against 3 systemic mycoses endemic to north America requires Th17 cells in mice</article-title>. <source>J Clin Invest</source> (<year>2011</year>) <volume>121</volume>:<page-range>554&#8211;68</page-range>. doi: <pub-id pub-id-type="doi">10.1172/JCI43984</pub-id><pub-id pub-id-type="pmcid">PMC3026727</pub-id><pub-id pub-id-type="pmid">21206087</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prieto</surname><given-names>D</given-names></name><name name-style="western"><surname>Carpena</surname><given-names>N</given-names></name><name name-style="western"><surname>Maneu</surname><given-names>V</given-names></name><name name-style="western"><surname>Gil</surname><given-names>ML</given-names></name><name name-style="western"><surname>Pla</surname><given-names>J</given-names></name><name name-style="western"><surname>Gozalbo</surname><given-names>D</given-names></name></person-group>. <article-title>TLR2 modulates gut colonization and dissemination of candida albicans in a murine model</article-title>. <source>Microbes Infect</source> (<year>2016</year>) <volume>18</volume>:<page-range>656&#8211;60</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.micinf.2016.05.005</pub-id><pub-id pub-id-type="pmid">27256463</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mir&#243;</surname><given-names>MS</given-names></name><name name-style="western"><surname>Rodr&#237;guez</surname><given-names>E</given-names></name><name name-style="western"><surname>Vigezzi</surname><given-names>C</given-names></name><name name-style="western"><surname>Icely</surname><given-names>PA</given-names></name><name name-style="western"><surname>Garc&#237;a</surname><given-names>LN</given-names></name><name name-style="western"><surname>Painetti</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Contribution of TLR2 pathway in the pathogenesis of vulvovaginal candidiasis</article-title>. <source>Pathog Dis</source> (<year>2017</year>) <volume>75</volume>(<issue>7</issue>). doi: <pub-id pub-id-type="doi">10.1093/femspd/ftx096</pub-id><pub-id pub-id-type="pmid">28911197</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Netea</surname><given-names>MG</given-names></name><name name-style="western"><surname>Sutmuller</surname><given-names>R</given-names></name><name name-style="western"><surname>Hermann</surname><given-names>C</given-names></name><name name-style="western"><surname>van der Graaf</surname><given-names>CA</given-names></name><name name-style="western"><surname>van der Meer</surname><given-names>JW</given-names></name><name name-style="western"><surname>Van Krieken</surname><given-names>JH</given-names></name><etal/></person-group>. <article-title>Toll-like receptor 2 suppresses immunity against candida albicans through induction of IL-10 and regulatory T cells</article-title>. <source>J Immunol</source> (<year>2004</year>) <volume>172</volume>:<page-range>3712&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.172.6.3712</pub-id><pub-id pub-id-type="pmid">15004175</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villamon</surname><given-names>E</given-names></name><name name-style="western"><surname>Gozalbo</surname><given-names>D</given-names></name><name name-style="western"><surname>Roig</surname><given-names>P</given-names></name><name name-style="western"><surname>O&#8217;connor</surname><given-names>JE</given-names></name><name name-style="western"><surname>Fradelizi</surname><given-names>D</given-names></name><name name-style="western"><surname>Gil</surname><given-names>ML</given-names></name></person-group>. <article-title>Toll-like receptor-2 is essential in murine defenses against candida albicans infections</article-title>. <source>Microbes Infect</source> (<year>2004</year>) <volume>6</volume>:<fpage>1</fpage>&#8211;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.micinf.2003.09.020</pub-id><pub-id pub-id-type="pmid">14738887</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dubourdeau</surname><given-names>M</given-names></name><name name-style="western"><surname>Athman</surname><given-names>R</given-names></name><name name-style="western"><surname>Balloy</surname><given-names>V</given-names></name><name name-style="western"><surname>Huerre</surname><given-names>M</given-names></name><name name-style="western"><surname>Chignard</surname><given-names>M</given-names></name><name name-style="western"><surname>Philpott</surname><given-names>DJ</given-names></name><etal/></person-group>. <article-title>Aspergillus fumigatus induces innate immune responses in alveolar macrophages through the MAPK pathway independently of TLR2 and TLR4</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>177</volume>:<fpage>3994</fpage>&#8211;<lpage>4001</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.177.6.3994</pub-id><pub-id pub-id-type="pmid">16951362</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carvalho</surname><given-names>A</given-names></name><name name-style="western"><surname>De Luca</surname><given-names>A</given-names></name><name name-style="western"><surname>Bozza</surname><given-names>S</given-names></name><name name-style="western"><surname>Cunha</surname><given-names>C</given-names></name><name name-style="western"><surname>D&#8217;angelo</surname><given-names>C</given-names></name><name name-style="western"><surname>Moretti</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>TLR3 essentially promotes protective class I&#8211;restricted memory CD8+ T-cell responses to aspergillus fumigatus in hematopoietic transplanted patients</article-title>. <source>Blood</source> (<year>2012</year>) <volume>119</volume>:<page-range>967&#8211;77</page-range>. doi: <pub-id pub-id-type="doi">10.1182/blood-2011-06-362582</pub-id><pub-id pub-id-type="pmid">22147891</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van De Veerdonk</surname><given-names>FL</given-names></name><name name-style="western"><surname>Joosten</surname><given-names>LA</given-names></name><name name-style="western"><surname>Netea</surname><given-names>MG</given-names></name></person-group>. <article-title>The interplay between inflammasome activation and antifungal host defense</article-title>. <source>Immunol Rev</source> (<year>2015</year>) <volume>265</volume>:<page-range>172&#8211;80</page-range>. doi: <pub-id pub-id-type="doi">10.1111/imr.12280</pub-id><pub-id pub-id-type="pmid">25879292</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Souza</surname><given-names>COS</given-names></name><name name-style="western"><surname>Ketelut-Carneiro</surname><given-names>N</given-names></name><name name-style="western"><surname>Milanezi</surname><given-names>CM</given-names></name><name name-style="western"><surname>Faccioli</surname><given-names>LH</given-names></name><name name-style="western"><surname>Gardinassi</surname><given-names>LG</given-names></name><name name-style="western"><surname>Silva</surname><given-names>JS</given-names></name></person-group>. <article-title>NLRC4 inhibits NLRP3 inflammasome and abrogates effective antifungal CD8+ T cell responses</article-title>. <source>iScience</source> (<year>2021</year>) <volume>24</volume>:<fpage>102548</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.isci.2021.102548</pub-id><pub-id pub-id-type="pmid">34142053</pub-id><pub-id pub-id-type="pmcid">PMC8184506</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bochud</surname><given-names>PY</given-names></name><name name-style="western"><surname>Chien</surname><given-names>JW</given-names></name><name name-style="western"><surname>Marr</surname><given-names>KA</given-names></name><name name-style="western"><surname>Leisenring</surname><given-names>WM</given-names></name><name name-style="western"><surname>Upton</surname><given-names>A</given-names></name><name name-style="western"><surname>Janer</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation</article-title>. <source>N Engl J Med</source> (<year>2008</year>) <volume>359</volume>:<page-range>1766&#8211;77</page-range>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa0802629</pub-id><pub-id pub-id-type="pmcid">PMC2656610</pub-id><pub-id pub-id-type="pmid">18946062</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carvalho</surname><given-names>A</given-names></name><name name-style="western"><surname>Cunha</surname><given-names>C</given-names></name><name name-style="western"><surname>Carotti</surname><given-names>A</given-names></name><name name-style="western"><surname>Aloisi</surname><given-names>T</given-names></name><name name-style="western"><surname>Guarrera</surname><given-names>O</given-names></name><name name-style="western"><surname>Di Ianni</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Polymorphisms in toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation</article-title>. <source>Exp Hematol</source> (<year>2009</year>) <volume>37</volume>:<page-range>1022&#8211;9</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.exphem.2009.06.004</pub-id><pub-id pub-id-type="pmid">19539691</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morre</surname><given-names>SA</given-names></name><name name-style="western"><surname>Murillo</surname><given-names>LS</given-names></name><name name-style="western"><surname>Spaargaren</surname><given-names>J</given-names></name><name name-style="western"><surname>Fennema</surname><given-names>HS</given-names></name><name name-style="western"><surname>Pena</surname><given-names>AS</given-names></name></person-group>. <article-title>Role of the toll-like receptor 4 Asp299Gly polymorphism in susceptibility to candida albicans infection</article-title>. <source>J Infect Dis</source> (<year>2002</year>) <volume>186</volume>:<fpage>1377</fpage>&#8211;<lpage>1379; author reply 1379</lpage>. doi: <pub-id pub-id-type="doi">10.1086/344328</pub-id><pub-id pub-id-type="pmid">12402214</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sainz</surname><given-names>J</given-names></name><name name-style="western"><surname>Perez</surname><given-names>E</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>L</given-names></name><name name-style="western"><surname>Moratalla</surname><given-names>A</given-names></name><name name-style="western"><surname>Romero</surname><given-names>A</given-names></name><name name-style="western"><surname>Collado</surname><given-names>MD</given-names></name><etal/></person-group>. <article-title>Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis</article-title>. <source>Hum Immunol</source> (<year>2007</year>) <volume>68</volume>:<fpage>41</fpage>&#8211;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.humimm.2006.10.011</pub-id><pub-id pub-id-type="pmid">17207711</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plantinga</surname><given-names>TS</given-names></name><name name-style="western"><surname>van der Velden</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Ferwerda</surname><given-names>B</given-names></name><name name-style="western"><surname>Van Spriel</surname><given-names>AB</given-names></name><name name-style="western"><surname>Adema</surname><given-names>G</given-names></name><name name-style="western"><surname>Feuth</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients</article-title>. <source>Clin Infect Dis</source> (<year>2009</year>) <volume>49</volume>:<page-range>724&#8211;32</page-range>. doi: <pub-id pub-id-type="doi">10.1086/604714</pub-id><pub-id pub-id-type="pmid">19614557</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cunha</surname><given-names>C</given-names></name><name name-style="western"><surname>Di Ianni</surname><given-names>M</given-names></name><name name-style="western"><surname>Bozza</surname><given-names>S</given-names></name><name name-style="western"><surname>Giovannini</surname><given-names>G</given-names></name><name name-style="western"><surname>Zagarella</surname><given-names>S</given-names></name><name name-style="western"><surname>Zelante</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity</article-title>. <source>Blood</source> (<year>2010</year>) <volume>116</volume>:<page-range>5394&#8211;402</page-range>. doi: <pub-id pub-id-type="doi">10.1182/blood-2010-04-279307</pub-id><pub-id pub-id-type="pmid">20807886</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Del Pilar Jimenez</surname><given-names>AM</given-names></name><name name-style="western"><surname>Viriyakosol</surname><given-names>S</given-names></name><name name-style="western"><surname>Walls</surname><given-names>L</given-names></name><name name-style="western"><surname>Datta</surname><given-names>SK</given-names></name><name name-style="western"><surname>Kirkland</surname><given-names>T</given-names></name><name name-style="western"><surname>Heinsbroek</surname><given-names>SE</given-names></name><etal/></person-group>. <article-title>Susceptibility to coccidioides species in C57BL/6 mice is associated with expression of a truncated splice variant of dectin-1 (Clec7a)</article-title>. <source>Genes Immun</source> (<year>2008</year>) <volume>9</volume>:<page-range>338&#8211;48</page-range>. doi: <pub-id pub-id-type="doi">10.1038/gene.2008.23</pub-id><pub-id pub-id-type="pmcid">PMC3681288</pub-id><pub-id pub-id-type="pmid">18418396</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Janeway</surname><given-names>CA</given-names><suffix>Jr</suffix></name></person-group>. <article-title>Approaching the asymptote? Evolution and revolution in immunology</article-title>. <source>Cold Spring Harb Symp Quant Biol</source> (<year>1989</year>) <volume>54 Pt 1</volume>:<fpage>1</fpage>&#8211;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1101/SQB.1989.054.01.003</pub-id><pub-id pub-id-type="pmid">2700931</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahman</surname><given-names>AH</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>DK</given-names></name><name name-style="western"><surname>Turka</surname><given-names>LA</given-names></name></person-group>. <article-title>The contribution of direct TLR signaling to T cell responses</article-title>. <source>Immunol Res</source> (<year>2009</year>) <volume>45</volume>:<fpage>25</fpage>&#8211;<lpage>36</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12026-009-8113-x</pub-id><pub-id pub-id-type="pmid">19597998</pub-id><pub-id pub-id-type="pmcid">PMC4486050</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Komai-Koma</surname><given-names>M</given-names></name><name name-style="western"><surname>Jones</surname><given-names>L</given-names></name><name name-style="western"><surname>Ogg</surname><given-names>GS</given-names></name><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name><name name-style="western"><surname>Liew</surname><given-names>FY</given-names></name></person-group>. <article-title>TLR2 is expressed on activated T cells as a costimulatory receptor</article-title>. <source>Proc Natl Acad Sci</source> (<year>2004</year>) <volume>101</volume>:<page-range>3029&#8211;34</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0400171101</pub-id><pub-id pub-id-type="pmcid">PMC365739</pub-id><pub-id pub-id-type="pmid">14981245</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Imanishi</surname><given-names>T</given-names></name><name name-style="western"><surname>Hara</surname><given-names>H</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>S</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>N</given-names></name><name name-style="western"><surname>Akira</surname><given-names>S</given-names></name><name name-style="western"><surname>Saito</surname><given-names>T</given-names></name></person-group>. <article-title>Cutting edge: TLR2 directly triggers Th1 effector functions</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>178</volume>:<page-range>6715&#8211;9</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.178.11.6715</pub-id><pub-id pub-id-type="pmid">17513716</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Imanishi</surname><given-names>T</given-names></name><name name-style="western"><surname>Unno</surname><given-names>M</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>W</given-names></name><name name-style="western"><surname>Yoneda</surname><given-names>N</given-names></name><name name-style="western"><surname>Akira</surname><given-names>S</given-names></name><name name-style="western"><surname>Saito</surname><given-names>T</given-names></name></person-group>. <article-title>mTORC1 signaling controls TLR2-mediated T-cell activation by inducing TIRAP expression</article-title>. <source>Cell Rep</source> (<year>2020</year>) <volume>32</volume>:<fpage>107911</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2020.107911</pub-id><pub-id pub-id-type="pmid">32698010</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Hung</surname><given-names>CY</given-names></name><name name-style="western"><surname>Sinha</surname><given-names>M</given-names></name><name name-style="western"><surname>Lee</surname><given-names>LM</given-names></name><name name-style="western"><surname>Wiesner</surname><given-names>DL</given-names></name><etal/></person-group>. <article-title>MyD88 shapes vaccine immunity by extrinsically regulating survival of CD4+ T cells during the contraction phase</article-title>. <source>PloS Pathog</source> (<year>2016</year>) <volume>12</volume>:<fpage>e1005787</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1005787</pub-id><pub-id pub-id-type="pmid">27542117</pub-id><pub-id pub-id-type="pmcid">PMC4991787</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nanjappa</surname><given-names>SG</given-names></name><name name-style="western"><surname>Hernandez-Santos</surname><given-names>N</given-names></name><name name-style="western"><surname>Galles</surname><given-names>K</given-names></name><name name-style="western"><surname>Wuthrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Suresh</surname><given-names>M</given-names></name><name name-style="western"><surname>Klein</surname><given-names>BS</given-names></name></person-group>. <article-title>Intrinsic MyD88-Akt1-mTOR signaling coordinates disparate Tc17 and Tc1 responses during vaccine immunity against fungal pneumonia</article-title>. <source>PloS Pathog</source> (<year>2015</year>) <volume>11</volume>:<fpage>e1005161</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1005161</pub-id><pub-id pub-id-type="pmid">26367276</pub-id><pub-id pub-id-type="pmcid">PMC4569330</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhaskaran</surname><given-names>N</given-names></name><name name-style="western"><surname>Faddoul</surname><given-names>F</given-names></name><name name-style="western"><surname>Paes Da Silva</surname><given-names>A</given-names></name><name name-style="western"><surname>Jayaraman</surname><given-names>S</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>E</given-names></name><name name-style="western"><surname>Mamileti</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Il-1&#946;-Myd88-Mtor axis promotes immune-protective IL-17a+ Foxp3+ cells during mucosal infection and is dysregulated with aging</article-title>. <source>Front Immunol</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>2818</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2020.595936</pub-id><pub-id pub-id-type="pmcid">PMC7677307</pub-id><pub-id pub-id-type="pmid">33240286</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>H</given-names></name><name name-style="western"><surname>Chan</surname><given-names>JFW</given-names></name><name name-style="western"><surname>Tan</surname><given-names>YP</given-names></name><name name-style="western"><surname>Kui</surname><given-names>L</given-names></name><name name-style="western"><surname>Tsang</surname><given-names>CC</given-names></name><name name-style="western"><surname>Pei</surname><given-names>SLC</given-names></name><etal/></person-group>. <article-title>NLRP3 inflammasome contributes to host defense against talaromyces marneffei infection</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>760095</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.760095</pub-id><pub-id pub-id-type="pmid">34912336</pub-id><pub-id pub-id-type="pmcid">PMC8666893</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arbore</surname><given-names>G</given-names></name><name name-style="western"><surname>West</surname><given-names>EE</given-names></name><name name-style="western"><surname>Spolski</surname><given-names>R</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>A</given-names></name><name name-style="western"><surname>Klos</surname><given-names>A</given-names></name><name name-style="western"><surname>Rheinheimer</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>T Helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4(+) T cells</article-title>. <source>Science</source> (<year>2016</year>) <volume>352</volume>:<elocation-id>aad1210</elocation-id>. doi: <pub-id pub-id-type="doi">10.1126/science.aad1210</pub-id><pub-id pub-id-type="pmid">27313051</pub-id><pub-id pub-id-type="pmcid">PMC5015487</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumaresan</surname><given-names>PR</given-names></name><name name-style="western"><surname>Manuri</surname><given-names>PR</given-names></name><name name-style="western"><surname>Albert</surname><given-names>ND</given-names></name><name name-style="western"><surname>Maiti</surname><given-names>S</given-names></name><name name-style="western"><surname>Singh</surname><given-names>H</given-names></name><name name-style="western"><surname>Mi</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection</article-title>. <source>Proc Natl Acad Sci U.S.A.</source> (<year>2014</year>) <volume>111</volume>:<page-range>10660&#8211;5</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1312789111</pub-id><pub-id pub-id-type="pmcid">PMC4115509</pub-id><pub-id pub-id-type="pmid">25002471</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roilides</surname><given-names>E</given-names></name><name name-style="western"><surname>Uhlig</surname><given-names>K</given-names></name><name name-style="western"><surname>Venzon</surname><given-names>D</given-names></name><name name-style="western"><surname>Pizzo</surname><given-names>PA</given-names></name><name name-style="western"><surname>Walsh</surname><given-names>TJ</given-names></name></person-group>. <article-title>Enhancement of oxidative response and damage caused by human neutrophils to aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon</article-title>. <source>Infect Immun</source> (<year>1993</year>) <volume>61</volume>:<page-range>1185&#8211;93</page-range>. doi: <pub-id pub-id-type="doi">10.1128/iai.61.4.1185-1193.1993</pub-id><pub-id pub-id-type="pmcid">PMC281347</pub-id><pub-id pub-id-type="pmid">7681040</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borghi</surname><given-names>M</given-names></name><name name-style="western"><surname>Renga</surname><given-names>G</given-names></name><name name-style="western"><surname>Puccetti</surname><given-names>M</given-names></name><name name-style="western"><surname>Oikonomou</surname><given-names>V</given-names></name><name name-style="western"><surname>Palmieri</surname><given-names>M</given-names></name><name name-style="western"><surname>Galosi</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Antifungal Th immunity: Growing up in family</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<elocation-id>506</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2014.00506</pub-id><pub-id pub-id-type="pmid">25360137</pub-id><pub-id pub-id-type="pmcid">PMC4197763</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mcdermott</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Klein</surname><given-names>BS</given-names></name></person-group>. <article-title>Helper T-cell responses and pulmonary fungal infections</article-title>. <source>Immunology</source> (<year>2018</year>) <volume>155</volume>:<page-range>155&#8211;63</page-range>. doi: <pub-id pub-id-type="doi">10.1111/imm.12953</pub-id><pub-id pub-id-type="pmcid">PMC6142286</pub-id><pub-id pub-id-type="pmid">29781185</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gray</surname><given-names>JI</given-names></name><name name-style="western"><surname>Westerhof</surname><given-names>LM</given-names></name><name name-style="western"><surname>Macleod</surname><given-names>MKL</given-names></name></person-group>. <article-title>The roles of resident, central and effector memory CD4 T-cells in protective immunity following infection or vaccination</article-title>. <source>Immunology</source> (<year>2018</year>) <volume>154</volume>(<issue>4</issue>):<page-range>574&#8211;581</page-range>. doi: <pub-id pub-id-type="doi">10.1111/imm.12929</pub-id><pub-id pub-id-type="pmcid">PMC6050220</pub-id><pub-id pub-id-type="pmid">29570776</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cenci</surname><given-names>E</given-names></name><name name-style="western"><surname>Mencacci</surname><given-names>A</given-names></name><name name-style="western"><surname>Bacci</surname><given-names>A</given-names></name><name name-style="western"><surname>Bistoni</surname><given-names>F</given-names></name><name name-style="western"><surname>Kurup</surname><given-names>VP</given-names></name><name name-style="western"><surname>Romani</surname><given-names>L</given-names></name></person-group>. <article-title>T Cell vaccination in mice with invasive pulmonary aspergillosis</article-title>. <source>J Immunol</source> (<year>2000</year>) <volume>165</volume>:<page-range>381&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.165.1.381</pub-id><pub-id pub-id-type="pmid">10861075</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jolink</surname><given-names>H</given-names></name><name name-style="western"><surname>De Boer</surname><given-names>R</given-names></name><name name-style="western"><surname>Hombrink</surname><given-names>P</given-names></name><name name-style="western"><surname>Jonkers</surname><given-names>RE</given-names></name><name name-style="western"><surname>Van Dissel</surname><given-names>JT</given-names></name><name name-style="western"><surname>Falkenburg</surname><given-names>JH</given-names></name><etal/></person-group>. <article-title>Pulmonary immune responses against aspergillus fumigatus are characterized by high frequencies of IL-17 producing T-cells</article-title>. <source>J Infect</source> (<year>2017</year>) <volume>74</volume>:<page-range>81&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jinf.2016.10.010</pub-id><pub-id pub-id-type="pmid">27838522</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jolink</surname><given-names>H</given-names></name><name name-style="western"><surname>Hagedoorn</surname><given-names>RS</given-names></name><name name-style="western"><surname>Lagendijk</surname><given-names>EL</given-names></name><name name-style="western"><surname>Drijfhout</surname><given-names>JW</given-names></name><name name-style="western"><surname>Van Dissel</surname><given-names>JT</given-names></name><name name-style="western"><surname>Falkenburg</surname><given-names>JH</given-names></name><etal/></person-group>. <article-title>Induction of a. Fumigatus-specific CD4-positive T cells in patients recovering from invasive aspergillosis</article-title>. <source>Haematologica</source> (<year>2014</year>) <volume>99</volume>:<page-range>1255&#8211;63</page-range>. doi: <pub-id pub-id-type="doi">10.3324/haematol.2013.098830</pub-id><pub-id pub-id-type="pmcid">PMC4077089</pub-id><pub-id pub-id-type="pmid">24747947</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nanjappa</surname><given-names>SG</given-names></name><name name-style="western"><surname>Heninger</surname><given-names>E</given-names></name><name name-style="western"><surname>Wuthrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Gasper</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Klein</surname><given-names>BS</given-names></name></person-group>. <article-title>Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells</article-title>. <source>PloS Pathog</source> (<year>2012</year>) <volume>8</volume>:<fpage>e1002771</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1002771</pub-id><pub-id pub-id-type="pmid">22829762</pub-id><pub-id pub-id-type="pmcid">PMC3400565</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hernandez-Santos</surname><given-names>N</given-names></name><name name-style="western"><surname>Huppler</surname><given-names>AR</given-names></name><name name-style="western"><surname>Peterson</surname><given-names>AC</given-names></name><name name-style="western"><surname>Khader</surname><given-names>SA</given-names></name><name name-style="western"><surname>Mckenna</surname><given-names>KC</given-names></name><name name-style="western"><surname>Gaffen</surname><given-names>SL</given-names></name></person-group>. <article-title>Th17 cells confer long-term adaptive immunity to oral mucosal candida albicans infections</article-title>. <source>Mucosal Immunol</source> (<year>2013</year>) <volume>6</volume>:<page-range>900&#8211;10</page-range>. doi: <pub-id pub-id-type="doi">10.1038/mi.2012.128</pub-id><pub-id pub-id-type="pmcid">PMC3608691</pub-id><pub-id pub-id-type="pmid">23250275</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Acosta-Rodriguez</surname><given-names>EV</given-names></name><name name-style="western"><surname>Rivino</surname><given-names>L</given-names></name><name name-style="western"><surname>Geginat</surname><given-names>J</given-names></name><name name-style="western"><surname>Jarrossay</surname><given-names>D</given-names></name><name name-style="western"><surname>Gattorno</surname><given-names>M</given-names></name><name name-style="western"><surname>Lanzavecchia</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells</article-title>. <source>Nat Immunol</source> (<year>2007</year>) <volume>8</volume>:<page-range>639&#8211;46</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni1467</pub-id><pub-id pub-id-type="pmid">17486092</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iannitti</surname><given-names>RG</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>A</given-names></name><name name-style="western"><surname>Romani</surname><given-names>L</given-names></name></person-group>. <article-title>From memory to antifungal vaccine design</article-title>. <source>Trends Immunol</source> (<year>2012</year>) <volume>33</volume>:<page-range>467&#8211;74</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.it.2012.04.008</pub-id><pub-id pub-id-type="pmid">22647597</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kirchner</surname><given-names>FR</given-names></name><name name-style="western"><surname>Leibundgut-Landmann</surname><given-names>S</given-names></name></person-group>. <article-title>Tissue-resident memory Th17 cells maintain stable fungal commensalism in the oral mucosa</article-title>. <source>Mucosal Immunol</source> (<year>2021</year>) <volume>14</volume>:<page-range>455&#8211;67</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41385-020-0327-1</pub-id><pub-id pub-id-type="pmcid">PMC7946631</pub-id><pub-id pub-id-type="pmid">32719409</pub-id></mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ueno</surname><given-names>K</given-names></name><name name-style="western"><surname>Urai</surname><given-names>M</given-names></name><name name-style="western"><surname>Sadamoto</surname><given-names>S</given-names></name><name name-style="western"><surname>Shinozaki</surname><given-names>M</given-names></name><name name-style="western"><surname>Takatsuka</surname><given-names>S</given-names></name><name name-style="western"><surname>Abe</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>A dendritic cell-based systemic vaccine induces long-lived lung-resident memory Th17 cells and ameliorates pulmonary mycosis</article-title>. <source>Mucosal Immunol</source> (<year>2019</year>) <volume>12</volume>:<page-range>265&#8211;76</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41385-018-0094-4</pub-id><pub-id pub-id-type="pmid">30279512</pub-id></mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ueno</surname><given-names>K</given-names></name><name name-style="western"><surname>Kinjo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Okubo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Aki</surname><given-names>K</given-names></name><name name-style="western"><surname>Urai</surname><given-names>M</given-names></name><name name-style="western"><surname>Kaneko</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Dendritic cell-based immunization ameliorates pulmonary infection with highly virulent cryptococcus gattii</article-title>. <source>Infect Immun</source> (<year>2015</year>) <volume>83</volume>:<page-range>1577&#8211;86</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.02827-14</pub-id><pub-id pub-id-type="pmcid">PMC4363414</pub-id><pub-id pub-id-type="pmid">25644007</pub-id></mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fierer</surname><given-names>J</given-names></name><name name-style="western"><surname>Waters</surname><given-names>C</given-names></name><name name-style="western"><surname>Walls</surname><given-names>L</given-names></name></person-group>. <article-title>Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against coccidioides immitis infection in mice</article-title>. <source>J Infect Dis</source> (<year>2006</year>) <volume>193</volume>:<page-range>1323&#8211;31</page-range>. doi: <pub-id pub-id-type="doi">10.1086/502972</pub-id><pub-id pub-id-type="pmid">16586371</pub-id></mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hung</surname><given-names>CY</given-names></name><name name-style="western"><surname>Castro-Lopez</surname><given-names>N</given-names></name><name name-style="western"><surname>Cole</surname><given-names>GT</given-names></name></person-group>. <article-title>Vaccinated C57BL/6 mice develop protective and memory T cell responses to coccidioides posadasii infection in the absence of interleukin-10</article-title>. <source>Infect Immun</source> (<year>2014</year>) <volume>82</volume>:<page-range>903&#8211;13</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.01148-13</pub-id><pub-id pub-id-type="pmcid">PMC3911407</pub-id><pub-id pub-id-type="pmid">24478103</pub-id></mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diep</surname><given-names>AL</given-names></name><name name-style="western"><surname>Hoyer</surname><given-names>KK</given-names></name></person-group>. <article-title>Host response to coccidioides infection: Fungal immunity</article-title>. <source>Front Cell Infect Microbiol</source> (<year>2020</year>) <volume>10</volume>:<elocation-id>581101</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2020.581101</pub-id><pub-id pub-id-type="pmid">33262956</pub-id><pub-id pub-id-type="pmcid">PMC7686801</pub-id></mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deepe</surname><given-names>JGS</given-names></name><name name-style="western"><surname>Buesing</surname><given-names>WR</given-names></name><name name-style="western"><surname>Ostroff</surname><given-names>GR</given-names></name><name name-style="western"><surname>Abraham</surname><given-names>A</given-names></name><name name-style="western"><surname>Specht</surname><given-names>CA</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Vaccination with an alkaline extract of histoplasma capsulatum packaged in glucan particles confers protective immunity in mice</article-title>. <source>Vaccine</source> (<year>2018</year>) <volume>36</volume>:<page-range>3359&#8211;67</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.vaccine.2018.04.047</pub-id><pub-id pub-id-type="pmcid">PMC5960637</pub-id><pub-id pub-id-type="pmid">29729993</pub-id></mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiarella</surname><given-names>AP</given-names></name><name name-style="western"><surname>Arruda</surname><given-names>C</given-names></name><name name-style="western"><surname>Pina</surname><given-names>A</given-names></name><name name-style="western"><surname>Costa</surname><given-names>TA</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>RC</given-names></name><name name-style="western"><surname>Calich</surname><given-names>VL</given-names></name></person-group>. <article-title>The relative importance of CD4+ and CD8+T cells in immunity to pulmonary paracoccidioidomycosis</article-title>. <source>Microbes Infect</source> (<year>2007</year>) <volume>9</volume>:<page-range>1078&#8211;88</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.micinf.2007.04.016</pub-id><pub-id pub-id-type="pmid">17692551</pub-id></mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De La Rua</surname><given-names>NM</given-names></name><name name-style="western"><surname>Samuelson</surname><given-names>DR</given-names></name><name name-style="western"><surname>Charles</surname><given-names>TP</given-names></name><name name-style="western"><surname>Welsh</surname><given-names>DA</given-names></name><name name-style="western"><surname>Shellito</surname><given-names>JE</given-names></name></person-group>. <article-title>CD4+ T-cell-independent secondary immune responses to pneumocystis pneumonia</article-title>. <source>Front Immunol</source> (<year>2016</year>) <volume>7</volume>:<fpage>178</fpage>.<pub-id pub-id-type="pmid">27242785</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2016.00178</pub-id><pub-id pub-id-type="pmcid">PMC4862974</pub-id></mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galdino</surname><given-names>N</given-names></name><name name-style="western"><surname>Loures</surname><given-names>FV</given-names></name><name name-style="western"><surname>De Ara&#250;jo</surname><given-names>EF</given-names></name><name name-style="western"><surname>Da Costa</surname><given-names>TA</given-names></name><name name-style="western"><surname>Preite</surname><given-names>NW</given-names></name><name name-style="western"><surname>Calich</surname><given-names>VLG</given-names></name></person-group>. <article-title>Depletion of regulatory T cells in ongoing paracoccidioidomycosis rescues protective Th1/Th17 immunity and prevents fatal disease outcome</article-title>. <source>Sci Rep</source> (<year>2018</year>) <volume>8</volume>(<issue>1</issue>):<elocation-id>16544</elocation-id>. doi: <pub-id pub-id-type="doi">10.1038/s41598-018-35037-8</pub-id><pub-id pub-id-type="pmid">30410119</pub-id><pub-id pub-id-type="pmcid">PMC6224548</pub-id></mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pruksaphon</surname><given-names>K</given-names></name><name name-style="western"><surname>Nosanchuk</surname><given-names>JD</given-names></name><name name-style="western"><surname>Ratanabanangkoon</surname><given-names>K</given-names></name><name name-style="western"><surname>Youngchim</surname><given-names>S</given-names></name></person-group>. <article-title>Talaromyces marneffei infection: Virulence, intracellular lifestyle and host defense mechanisms</article-title>. <source>J Fungi</source> (<year>2022</year>) <volume>8</volume>:<fpage>200</fpage>. doi: <pub-id pub-id-type="doi">10.3390/jof8020200</pub-id><pub-id pub-id-type="pmcid">PMC8880324</pub-id><pub-id pub-id-type="pmid">35205954</pub-id></mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>CO</given-names></name><name name-style="western"><surname>Fu</surname><given-names>X</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>X</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Teague</surname><given-names>JE</given-names></name><name name-style="western"><surname>Collins</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Staged development of long-lived T-cell receptor &#945;&#946; TH17 resident memory T-cell population to candida albicans after skin infection</article-title>. <source>J Allergy Clin Immunol</source> (<year>2018</year>) <volume>142</volume>:<page-range>647&#8211;62</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2017.09.042</pub-id><pub-id pub-id-type="pmcid">PMC5943196</pub-id><pub-id pub-id-type="pmid">29128674</pub-id></mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pietrella</surname><given-names>D</given-names></name><name name-style="western"><surname>Rachini</surname><given-names>A</given-names></name><name name-style="western"><surname>Pines</surname><given-names>M</given-names></name><name name-style="western"><surname>Pandey</surname><given-names>N</given-names></name><name name-style="western"><surname>Mosci</surname><given-names>P</given-names></name><name name-style="western"><surname>Bistoni</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Th17 cells and IL-17 in protective immunity to vaginal candidiasis</article-title>. <source>PloS One</source> (<year>2011</year>) <volume>6</volume>:<fpage>e22770</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0022770</pub-id><pub-id pub-id-type="pmid">21818387</pub-id><pub-id pub-id-type="pmcid">PMC3144947</pub-id></mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alqarihi</surname><given-names>A</given-names></name><name name-style="western"><surname>Singh</surname><given-names>S</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>JE</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Ibrahim</surname><given-names>AS</given-names></name><name name-style="western"><surname>Uppuluri</surname><given-names>P</given-names></name></person-group>. <article-title>NDV-3A vaccination prevents c. albicans colonization of jugular vein catheters in mice</article-title>. <source>Sci Rep</source> (<year>2019</year>) <volume>9</volume>:<fpage>6194</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-019-42517-y</pub-id><pub-id pub-id-type="pmid">30996274</pub-id><pub-id pub-id-type="pmcid">PMC6470131</pub-id></mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ibrahim</surname><given-names>AS</given-names></name><name name-style="western"><surname>Luo</surname><given-names>G</given-names></name><name name-style="western"><surname>Gebremariam</surname><given-names>T</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>CS</given-names></name><name name-style="western"><surname>Hennessey</surname><given-names>JP</given-names><suffix>Jr.</suffix></name><etal/></person-group>. <article-title>NDV-3 protects mice from vulvovaginal candidiasis through T- and b-cell immune response</article-title>. <source>Vaccine</source> (<year>2013</year>) <volume>31</volume>:<page-range>5549&#8211;56</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.vaccine.2013.09.016</pub-id><pub-id pub-id-type="pmcid">PMC3866209</pub-id><pub-id pub-id-type="pmid">24063977</pub-id></mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edwards</surname><given-names>JE</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Schwartz</surname><given-names>MM</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>CS</given-names></name><name name-style="western"><surname>Sobel</surname><given-names>JD</given-names></name><name name-style="western"><surname>Nyirjesy</surname><given-names>P</given-names></name><name name-style="western"><surname>Schodel</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>A fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis-a phase 2 randomized, double-blind, placebo-controlled trial</article-title>. <source>Clin Infect Dis</source> (<year>2018</year>) <volume>66</volume>:<page-range>1928&#8211;36</page-range>. doi: <pub-id pub-id-type="doi">10.1093/cid/ciy185</pub-id><pub-id pub-id-type="pmcid">PMC5982716</pub-id><pub-id pub-id-type="pmid">29697768</pub-id></mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zielinski</surname><given-names>CE</given-names></name><name name-style="western"><surname>Mele</surname><given-names>F</given-names></name><name name-style="western"><surname>Aschenbrenner</surname><given-names>D</given-names></name><name name-style="western"><surname>Jarrossay</surname><given-names>D</given-names></name><name name-style="western"><surname>Ronchi</surname><given-names>F</given-names></name><name name-style="western"><surname>Gattorno</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta</article-title>. <source>Nature</source> (<year>2012</year>) <volume>484</volume>:<page-range>514&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nature10957</pub-id><pub-id pub-id-type="pmid">22466287</pub-id></mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Becattini</surname><given-names>S</given-names></name><name name-style="western"><surname>Latorre</surname><given-names>D</given-names></name><name name-style="western"><surname>Mele</surname><given-names>F</given-names></name><name name-style="western"><surname>Foglierini</surname><given-names>M</given-names></name><name name-style="western"><surname>De Gregorio</surname><given-names>C</given-names></name><name name-style="western"><surname>Cassotta</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>T Cell immunity. functional heterogeneity of human memory CD4(+) T cell clones primed by pathogens or vaccines</article-title>. <source>Science</source> (<year>2015</year>) <volume>347</volume>:<page-range>400&#8211;6</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.1260668</pub-id><pub-id pub-id-type="pmid">25477212</pub-id></mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kirchner</surname><given-names>FR</given-names></name><name name-style="western"><surname>Leibundgut-Landmann</surname><given-names>S</given-names></name></person-group>. <article-title>Tissue-resident memory Th17 cells maintain stable fungal commensalism in the oral mucosa</article-title>. <source>Mucosal Immunol</source> (<year>2020</year>) <volume>14</volume>:<page-range>455&#8211;67</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41385-020-0327-1</pub-id><pub-id pub-id-type="pmcid">PMC7946631</pub-id><pub-id pub-id-type="pmid">32719409</pub-id></mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schlapbach</surname><given-names>C</given-names></name><name name-style="western"><surname>Gehad</surname><given-names>A</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>R</given-names></name><name name-style="western"><surname>Guenova</surname><given-names>E</given-names></name><name name-style="western"><surname>Teague</surname><given-names>JE</given-names></name><etal/></person-group>. <article-title>Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity</article-title>. <source>Sci Transl Med</source> (<year>2014</year>) <volume>6</volume>:<fpage>219ra218</fpage>. doi: <pub-id pub-id-type="doi">10.1126/scitranslmed.3007828</pub-id><pub-id pub-id-type="pmcid">PMC4102325</pub-id><pub-id pub-id-type="pmid">24431112</pub-id></mixed-citation></ref><ref id="B114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Renga</surname><given-names>G</given-names></name><name name-style="western"><surname>Moretti</surname><given-names>S</given-names></name><name name-style="western"><surname>Oikonomou</surname><given-names>V</given-names></name><name name-style="western"><surname>Borghi</surname><given-names>M</given-names></name><name name-style="western"><surname>Zelante</surname><given-names>T</given-names></name><name name-style="western"><surname>Paolicelli</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>IL-9 and mast cells are key players of candida albicans commensalism and pathogenesis in the gut</article-title>. <source>Cell Rep</source> (<year>2018</year>) <volume>23</volume>:<page-range>1767&#8211;78</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2018.04.034</pub-id><pub-id pub-id-type="pmcid">PMC5976578</pub-id><pub-id pub-id-type="pmid">29742432</pub-id></mixed-citation></ref><ref id="B115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Memory IL-22-producing CD4+ T cells specific for candida albicans are present in humans</article-title>. <source>Eur J Immunol</source> (<year>2009</year>) <volume>39</volume>:<page-range>1472&#8211;9</page-range>. doi: <pub-id pub-id-type="doi">10.1002/eji.200838811</pub-id><pub-id pub-id-type="pmid">19449309</pub-id></mixed-citation></ref><ref id="B116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Luca</surname><given-names>A</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>A</given-names></name><name name-style="western"><surname>Cunha</surname><given-names>C</given-names></name><name name-style="western"><surname>Iannitti</surname><given-names>RG</given-names></name><name name-style="western"><surname>Pitzurra</surname><given-names>L</given-names></name><name name-style="western"><surname>Giovannini</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis</article-title>. <source>PloS Pathog</source> (<year>2013</year>) <volume>9</volume>:<elocation-id>e1003486</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1003486</pub-id><pub-id pub-id-type="pmid">23853597</pub-id><pub-id pub-id-type="pmcid">PMC3708875</pub-id></mixed-citation></ref><ref id="B117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zelante</surname><given-names>T</given-names></name><name name-style="western"><surname>Iannitti</surname><given-names>R</given-names></name><name name-style="western"><surname>De Luca</surname><given-names>A</given-names></name><name name-style="western"><surname>Romani</surname><given-names>L</given-names></name></person-group>. <article-title>IL-22 in antifungal immunity</article-title>. <source>Eur J Immunol</source> (<year>2011</year>) <volume>41</volume>:<page-range>270&#8211;5</page-range>. doi: <pub-id pub-id-type="doi">10.1002/eji.201041246</pub-id><pub-id pub-id-type="pmid">21267995</pub-id></mixed-citation></ref><ref id="B118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moser</surname><given-names>D</given-names></name><name name-style="western"><surname>Biere</surname><given-names>K</given-names></name><name name-style="western"><surname>Han</surname><given-names>B</given-names></name><name name-style="western"><surname>Hoerl</surname><given-names>M</given-names></name><name name-style="western"><surname>Schelling</surname><given-names>G</given-names></name><name name-style="western"><surname>Chouker</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>COVID-19 impairs immune response to candida albicans</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>640644</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.640644</pub-id><pub-id pub-id-type="pmid">33717195</pub-id><pub-id pub-id-type="pmcid">PMC7953065</pub-id></mixed-citation></ref><ref id="B119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghaleb</surname><given-names>M</given-names></name><name name-style="western"><surname>Hamad</surname><given-names>M</given-names></name><name name-style="western"><surname>Abu-Elteen</surname><given-names>KH</given-names></name></person-group>. <article-title>Vaginal T lymphocyte population kinetics during experimental vaginal candidosis: evidence for a possible role of CD8+ T cells in protection against vaginal candidosis</article-title>. <source>Clin Exp Immunol</source> (<year>2003</year>) <volume>131</volume>:<fpage>26</fpage>&#8211;<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1365-2249.2003.02032.x</pub-id><pub-id pub-id-type="pmid">12519382</pub-id><pub-id pub-id-type="pmcid">PMC1808609</pub-id></mixed-citation></ref><ref id="B120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones-Carson</surname><given-names>J</given-names></name><name name-style="western"><surname>Vazquez-Torres</surname><given-names>FA</given-names></name><name name-style="western"><surname>Balish</surname><given-names>E</given-names></name></person-group>. <article-title>B cell-independent selection of memory T cells after mucosal immunization with candida albicans</article-title>. <source>J Immunol</source> (<year>1997</year>) <volume>158</volume>:<page-range>4328&#8211;35</page-range>.<pub-id pub-id-type="pmid">9126995</pub-id></mixed-citation></ref><ref id="B121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Breinig</surname><given-names>T</given-names></name><name name-style="western"><surname>Scheller</surname><given-names>N</given-names></name><name name-style="western"><surname>Glombitza</surname><given-names>B</given-names></name><name name-style="western"><surname>Breinig</surname><given-names>F</given-names></name><name name-style="western"><surname>Meyerhans</surname><given-names>A</given-names></name></person-group>. <article-title>Human yeast-specific CD8 T lymphocytes show a nonclassical effector molecule profile</article-title>. <source>Med Microbiol Immunol</source> (<year>2012</year>) <volume>201</volume>:<page-range>127&#8211;36</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s00430-011-0213-2</pub-id><pub-id pub-id-type="pmid">21947167</pub-id></mixed-citation></ref><ref id="B122"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heintel</surname><given-names>T</given-names></name><name name-style="western"><surname>Breinig</surname><given-names>F</given-names></name><name name-style="western"><surname>Schmitt</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Meyerhans</surname><given-names>A</given-names></name></person-group>. <article-title>Extensive MHC class I-restricted CD8 T lymphocyte responses against various yeast genera in humans</article-title>. <source>FEMS Immunol Med Microbiol</source> (<year>2003</year>) <volume>39</volume>:<page-range>279&#8211;86</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0928-8244(03)00294-3</pub-id><pub-id pub-id-type="pmid">14642314</pub-id></mixed-citation></ref><ref id="B123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Myers</surname><given-names>TA</given-names></name><name name-style="western"><surname>Leigh</surname><given-names>JE</given-names></name><name name-style="western"><surname>Arribas</surname><given-names>AR</given-names></name><name name-style="western"><surname>Hager</surname><given-names>S</given-names></name><name name-style="western"><surname>Clark</surname><given-names>R</given-names></name><name name-style="western"><surname>Lilly</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Immunohistochemical evaluation of T cells in oral lesions from human immunodeficiency virus-positive persons with oropharyngeal candidiasis</article-title>. <source>Infect Immun</source> (<year>2003</year>) <volume>71</volume>:<page-range>956&#8211;63</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.71.2.956-963.2003</pub-id><pub-id pub-id-type="pmcid">PMC145388</pub-id><pub-id pub-id-type="pmid">12540578</pub-id></mixed-citation></ref><ref id="B124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ickrath</surname><given-names>P</given-names></name><name name-style="western"><surname>Sprugel</surname><given-names>L</given-names></name><name name-style="western"><surname>Beyersdorf</surname><given-names>N</given-names></name><name name-style="western"><surname>Scherzad</surname><given-names>A</given-names></name><name name-style="western"><surname>Hagen</surname><given-names>R</given-names></name><name name-style="western"><surname>Hackenberg</surname><given-names>S</given-names></name></person-group>. <article-title>Detection of candida albicans-specific CD4+ and CD8+ T cells in the blood and nasal mucosa of patients with chronic rhinosinusitis</article-title>. <source>J Fungi (Basel)</source> (<year>2021</year>) <volume>7</volume>(<issue>6</issue>):<elocation-id>403</elocation-id>. doi: <pub-id pub-id-type="doi">10.3390/jof7060403</pub-id><pub-id pub-id-type="pmid">34063898</pub-id><pub-id pub-id-type="pmcid">PMC8224094</pub-id></mixed-citation></ref><ref id="B125"><label>125</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roilides</surname><given-names>E</given-names></name><name name-style="western"><surname>Dimitriadou</surname><given-names>A</given-names></name><name name-style="western"><surname>Kadiltsoglou</surname><given-names>I</given-names></name><name name-style="western"><surname>Sein</surname><given-names>T</given-names></name><name name-style="western"><surname>Karpouzas</surname><given-names>J</given-names></name><name name-style="western"><surname>Pizzo</surname><given-names>PA</given-names></name><etal/></person-group>. <article-title>IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against aspergillus fumigatus</article-title>. <source>J Immunol</source> (<year>1997</year>) <volume>158</volume>:<page-range>322&#8211;9</page-range>.<pub-id pub-id-type="pmid">8977206</pub-id></mixed-citation></ref><ref id="B126"><label>126</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cenci</surname><given-names>E</given-names></name><name name-style="western"><surname>Mencacci</surname><given-names>A</given-names></name><name name-style="western"><surname>Fe D&#8217;ostiani</surname><given-names>C</given-names></name><name name-style="western"><surname>Del Sero</surname><given-names>G</given-names></name><name name-style="western"><surname>Mosci</surname><given-names>P</given-names></name><name name-style="western"><surname>Montagnoli</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis</article-title>. <source>J Infect Dis</source> (<year>1998</year>) <volume>178</volume>:<page-range>1750&#8211;60</page-range>. doi: <pub-id pub-id-type="doi">10.1086/314493</pub-id><pub-id pub-id-type="pmid">9815229</pub-id></mixed-citation></ref><ref id="B127"><label>127</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cenci</surname><given-names>E</given-names></name><name name-style="western"><surname>Mencacci</surname><given-names>A</given-names></name><name name-style="western"><surname>Del Sero</surname><given-names>G</given-names></name><name name-style="western"><surname>Bacci</surname><given-names>A</given-names></name><name name-style="western"><surname>Montagnoli</surname><given-names>C</given-names></name><name name-style="western"><surname>D&#8217;ostiani</surname><given-names>CF</given-names></name><etal/></person-group>. <article-title>Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses</article-title>. <source>J Infect Dis</source> (<year>1999</year>) <volume>180</volume>:<page-range>1957&#8211;68</page-range>. doi: <pub-id pub-id-type="doi">10.1086/315142</pub-id><pub-id pub-id-type="pmid">10558953</pub-id></mixed-citation></ref><ref id="B128"><label>128</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bozza</surname><given-names>S</given-names></name><name name-style="western"><surname>Gaziano</surname><given-names>R</given-names></name><name name-style="western"><surname>Lipford</surname><given-names>GB</given-names></name><name name-style="western"><surname>Montagnoli</surname><given-names>C</given-names></name><name name-style="western"><surname>Bacci</surname><given-names>A</given-names></name><name name-style="western"><surname>Di Francesco</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Vaccination of mice against invasive aspergillosis with recombinant aspergillus proteins and CpG oligodeoxynucleotides as adjuvants</article-title>. <source>Microbes Infect</source> (<year>2002</year>) <volume>4</volume>:<page-range>1281&#8211;90</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S1286-4579(02)00007-2</pub-id><pub-id pub-id-type="pmid">12443892</pub-id></mixed-citation></ref><ref id="B129"><label>129</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ito</surname><given-names>JI</given-names></name><name name-style="western"><surname>Lyons</surname><given-names>JM</given-names></name></person-group>. <article-title>Vaccination of corticosteroid immunosuppressed mice against invasive pulmonary aspergillosis</article-title>. <source>J Infect Dis</source> (<year>2002</year>) <volume>186</volume>:<page-range>869&#8211;71</page-range>. doi: <pub-id pub-id-type="doi">10.1086/342509</pub-id><pub-id pub-id-type="pmid">12198627</pub-id></mixed-citation></ref><ref id="B130"><label>130</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stuehler</surname><given-names>C</given-names></name><name name-style="western"><surname>Khanna</surname><given-names>N</given-names></name><name name-style="western"><surname>Bozza</surname><given-names>S</given-names></name><name name-style="western"><surname>Zelante</surname><given-names>T</given-names></name><name name-style="western"><surname>Moretti</surname><given-names>S</given-names></name><name name-style="western"><surname>Kruhm</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Cross-protective TH1 immunity against aspergillus fumigatus and candida albicans</article-title>. <source>Blood</source> (<year>2011</year>) <volume>117</volume>:<page-range>5881&#8211;91</page-range>. doi: <pub-id pub-id-type="doi">10.1182/blood-2010-12-325084</pub-id><pub-id pub-id-type="pmid">21441461</pub-id></mixed-citation></ref><ref id="B131"><label>131</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levitz</surname><given-names>SM</given-names></name></person-group>. <article-title>Aspergillus vaccines: Hardly worth studying or worthy of hard study</article-title>? <source>Med Mycol</source> (<year>2017</year>) <volume>55</volume>:<page-range>103&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.1093/mmy/myw081</pub-id><pub-id pub-id-type="pmcid">PMC5166590</pub-id><pub-id pub-id-type="pmid">27639242</pub-id></mixed-citation></ref><ref id="B132"><label>132</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rai</surname><given-names>G</given-names></name><name name-style="western"><surname>Das</surname><given-names>S</given-names></name><name name-style="western"><surname>Ansari</surname><given-names>MA</given-names></name><name name-style="western"><surname>Singh</surname><given-names>PK</given-names></name><name name-style="western"><surname>Dar</surname><given-names>SA</given-names></name><name name-style="western"><surname>Haque</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>TLR-2 expression and dysregulated human Treg/Th17 phenotype in aspergillus flavus infected patients of chronic rhinosinusitis with nasal polyposis</article-title>. <source>Microb Cell Fact</source> (<year>2020</year>) <volume>19</volume>:<fpage>215</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12934-020-01481-3</pub-id><pub-id pub-id-type="pmid">33238997</pub-id><pub-id pub-id-type="pmcid">PMC7689976</pub-id></mixed-citation></ref><ref id="B133"><label>133</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clemons</surname><given-names>KV</given-names></name><name name-style="western"><surname>Grunig</surname><given-names>G</given-names></name><name name-style="western"><surname>Sobel</surname><given-names>RA</given-names></name><name name-style="western"><surname>Mirels</surname><given-names>LF</given-names></name><name name-style="western"><surname>Rennick</surname><given-names>DM</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>DA</given-names></name></person-group>. <article-title>Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis</article-title>. <source>Clin Exp Immunol</source> (<year>2000</year>) <volume>122</volume>:<page-range>186&#8211;91</page-range>. doi: <pub-id pub-id-type="doi">10.1046/j.1365-2249.2000.01382.x</pub-id><pub-id pub-id-type="pmcid">PMC1905763</pub-id><pub-id pub-id-type="pmid">11091273</pub-id></mixed-citation></ref><ref id="B134"><label>134</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sainz</surname><given-names>J</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>L</given-names></name><name name-style="western"><surname>Perez</surname><given-names>E</given-names></name><name name-style="western"><surname>Romero</surname><given-names>A</given-names></name><name name-style="western"><surname>Moratalla</surname><given-names>A</given-names></name><name name-style="western"><surname>Lopez-Fernandez</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosis</article-title>. <source>Immunol Lett</source> (<year>2007</year>) <volume>109</volume>:<fpage>76</fpage>&#8211;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.imlet.2007.01.005</pub-id><pub-id pub-id-type="pmid">17321603</pub-id></mixed-citation></ref><ref id="B135"><label>135</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cunha</surname><given-names>C</given-names></name><name name-style="western"><surname>Goncalves</surname><given-names>SM</given-names></name><name name-style="western"><surname>Duarte-Oliveira</surname><given-names>C</given-names></name><name name-style="western"><surname>Leite</surname><given-names>L</given-names></name><name name-style="western"><surname>Lagrou</surname><given-names>K</given-names></name><name name-style="western"><surname>Marques</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity</article-title>. <source>J Allergy Clin Immunol</source> (<year>2017</year>) <volume>140</volume>:<fpage>867</fpage>&#8211;<lpage>870 e869</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2017.02.034</pub-id><pub-id pub-id-type="pmid">28389392</pub-id></mixed-citation></ref><ref id="B136"><label>136</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grunig</surname><given-names>G</given-names></name><name name-style="western"><surname>Corry</surname><given-names>DB</given-names></name><name name-style="western"><surname>Leach</surname><given-names>MW</given-names></name><name name-style="western"><surname>Seymour</surname><given-names>BW</given-names></name><name name-style="western"><surname>Kurup</surname><given-names>VP</given-names></name><name name-style="western"><surname>Rennick</surname><given-names>DM</given-names></name></person-group>. <article-title>Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis</article-title>. <source>J Exp Med</source> (<year>1997</year>) <volume>185</volume>:<page-range>1089&#8211;99</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.185.6.1089</pub-id><pub-id pub-id-type="pmcid">PMC2196229</pub-id><pub-id pub-id-type="pmid">9091582</pub-id></mixed-citation></ref><ref id="B137"><label>137</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bacher</surname><given-names>P</given-names></name><name name-style="western"><surname>Schink</surname><given-names>C</given-names></name><name name-style="western"><surname>Teutschbein</surname><given-names>J</given-names></name><name name-style="western"><surname>Kniemeyer</surname><given-names>O</given-names></name><name name-style="western"><surname>Assenmacher</surname><given-names>M</given-names></name><name name-style="western"><surname>Brakhage</surname><given-names>AA</given-names></name><etal/></person-group>. <article-title>Antigen-reactive T cell enrichment for direct, high-resolution analysis of the human naive and memory Th cell repertoire</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>190</volume>:<page-range>3967&#8211;76</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1202221</pub-id><pub-id pub-id-type="pmid">23479226</pub-id></mixed-citation></ref><ref id="B138"><label>138</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stuehler</surname><given-names>C</given-names></name><name name-style="western"><surname>Nowakowska</surname><given-names>J</given-names></name><name name-style="western"><surname>Bernardini</surname><given-names>C</given-names></name><name name-style="western"><surname>Topp</surname><given-names>MS</given-names></name><name name-style="western"><surname>Battegay</surname><given-names>M</given-names></name><name name-style="western"><surname>Passweg</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Multispecific aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections</article-title>. <source>J Infect Dis</source> (<year>2015</year>) <volume>211</volume>:<page-range>1251&#8211;61</page-range>. doi: <pub-id pub-id-type="doi">10.1093/infdis/jiu607</pub-id><pub-id pub-id-type="pmid">25367298</pub-id></mixed-citation></ref><ref id="B139"><label>139</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gottlieb</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Clancy</surname><given-names>LE</given-names></name><name name-style="western"><surname>Withers</surname><given-names>B</given-names></name><name name-style="western"><surname>Mcguire</surname><given-names>HM</given-names></name><name name-style="western"><surname>Luciani</surname><given-names>F</given-names></name><name name-style="western"><surname>Singh</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Prophylactic antigen-specific T-cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant</article-title>. <source>Clin Transl Immunol</source> (<year>2021</year>) <volume>10</volume>:<elocation-id>e1249</elocation-id>. doi: <pub-id pub-id-type="doi">10.1002/cti2.1249</pub-id><pub-id pub-id-type="pmcid">PMC7960021</pub-id><pub-id pub-id-type="pmid">33747509</pub-id></mixed-citation></ref><ref id="B140"><label>140</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inam</surname><given-names>SS,G</given-names></name><name name-style="western"><surname>Avdic</surname><given-names>S</given-names></name><name name-style="western"><surname>Street</surname><given-names>J</given-names></name><name name-style="western"><surname>Atkins</surname><given-names>E</given-names></name><name name-style="western"><surname>Clany</surname><given-names>LE</given-names></name><name name-style="western"><surname>Gottlieb</surname><given-names>DJ</given-names></name></person-group>. <article-title>Third-party partially HLA matched fungus-specific T-cells (FSTs) used to treat invasive fungal infection (IFI) with scedosporium aurantiacum after allogeneic hemopoietic stem cell transplant (aHSCT)</article-title>. <source>Blood</source> (<year>2021</year>) <volume>138</volume>(<issue>1</issue>):<elocation-id>2825</elocation-id>. doi: <pub-id pub-id-type="doi">10.1182/blood-2021-152384</pub-id></mixed-citation></ref><ref id="B141"><label>141</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Castellano-Gonzalez</surname><given-names>G</given-names></name><name name-style="western"><surname>Mcguire</surname><given-names>HM</given-names></name><name name-style="western"><surname>Luciani</surname><given-names>F</given-names></name><name name-style="western"><surname>Clancy</surname><given-names>LE</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Avdic</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Rapidly expanded partially HLA DRB1-matched fungus-specific T cells mediate <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> antifungal activity</article-title>. <source>Blood Adv</source> (<year>2020</year>) <volume>4</volume>:<page-range>3443&#8211;56</page-range>. doi: <pub-id pub-id-type="doi">10.1182/bloodadvances.2020001565</pub-id><pub-id pub-id-type="pmcid">PMC7391149</pub-id><pub-id pub-id-type="pmid">32722785</pub-id></mixed-citation></ref><ref id="B142"><label>142</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirahara</surname><given-names>K</given-names></name><name name-style="western"><surname>Kokubo</surname><given-names>K</given-names></name><name name-style="western"><surname>Aoki</surname><given-names>A</given-names></name><name name-style="western"><surname>Kiuchi</surname><given-names>M</given-names></name><name name-style="western"><surname>Nakayama</surname><given-names>T</given-names></name></person-group>. <article-title>The role of CD4(+) resident memory T cells in local immunity in the mucosal tissue - protection versus pathology</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>616309</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.616309</pub-id><pub-id pub-id-type="pmid">33968018</pub-id><pub-id pub-id-type="pmcid">PMC8097179</pub-id></mixed-citation></ref><ref id="B143"><label>143</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaudhary</surname><given-names>N</given-names></name><name name-style="western"><surname>Staab</surname><given-names>JF</given-names></name><name name-style="western"><surname>Marr</surname><given-names>KA</given-names></name></person-group>. <article-title>Healthy human T-cell responses to aspergillus fumigatus antigens</article-title>. <source>PloS One</source> (<year>2010</year>) <volume>5</volume>:<elocation-id>e9036</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0009036</pub-id><pub-id pub-id-type="pmid">20174463</pub-id><pub-id pub-id-type="pmcid">PMC2822840</pub-id></mixed-citation></ref><ref id="B144"><label>144</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>L</given-names></name><name name-style="western"><surname>Cisse</surname><given-names>OH</given-names></name><name name-style="western"><surname>Kovacs</surname><given-names>JA</given-names></name></person-group>. <article-title>A molecular window into the biology and epidemiology of pneumocystis spp</article-title>. <source>Clin Microbiol Rev</source> (<year>2018</year>) <volume>31</volume>(<issue>3</issue>):<elocation-id>e00009-18</elocation-id>. doi: <pub-id pub-id-type="doi">10.1128/CMR.00009-18</pub-id><pub-id pub-id-type="pmid">29899010</pub-id><pub-id pub-id-type="pmcid">PMC6056843</pub-id></mixed-citation></ref><ref id="B145"><label>145</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elsegeiny</surname><given-names>W</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>M</given-names></name><name name-style="western"><surname>Eddens</surname><given-names>T</given-names></name><name name-style="western"><surname>Gallo</surname><given-names>RL</given-names></name><name name-style="western"><surname>Dai</surname><given-names>G</given-names></name><name name-style="western"><surname>Trevejo-Nunez</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Murine models of pneumocystis infection recapitulate human primary immune disorders</article-title>. <source>JCI Insight</source> (<year>2018</year>) <volume>3</volume>(<issue>12</issue>):<elocation-id>e91894</elocation-id>. doi: <pub-id pub-id-type="doi">10.1172/jci.insight.91894</pub-id><pub-id pub-id-type="pmcid">PMC6124425</pub-id><pub-id pub-id-type="pmid">29925696</pub-id></mixed-citation></ref><ref id="B146"><label>146</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elsegeiny</surname><given-names>W</given-names></name><name name-style="western"><surname>Eddens</surname><given-names>T</given-names></name><name name-style="western"><surname>Chen</surname><given-names>K</given-names></name><name name-style="western"><surname>Kolls</surname><given-names>JK</given-names></name></person-group>. <article-title>Anti-CD20 antibody therapy and susceptibility to pneumocystis pneumonia</article-title>. <source>Infect Immun</source> (<year>2015</year>) <volume>83</volume>:<page-range>2043&#8211;52</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.03099-14</pub-id><pub-id pub-id-type="pmcid">PMC4399075</pub-id><pub-id pub-id-type="pmid">25733518</pub-id></mixed-citation></ref><ref id="B147"><label>147</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hofmann</surname><given-names>K</given-names></name><name name-style="western"><surname>Clauder</surname><given-names>AK</given-names></name><name name-style="western"><surname>Manz</surname><given-names>RA</given-names></name></person-group>. <article-title>Targeting b cells and plasma cells in autoimmune diseases</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>9</volume>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.00835</pub-id><pub-id pub-id-type="pmcid">PMC5924791</pub-id><pub-id pub-id-type="pmid">29740441</pub-id></mixed-citation></ref><ref id="B148"><label>148</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lund</surname><given-names>FE</given-names></name><name name-style="western"><surname>Hollifield</surname><given-names>M</given-names></name><name name-style="western"><surname>Schuer</surname><given-names>K</given-names></name><name name-style="western"><surname>Lines</surname><given-names>JL</given-names></name><name name-style="western"><surname>Randall</surname><given-names>TD</given-names></name><name name-style="western"><surname>Garvy</surname><given-names>BA</given-names></name></person-group>. <article-title>B cells are required for generation of protective effector and memory CD4 cells in response to pneumocystis lung infection</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>176</volume>:<page-range>6147&#8211;54</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.176.10.6147</pub-id><pub-id pub-id-type="pmid">16670323</pub-id></mixed-citation></ref><ref id="B149"><label>149</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Opata</surname><given-names>MM</given-names></name><name name-style="western"><surname>Hollifield</surname><given-names>ML</given-names></name><name name-style="western"><surname>Lund</surname><given-names>FE</given-names></name><name name-style="western"><surname>Randall</surname><given-names>TD</given-names></name><name name-style="western"><surname>Dunn</surname><given-names>R</given-names></name><name name-style="western"><surname>Garvy</surname><given-names>BA</given-names></name><etal/></person-group>. <article-title>B lymphocytes are required during the early priming of CD4(+) T cells for clearance of pneumocystis infection in mice</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>195</volume>:<page-range>611&#8211;20</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1500112</pub-id><pub-id pub-id-type="pmcid">PMC4491042</pub-id><pub-id pub-id-type="pmid">26041535</pub-id></mixed-citation></ref><ref id="B150"><label>150</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kling</surname><given-names>HM</given-names></name><name name-style="western"><surname>Norris</surname><given-names>KA</given-names></name></person-group>. <article-title>Vaccine-induced immunogenicity and protection against pneumocystis pneumonia in a nonhuman primate model of HIV and pneumocystis coinfection</article-title>. <source>J Infect Dis</source> (<year>2016</year>) <volume>213</volume>:<page-range>1586&#8211;95</page-range>. doi: <pub-id pub-id-type="doi">10.1093/infdis/jiw032</pub-id><pub-id pub-id-type="pmcid">PMC4837913</pub-id><pub-id pub-id-type="pmid">26823337</pub-id></mixed-citation></ref><ref id="B151"><label>151</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>MN</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>M</given-names></name><name name-style="western"><surname>Ruan</surname><given-names>S</given-names></name><name name-style="western"><surname>Kolls</surname><given-names>J</given-names></name><name name-style="western"><surname>D&#8217;souza</surname><given-names>A</given-names></name><name name-style="western"><surname>Shellito</surname><given-names>JE</given-names></name></person-group>. <article-title>Memory CD4+ T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen pneumocystis murina</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>190</volume>:<page-range>285&#8211;95</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1200861</pub-id><pub-id pub-id-type="pmcid">PMC3711123</pub-id><pub-id pub-id-type="pmid">23203926</pub-id></mixed-citation></ref><ref id="B152"><label>152</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tesini</surname><given-names>BL</given-names></name><name name-style="western"><surname>Wright</surname><given-names>TW</given-names></name><name name-style="western"><surname>Malone</surname><given-names>JE</given-names></name><name name-style="western"><surname>Haidaris</surname><given-names>CG</given-names></name><name name-style="western"><surname>Harber</surname><given-names>M</given-names></name><name name-style="western"><surname>Sant</surname><given-names>AJ</given-names></name><etal/></person-group>. <article-title>Immunization with pneumocystis cross-reactive antigen 1 (Pca1) protects mice against pneumocystis pneumonia and generates antibody to pneumocystis jirovecii</article-title>. <source>Infect Immun</source> (<year>2017</year>) <volume>85</volume>(<issue>4</issue>):<elocation-id>e00850-16</elocation-id>. doi: <pub-id pub-id-type="doi">10.1128/IAI.00850-16</pub-id><pub-id pub-id-type="pmid">28031260</pub-id><pub-id pub-id-type="pmcid">PMC5364303</pub-id></mixed-citation></ref><ref id="B153"><label>153</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huffnagle</surname><given-names>GB</given-names></name><name name-style="western"><surname>Yates</surname><given-names>JL</given-names></name><name name-style="western"><surname>Lipscomb</surname><given-names>MF</given-names></name></person-group>. <article-title>Immunity to a pulmonary cryptococcus neoformans infection requires both CD4+ and CD8+ T cells</article-title>. <source>J Exp Med</source> (<year>1991</year>) <volume>173</volume>:<fpage>793</fpage>&#8211;<lpage>800</lpage>. doi: <pub-id pub-id-type="doi">10.1084/jem.173.4.793</pub-id><pub-id pub-id-type="pmid">1672543</pub-id><pub-id pub-id-type="pmcid">PMC2190813</pub-id></mixed-citation></ref><ref id="B154"><label>154</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wormley</surname><given-names>FL</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Perfect</surname><given-names>JR</given-names></name><name name-style="western"><surname>Steele</surname><given-names>C</given-names></name><name name-style="western"><surname>Cox</surname><given-names>GM</given-names></name></person-group>. <article-title>Protection against cryptococcosis by using a murine gamma interferon-producing cryptococcus neoformans strain</article-title>. <source>Infect Immun</source> (<year>2007</year>) <volume>75</volume>:<page-range>1453&#8211;62</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.00274-06</pub-id><pub-id pub-id-type="pmcid">PMC1828544</pub-id><pub-id pub-id-type="pmid">17210668</pub-id></mixed-citation></ref><ref id="B155"><label>155</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wozniak</surname><given-names>KL</given-names></name><name name-style="western"><surname>Young</surname><given-names>ML</given-names></name><name name-style="western"><surname>Wormley</surname><given-names>FL</given-names><suffix>Jr</suffix></name></person-group>. <article-title>Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice</article-title>. <source>Clin Vaccine Immunol</source> (<year>2011</year>) <volume>18</volume>:<page-range>717&#8211;23</page-range>. doi: <pub-id pub-id-type="doi">10.1128/CVI.00036-11</pub-id><pub-id pub-id-type="pmcid">PMC3122518</pub-id><pub-id pub-id-type="pmid">21450975</pub-id></mixed-citation></ref><ref id="B156"><label>156</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Specht</surname><given-names>CA</given-names></name><name name-style="western"><surname>Homan</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>CK</given-names></name><name name-style="western"><surname>Mou</surname><given-names>Z</given-names></name><name name-style="western"><surname>Gomez</surname><given-names>CL</given-names></name><name name-style="western"><surname>Hester</surname><given-names>MM</given-names></name><etal/></person-group>. <article-title>Protection of mice against experimental cryptococcosis by synthesized peptides delivered in glucan particles</article-title>. <source>mBio</source> (<year>2022</year>) <volume>13</volume>(<issue>1</issue>):<elocation-id>e0336721</elocation-id>. doi: <pub-id pub-id-type="doi">10.1128/mbio.03367-21</pub-id><pub-id pub-id-type="pmcid">PMC8725579</pub-id><pub-id pub-id-type="pmid">35089095</pub-id></mixed-citation></ref><ref id="B157"><label>157</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hester</surname><given-names>MM</given-names></name><name name-style="western"><surname>Lee</surname><given-names>CK</given-names></name><name name-style="western"><surname>Abraham</surname><given-names>A</given-names></name><name name-style="western"><surname>Khoshkenar</surname><given-names>P</given-names></name><name name-style="western"><surname>Ostroff</surname><given-names>GR</given-names></name><name name-style="western"><surname>Levitz</surname><given-names>SM</given-names></name><etal/></person-group>. <article-title>Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens</article-title>. <source>Vaccine</source> (<year>2020</year>) <volume>38</volume>:<page-range>620&#8211;6</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.vaccine.2019.10.051</pub-id><pub-id pub-id-type="pmcid">PMC6954324</pub-id><pub-id pub-id-type="pmid">31699504</pub-id></mixed-citation></ref><ref id="B158"><label>158</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaturvedi</surname><given-names>AK</given-names></name><name name-style="western"><surname>Hameed</surname><given-names>RS</given-names></name><name name-style="western"><surname>Wozniak</surname><given-names>KL</given-names></name><name name-style="western"><surname>Hole</surname><given-names>CR</given-names></name><name name-style="western"><surname>Leopold Wager</surname><given-names>CM</given-names></name><name name-style="western"><surname>Weintraub</surname><given-names>ST</given-names></name><etal/></person-group>. <article-title>Vaccine-mediated immune responses to experimental pulmonary cryptococcus gattii infection in mice</article-title>. <source>PloS One</source> (<year>2014</year>) <volume>9</volume>:<elocation-id>e104316</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0104316</pub-id><pub-id pub-id-type="pmid">25119981</pub-id><pub-id pub-id-type="pmcid">PMC4132117</pub-id></mixed-citation></ref><ref id="B159"><label>159</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Normile</surname><given-names>TG</given-names></name><name name-style="western"><surname>Rella</surname><given-names>A</given-names></name><name name-style="western"><surname>Del Poeta</surname><given-names>M</given-names></name></person-group>. <article-title>Cryptococcus neoformans Deltasgl1 vaccination requires either CD4(+) or CD8(+) T cells for complete host protection</article-title>. <source>Front Cell Infect Microbiol</source> (<year>2021</year>) <volume>11</volume>:<elocation-id>739027</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2021.739027</pub-id><pub-id pub-id-type="pmid">34568097</pub-id><pub-id pub-id-type="pmcid">PMC8455912</pub-id></mixed-citation></ref><ref id="B160"><label>160</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jarvis</surname><given-names>JN</given-names></name><name name-style="western"><surname>Casazza</surname><given-names>JP</given-names></name><name name-style="western"><surname>Stone</surname><given-names>HH</given-names></name><name name-style="western"><surname>Meintjes</surname><given-names>G</given-names></name><name name-style="western"><surname>Lawn</surname><given-names>SD</given-names></name><name name-style="western"><surname>Levitz</surname><given-names>SM</given-names></name><etal/></person-group>. <article-title>The phenotype of the cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis</article-title>. <source>J Infect Dis</source> (<year>2013</year>) <volume>207</volume>:<page-range>1817&#8211;28</page-range>. doi: <pub-id pub-id-type="doi">10.1093/infdis/jit099</pub-id><pub-id pub-id-type="pmcid">PMC3654748</pub-id><pub-id pub-id-type="pmid">23493728</pub-id></mixed-citation></ref><ref id="B161"><label>161</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meya</surname><given-names>DB</given-names></name><name name-style="western"><surname>Okurut</surname><given-names>S</given-names></name><name name-style="western"><surname>Zziwa</surname><given-names>G</given-names></name><name name-style="western"><surname>Cose</surname><given-names>S</given-names></name><name name-style="western"><surname>Boulware</surname><given-names>DR</given-names></name><name name-style="western"><surname>Janoff</surname><given-names>EN</given-names></name></person-group>. <article-title>HIV-Associated cryptococcal immune reconstitution inflammatory syndrome is associated with aberrant T cell function and increased cytokine responses</article-title>. <source>J Fungi (Basel)</source> (<year>2019</year>) <volume>5</volume>(<issue>2</issue>):<page-range>42</page-range>. doi: <pub-id pub-id-type="doi">10.20944/preprints201904.0086.v1</pub-id><pub-id pub-id-type="pmcid">PMC6616503</pub-id><pub-id pub-id-type="pmid">31126019</pub-id></mixed-citation></ref><ref id="B162"><label>162</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wuthrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Hung</surname><given-names>CY</given-names></name><name name-style="western"><surname>Gern</surname><given-names>BH</given-names></name><name name-style="western"><surname>Pick-Jacobs</surname><given-names>JC</given-names></name><name name-style="western"><surname>Galles</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Filutowicz</surname><given-names>HI</given-names></name><etal/></person-group>. <article-title>A TCR transgenic mouse reactive with multiple systemic dimorphic fungi</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>187</volume>:<page-range>1421&#8211;31</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1100921</pub-id><pub-id pub-id-type="pmcid">PMC3140549</pub-id><pub-id pub-id-type="pmid">21705621</pub-id></mixed-citation></ref><ref id="B163"><label>163</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wuthrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Brandhorst</surname><given-names>TT</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>TD</given-names></name><name name-style="western"><surname>Filutowicz</surname><given-names>H</given-names></name><name name-style="western"><surname>Sterkel</surname><given-names>A</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Calnexin induces expansion of antigen-specific CD4(+) T cells that confer immunity to fungal ascomycetes <italic toggle="yes">via</italic> conserved epitopes</article-title>. <source>Cell Host Microbe</source> (<year>2015</year>) <volume>17</volume>:<page-range>452&#8211;65</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2015.02.009</pub-id><pub-id pub-id-type="pmcid">PMC4484745</pub-id><pub-id pub-id-type="pmid">25800545</pub-id></mixed-citation></ref><ref id="B164"><label>164</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rivera</surname><given-names>A</given-names></name><name name-style="western"><surname>Hohl</surname><given-names>TM</given-names></name></person-group>. <article-title>Calnexin bridges the gap toward a pan-fungal vaccine</article-title>. <source>Cell Host Microbe</source> (<year>2015</year>) <volume>17</volume>:<page-range>421&#8211;3</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2015.03.012</pub-id><pub-id pub-id-type="pmid">25856750</pub-id></mixed-citation></ref><ref id="B165"><label>165</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dobson</surname><given-names>HE</given-names></name><name name-style="western"><surname>Dias</surname><given-names>LDS</given-names></name><name name-style="western"><surname>Kohn</surname><given-names>EM</given-names></name><name name-style="western"><surname>Fites</surname><given-names>S</given-names></name><name name-style="western"><surname>Wiesner</surname><given-names>DL</given-names></name><name name-style="western"><surname>Dileepan</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Antigen discovery unveils resident memory and migratory cell roles in antifungal resistance</article-title>. <source>Mucosal Immunol</source> (<year>2020</year>) <volume>13</volume>:<page-range>518&#8211;29</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41385-019-0244-3</pub-id><pub-id pub-id-type="pmcid">PMC7183437</pub-id><pub-id pub-id-type="pmid">31900406</pub-id></mixed-citation></ref><ref id="B166"><label>166</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dos Santos Dias</surname><given-names>L</given-names></name><name name-style="western"><surname>Dobson</surname><given-names>HE</given-names></name><name name-style="western"><surname>Bakke</surname><given-names>BK</given-names></name><name name-style="western"><surname>Kujoth</surname><given-names>GC</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><name name-style="western"><surname>Kohn</surname><given-names>EM</given-names></name><etal/></person-group>. <article-title>Structural basis of blastomyces endoglucanase-2 adjuvancy in anti-fungal and -viral immunity</article-title>. <source>PloS Pathog</source> (<year>2021</year>) <volume>17</volume>:<elocation-id>e1009324</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1009324</pub-id><pub-id pub-id-type="pmid">33735218</pub-id><pub-id pub-id-type="pmcid">PMC8009368</pub-id></mixed-citation></ref><ref id="B167"><label>167</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wuthrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Dobson</surname><given-names>HE</given-names></name><name name-style="western"><surname>Ledesma Taira</surname><given-names>C</given-names></name><name name-style="western"><surname>Okaa</surname><given-names>UJ</given-names></name><name name-style="western"><surname>Dos Santos Dias</surname><given-names>L</given-names></name><name name-style="western"><surname>Isidoro-Ayza</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Combination adjuvants enhance recombinant protein vaccine protection against fungal infection</article-title>. <source>mBio</source> (<year>2021</year>) <volume>12</volume>:<fpage>e0201821</fpage>. doi: <pub-id pub-id-type="doi">10.1128/mBio.02018-21</pub-id><pub-id pub-id-type="pmid">34399628</pub-id><pub-id pub-id-type="pmcid">PMC8406321</pub-id></mixed-citation></ref><ref id="B168"><label>168</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wuthrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Filutowicz</surname><given-names>HI</given-names></name><name name-style="western"><surname>Warner</surname><given-names>T</given-names></name><name name-style="western"><surname>Deepe</surname><given-names>GS</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Klein</surname><given-names>BS</given-names></name></person-group>. <article-title>Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts</article-title>. <source>J Exp Med</source> (<year>2003</year>) <volume>197</volume>:<page-range>1405&#8211;16</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.20030109</pub-id><pub-id pub-id-type="pmcid">PMC2193905</pub-id><pub-id pub-id-type="pmid">12782709</pub-id></mixed-citation></ref><ref id="B169"><label>169</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nanjappa</surname><given-names>SG</given-names></name><name name-style="western"><surname>Heninger</surname><given-names>E</given-names></name><name name-style="western"><surname>Wuthrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>T</given-names></name><name name-style="western"><surname>Klein</surname><given-names>B</given-names></name></person-group>. <article-title>Protective antifungal memory CD8(+) T cells are maintained in the absence of CD4(+) T cell help and cognate antigen in mice</article-title>. <source>J Clin Invest</source> (<year>2012</year>) <volume>122</volume>:<page-range>987&#8211;99</page-range>. doi: <pub-id pub-id-type="doi">10.1172/JCI58762</pub-id><pub-id pub-id-type="pmcid">PMC3287218</pub-id><pub-id pub-id-type="pmid">22354169</pub-id></mixed-citation></ref><ref id="B170"><label>170</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nanjappa</surname><given-names>SG</given-names></name><name name-style="western"><surname>Mudalagiriyappa</surname><given-names>S</given-names></name><name name-style="western"><surname>Fites</surname><given-names>JS</given-names></name><name name-style="western"><surname>Suresh</surname><given-names>M</given-names></name><name name-style="western"><surname>Klein</surname><given-names>BS</given-names></name></person-group>. <article-title>CBLB constrains inactivated vaccine-induced CD8(+) T cell responses and immunity against lethal fungal pneumonia</article-title>. <source>J Immunol</source> (<year>2018</year>) <volume>201</volume>:<page-range>1717&#8211;26</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1701241</pub-id><pub-id pub-id-type="pmcid">PMC6125178</pub-id><pub-id pub-id-type="pmid">30054317</pub-id></mixed-citation></ref><ref id="B171"><label>171</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mudalagiriyappa</surname><given-names>SS,J</given-names></name><name name-style="western"><surname>Vieson</surname><given-names>M</given-names></name><name name-style="western"><surname>Klein</surname><given-names>BS</given-names></name><name name-style="western"><surname>Nanjappa</surname><given-names>SG</given-names></name></person-group>. <article-title>GM-CSF + Tc17 cells are required to bolster vaccine immunity against lethal fungal pneumonia without causing overt pathology</article-title>. <source>SSRN</source> (<year>2022</year>). doi: <pub-id pub-id-type="doi">10.2139/ssrn.4099074</pub-id><pub-id pub-id-type="pmcid">PMC9641983</pub-id><pub-id pub-id-type="pmid">36288707</pub-id></mixed-citation></ref><ref id="B172"><label>172</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edwards</surname><given-names>LB</given-names></name><name name-style="western"><surname>Acquaviva</surname><given-names>FA</given-names></name><name name-style="western"><surname>Livesay</surname><given-names>VT</given-names></name><name name-style="western"><surname>Cross</surname><given-names>FW</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>CE</given-names></name></person-group>. <article-title>An atlas of sensitivity to tuberculin, PPD-b, and histoplasmin in the united states</article-title>. <source>Am Rev Respir Dis</source> (<year>1969</year>) <volume>99</volume>:<page-range>Suppl:1&#8211;132</page-range>.<pub-id pub-id-type="pmid">5767603</pub-id></mixed-citation></ref><ref id="B173"><label>173</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allendorfer</surname><given-names>R</given-names></name><name name-style="western"><surname>Brunner</surname><given-names>GD</given-names></name><name name-style="western"><surname>Deepe</surname><given-names>GS</given-names><suffix>Jr</suffix></name></person-group>. <article-title>Complex requirements for nascent and memory immunity in pulmonary histoplasmosis</article-title>. <source>J Immunol</source> (<year>1999</year>) <volume>162</volume>:<page-range>7389&#8211;96</page-range>.<pub-id pub-id-type="pmid">10358191</pub-id></mixed-citation></ref><ref id="B174"><label>174</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deepe</surname><given-names>GS</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Gibbons</surname><given-names>RS</given-names></name></person-group>. <article-title>Protective and memory immunity to histoplasma capsulatum in the absence of IL-10</article-title>. <source>J Immunol</source> (<year>2003</year>) <volume>171</volume>:<page-range>5353&#8211;62</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.171.10.5353</pub-id><pub-id pub-id-type="pmid">14607938</pub-id></mixed-citation></ref><ref id="B175"><label>175</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deepe</surname><given-names>GS</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Gibbons</surname><given-names>RS</given-names></name></person-group>. <article-title>Interleukins 17 and 23 influence the host response to histoplasma capsulatum</article-title>. <source>J Infect Dis</source> (<year>2009</year>) <volume>200</volume>:<page-range>142&#8211;51</page-range>. doi: <pub-id pub-id-type="doi">10.1086/599333</pub-id><pub-id pub-id-type="pmcid">PMC2715335</pub-id><pub-id pub-id-type="pmid">19469707</pub-id></mixed-citation></ref><ref id="B176"><label>176</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deepe</surname><given-names>GS</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Gibbons</surname><given-names>RS</given-names></name></person-group>. <article-title>Cellular and molecular regulation of vaccination with heat shock protein 60 from histoplasma capsulatum</article-title>. <source>Infect Immun</source> (<year>2002</year>) <volume>70</volume>:<page-range>3759&#8211;67</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.70.7.3759-3767.2002</pub-id><pub-id pub-id-type="pmcid">PMC128065</pub-id><pub-id pub-id-type="pmid">12065519</pub-id></mixed-citation></ref><ref id="B177"><label>177</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deepe</surname><given-names>GS</given-names></name></person-group>. <article-title>Role of Cd8(+) T-cells in host-resistance to systemic infection with histoplasma-capsulatum in mice</article-title>. <source>J Immunol</source> (<year>1994</year>) <volume>152</volume>:<page-range>3491&#8211;500</page-range>.<pub-id pub-id-type="pmid">8144930</pub-id></mixed-citation></ref><ref id="B178"><label>178</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>P</given-names></name><name name-style="western"><surname>Freidag</surname><given-names>BL</given-names></name><name name-style="western"><surname>Caldwell</surname><given-names>CC</given-names></name><name name-style="western"><surname>Seder</surname><given-names>RA</given-names></name></person-group>. <article-title>Perforin is required for primary immunity to histoplasma capsulatum</article-title>. <source>J Immunol</source> (<year>2001</year>) <volume>166</volume>:<page-range>1968&#8211;74</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.166.3.1968</pub-id><pub-id pub-id-type="pmid">11160245</pub-id></mixed-citation></ref><ref id="B179"><label>179</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hung</surname><given-names>CY</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>AP</given-names></name><name name-style="western"><surname>Holland</surname><given-names>SM</given-names></name><name name-style="western"><surname>Fierer</surname><given-names>J</given-names></name></person-group>. <article-title>A review of innate and adaptive immunity to coccidioidomycosis</article-title>. <source>Med Mycol</source> (<year>2019</year>) <volume>57</volume>:<page-range>S85&#8211;92</page-range>. doi: <pub-id pub-id-type="doi">10.1093/mmy/myy146</pub-id><pub-id pub-id-type="pmcid">PMC6347076</pub-id><pub-id pub-id-type="pmid">30690602</pub-id></mixed-citation></ref><ref id="B180"><label>180</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ward</surname><given-names>RA</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>GR</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Villani</surname><given-names>AC</given-names></name><name name-style="western"><surname>Li</surname><given-names>B</given-names></name><name name-style="western"><surname>Mansour</surname><given-names>MK</given-names></name><name name-style="western"><surname>Wuethrich</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>The known unknowns of the immune response to coccidioides</article-title>. <source>J Fungi (Basel)</source> (<year>2021</year>) <volume>7</volume>(<issue>5</issue>):<elocation-id>377</elocation-id>. doi: <pub-id pub-id-type="doi">10.3390/jof7050377</pub-id><pub-id pub-id-type="pmid">34065016</pub-id><pub-id pub-id-type="pmcid">PMC8151481</pub-id></mixed-citation></ref><ref id="B181"><label>181</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fierer</surname><given-names>J</given-names></name><name name-style="western"><surname>Walls</surname><given-names>L</given-names></name><name name-style="western"><surname>Eckmann</surname><given-names>L</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>T</given-names></name><name name-style="western"><surname>Kirkland</surname><given-names>TN</given-names></name></person-group>. <article-title>Importance of interleukin-10 in genetic susceptibility of mice to coccidioides immitis</article-title>. <source>Infect Immun</source> (<year>1998</year>) <volume>66</volume>:<page-range>4397&#8211;402</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.66.9.4397-4402.1998</pub-id><pub-id pub-id-type="pmcid">PMC108531</pub-id><pub-id pub-id-type="pmid">9712793</pub-id></mixed-citation></ref><ref id="B182"><label>182</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davini</surname><given-names>D</given-names></name><name name-style="western"><surname>Naeem</surname><given-names>F</given-names></name><name name-style="western"><surname>Phong</surname><given-names>A</given-names></name><name name-style="western"><surname>Al-Kuhlani</surname><given-names>M</given-names></name><name name-style="western"><surname>Valentine</surname><given-names>KM</given-names></name><name name-style="western"><surname>Mccarty</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Elevated regulatory T cells at diagnosis of coccidioides infection associates with chronicity in pediatric patients</article-title>. <source>J Allergy Clin Immunol</source> (<year>2018</year>) <volume>142</volume>:<fpage>1971</fpage>&#8211;<lpage>1974 e1977</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2018.10.022</pub-id><pub-id pub-id-type="pmid">30539725</pub-id></mixed-citation></ref><ref id="B183"><label>183</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nesbit</surname><given-names>L</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>SM</given-names></name><name name-style="western"><surname>Pappagianis</surname><given-names>D</given-names></name><name name-style="western"><surname>Ampel</surname><given-names>NM</given-names></name></person-group>. <article-title>Polyfunctional T lymphocytes are in the peripheral blood of donors naturally immune to coccidioidomycosis and are not induced by dendritic cells</article-title>. <source>Infect Immun</source> (<year>2010</year>) <volume>78</volume>:<page-range>309&#8211;15</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.00953-09</pub-id><pub-id pub-id-type="pmcid">PMC2798172</pub-id><pub-id pub-id-type="pmid">19901066</pub-id></mixed-citation></ref><ref id="B184"><label>184</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pappagianis</surname><given-names>D</given-names></name></person-group>. <article-title>Evaluation of the protective efficacy of the killed coccidioides immitis spherule vaccine in humans. the valley fever vaccine study group</article-title>. <source>Am Rev Respir Dis</source> (<year>1993</year>) <volume>148</volume>:<page-range>656&#8211;60</page-range>. doi: <pub-id pub-id-type="doi">10.1164/ajrccm/148.3.656</pub-id><pub-id pub-id-type="pmid">8368636</pub-id></mixed-citation></ref><ref id="B185"><label>185</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tarcha</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Basrur</surname><given-names>V</given-names></name><name name-style="western"><surname>Hung</surname><given-names>CY</given-names></name><name name-style="western"><surname>Gardner</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Cole</surname><given-names>GT</given-names></name></person-group>. <article-title>Multivalent recombinant protein vaccine against coccidioidomycosis</article-title>. <source>Infect Immun</source> (<year>2006</year>) <volume>74</volume>:<page-range>5802&#8211;13</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.00961-06</pub-id><pub-id pub-id-type="pmcid">PMC1594896</pub-id><pub-id pub-id-type="pmid">16988258</pub-id></mixed-citation></ref><ref id="B186"><label>186</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campuzano</surname><given-names>AP</given-names></name><name name-style="western"><surname>Komali Devi</surname><given-names>P</given-names></name><name name-style="western"><surname>Liao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Wiederhold</surname><given-names>N</given-names></name><name name-style="western"><surname>Ostroff</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>A recombinant multivalent vaccine (rCpa1) induces protection for C57BL/6 and HLA transgenic mice against pulmonary infection with both species of coccidioides</article-title>. <source>bioRxiv</source> (<year>2021</year>). doi: <pub-id pub-id-type="doi">10.1101/2021.10.20.465232</pub-id><pub-id pub-id-type="pmcid">PMC10819930</pub-id><pub-id pub-id-type="pmid">38250880</pub-id></mixed-citation></ref><ref id="B187"><label>187</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burger</surname><given-names>E</given-names></name></person-group>. <article-title>Paracoccidioidomycosis protective immunity</article-title>. <source>J Fungi (Basel)</source> (<year>2021</year>) <volume>7</volume>(<issue>2</issue>):<elocation-id>137</elocation-id>. doi: <pub-id pub-id-type="doi">10.3390/jof7020137</pub-id><pub-id pub-id-type="pmid">33668671</pub-id><pub-id pub-id-type="pmcid">PMC7918802</pub-id></mixed-citation></ref><ref id="B188"><label>188</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Castro</surname><given-names>LF</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>MC</given-names></name><name name-style="western"><surname>Da Silva</surname><given-names>RM</given-names></name><name name-style="western"><surname>Blotta</surname><given-names>MH</given-names></name><name name-style="western"><surname>Longhi</surname><given-names>LN</given-names></name><name name-style="western"><surname>Mamoni</surname><given-names>RL</given-names></name></person-group>. <article-title>Characterization of the immune response in human paracoccidioidomycosis</article-title>. <source>J Infect</source> (<year>2013</year>) <volume>67</volume>:<page-range>470&#8211;85</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jinf.2013.07.019</pub-id><pub-id pub-id-type="pmid">23872208</pub-id></mixed-citation></ref><ref id="B189"><label>189</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mayorga</surname><given-names>O</given-names></name><name name-style="western"><surname>Munoz</surname><given-names>JE</given-names></name><name name-style="western"><surname>Lincopan</surname><given-names>N</given-names></name><name name-style="western"><surname>Teixeira</surname><given-names>AF</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>LC</given-names></name><name name-style="western"><surname>Travassos</surname><given-names>LR</given-names></name><etal/></person-group>. <article-title>The role of adjuvants in therapeutic protection against paracoccidioidomycosis after immunization with the P10 peptide</article-title>. <source>Front Microbiol</source> (<year>2012</year>) <volume>3</volume>:<elocation-id>154</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2012.00154</pub-id><pub-id pub-id-type="pmid">22586420</pub-id><pub-id pub-id-type="pmcid">PMC3343455</pub-id></mixed-citation></ref><ref id="B190"><label>190</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holanda</surname><given-names>RA</given-names></name><name name-style="western"><surname>Munoz</surname><given-names>JE</given-names></name><name name-style="western"><surname>Dias</surname><given-names>LS</given-names></name><name name-style="western"><surname>Silva</surname><given-names>LBR</given-names></name><name name-style="western"><surname>Santos</surname><given-names>JRA</given-names></name><name name-style="western"><surname>Pagliari</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Recombinant vaccines of a CD4+ T-cell epitope promote efficient control of paracoccidioides brasiliensis burden by restraining primary organ infection</article-title>. <source>PloS Negl Trop Dis</source> (<year>2017</year>) <volume>11</volume>:<elocation-id>e0005927</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0005927</pub-id><pub-id pub-id-type="pmid">28938005</pub-id><pub-id pub-id-type="pmcid">PMC5627964</pub-id></mixed-citation></ref><ref id="B191"><label>191</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bozzi</surname><given-names>A</given-names></name><name name-style="western"><surname>Reis</surname><given-names>BS</given-names></name><name name-style="western"><surname>Goulart</surname><given-names>MI</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>MC</given-names></name><name name-style="western"><surname>Pedroso</surname><given-names>EP</given-names></name><name name-style="western"><surname>Goes</surname><given-names>AM</given-names></name></person-group>. <article-title>Analysis of memory T cells in the human paracoccidioidomycosis before and during chemotherapy treatment</article-title>. <source>Immunol Lett</source> (<year>2007</year>) <volume>114</volume>:<fpage>23</fpage>&#8211;<lpage>30</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.imlet.2007.08.004</pub-id><pub-id pub-id-type="pmid">17897724</pub-id></mixed-citation></ref><ref id="B192"><label>192</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernardino</surname><given-names>S</given-names></name><name name-style="western"><surname>Pina</surname><given-names>A</given-names></name><name name-style="western"><surname>Felonato</surname><given-names>M</given-names></name><name name-style="western"><surname>Costa</surname><given-names>TA</given-names></name><name name-style="western"><surname>Frank De Araujo</surname><given-names>E</given-names></name><name name-style="western"><surname>Feriotti</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>TNF-alpha and CD8+ T cells mediate the beneficial effects of nitric oxide synthase-2 deficiency in pulmonary paracoccidioidomycosis</article-title>. <source>PloS Negl Trop Dis</source> (<year>2013</year>) <volume>7</volume>:<elocation-id>e2325</elocation-id>.<pub-id pub-id-type="pmid">23936574</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pntd.0002325</pub-id><pub-id pub-id-type="pmcid">PMC3731220</pub-id></mixed-citation></ref><ref id="B193"><label>193</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deo</surname><given-names>SS</given-names></name><name name-style="western"><surname>Virassamy</surname><given-names>B</given-names></name><name name-style="western"><surname>Halliday</surname><given-names>C</given-names></name><name name-style="western"><surname>Clancy</surname><given-names>L</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Stimulation with lysates of aspergillus terreus, candida krusei and rhizopus oryzae maximizes cross-reactivity of anti-fungal T cells</article-title>. <source>Cytotherapy</source> (<year>2016</year>) <volume>18</volume>:<fpage>65</fpage>&#8211;<lpage>79</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jcyt.2015.09.013</pub-id><pub-id pub-id-type="pmid">26552765</pub-id></mixed-citation></ref><ref id="B194"><label>194</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aggor</surname><given-names>FEY</given-names></name><name name-style="western"><surname>Way</surname><given-names>SS</given-names></name><name name-style="western"><surname>Gaffen</surname><given-names>SL</given-names></name></person-group>. <article-title>Fungus among us: The frenemies within</article-title>. <source>Trends Immunol</source> (<year>2019</year>) <volume>40</volume>:<page-range>469&#8211;71</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.it.2019.04.007</pub-id><pub-id pub-id-type="pmcid">PMC6607908</pub-id><pub-id pub-id-type="pmid">31053496</pub-id></mixed-citation></ref><ref id="B195"><label>195</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bacher</surname><given-names>P</given-names></name><name name-style="western"><surname>Hohnstein</surname><given-names>T</given-names></name><name name-style="western"><surname>Beerbaum</surname><given-names>E</given-names></name><name name-style="western"><surname>R&#246;cker</surname><given-names>M</given-names></name><name name-style="western"><surname>Blango</surname><given-names>MG</given-names></name><name name-style="western"><surname>Kaufmann</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against candida albicans</article-title>. <source>Cell</source> (<year>2019</year>) <volume>176</volume>:<page-range>1340&#8211;55</page-range>:<elocation-id>e1315</elocation-id>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2019.01.041</pub-id><pub-id pub-id-type="pmid">30799037</pub-id></mixed-citation></ref><ref id="B196"><label>196</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaundar</surname><given-names>SS</given-names></name><name name-style="western"><surname>Clancy</surname><given-names>L</given-names></name><name name-style="western"><surname>Blyth</surname><given-names>E</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>W</given-names></name><name name-style="western"><surname>Gottlieb</surname><given-names>DJ</given-names></name></person-group>. <article-title>Robust polyfunctional T-helper 1 responses to multiple fungal antigens from a cell population generated using an environmental strain of aspergillus fumigatus</article-title>. <source>Cytotherapy</source> (<year>2012</year>) <volume>14</volume>:<page-range>1119&#8211;30</page-range>. doi: <pub-id pub-id-type="doi">10.3109/14653249.2012.704013</pub-id><pub-id pub-id-type="pmid">22866666</pub-id></mixed-citation></ref><ref id="B197"><label>197</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buldain</surname><given-names>I</given-names></name><name name-style="western"><surname>Pellon</surname><given-names>A</given-names></name><name name-style="western"><surname>Zaldibar</surname><given-names>B</given-names></name><name name-style="western"><surname>Antoran</surname><given-names>A</given-names></name><name name-style="western"><surname>Martin-Souto</surname><given-names>L</given-names></name><name name-style="western"><surname>Aparicio-Fernandez</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Study of humoral responses against Lomentospora/Scedosporium spp. and aspergillus fumigatus to identify l. prolificans antigens of interest for diagnosis and treatment</article-title>. <source>Vaccines</source> (<year>2019</year>) <volume>7</volume>:<fpage>212</fpage>. doi: <pub-id pub-id-type="doi">10.3390/vaccines7040212</pub-id><pub-id pub-id-type="pmcid">PMC6963885</pub-id><pub-id pub-id-type="pmid">31835471</pub-id></mixed-citation></ref><ref id="B198"><label>198</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>L</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>AS</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Farber</surname><given-names>JM</given-names></name><name name-style="western"><surname>Avanesian</surname><given-names>V</given-names></name><name name-style="western"><surname>Baquir</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Th1-Th17 cells mediate protective adaptive immunity against staphylococcus aureus and candida albicans infection in mice</article-title>. <source>PloS Pathog</source> (<year>2009</year>) <volume>5</volume>:<fpage>e1000703</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1000703</pub-id><pub-id pub-id-type="pmid">20041174</pub-id><pub-id pub-id-type="pmcid">PMC2792038</pub-id></mixed-citation></ref><ref id="B199"><label>199</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>S</given-names></name><name name-style="western"><surname>Uppuluri</surname><given-names>P</given-names></name><name name-style="western"><surname>Mamouei</surname><given-names>Z</given-names></name><name name-style="western"><surname>Alqarihi</surname><given-names>A</given-names></name><name name-style="western"><surname>Elhassan</surname><given-names>H</given-names></name><name name-style="western"><surname>French</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>The NDV-3A vaccine protects mice from multidrug resistant candida auris infection</article-title>. <source>PloS Pathog</source> (<year>2019</year>) <volume>15</volume>:<fpage>e1007460</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1007460</pub-id><pub-id pub-id-type="pmid">31381597</pub-id><pub-id pub-id-type="pmcid">PMC6695204</pub-id></mixed-citation></ref><ref id="B200"><label>200</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>LF</given-names></name><name name-style="western"><surname>Kidd</surname><given-names>BA</given-names></name><name name-style="western"><surname>Han</surname><given-names>A</given-names></name><name name-style="western"><surname>Kotzin</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Davis</surname><given-names>MM</given-names></name></person-group>. <article-title>Virus-specific CD4+ memory-phenotype T cells are abundant in unexposed adults</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>:<page-range>373&#8211;83</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2012.10.021</pub-id><pub-id pub-id-type="pmcid">PMC3626102</pub-id><pub-id pub-id-type="pmid">23395677</pub-id></mixed-citation></ref><ref id="B201"><label>201</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Birnbaum</surname><given-names>ME</given-names></name><name name-style="western"><surname>Mendoza</surname><given-names>JL</given-names></name><name name-style="western"><surname>Sethi</surname><given-names>DK</given-names></name><name name-style="western"><surname>Dong</surname><given-names>S</given-names></name><name name-style="western"><surname>Glanville</surname><given-names>J</given-names></name><name name-style="western"><surname>Dobbins</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Deconstructing the peptide-MHC specificity of T cell recognition</article-title>. <source>Cell</source> (<year>2014</year>) <volume>157</volume>:<page-range>1073&#8211;87</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2014.03.047</pub-id><pub-id pub-id-type="pmcid">PMC4071348</pub-id><pub-id pub-id-type="pmid">24855945</pub-id></mixed-citation></ref><ref id="B202"><label>202</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>H-G</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J-U</given-names></name><name name-style="western"><surname>Kim</surname><given-names>D-H</given-names></name><name name-style="western"><surname>Lim</surname><given-names>S</given-names></name><name name-style="western"><surname>Kang</surname><given-names>I</given-names></name><name name-style="western"><surname>Choi</surname><given-names>J-M</given-names></name></person-group>. <article-title>Pathogenic function of bystander-activated memory-like CD4+ T cells in autoimmune encephalomyelitis</article-title>. <source>Nat Commun</source> (<year>2019</year>) <volume>10</volume>:<fpage>1</fpage>&#8211;<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-019-08482-w</pub-id><pub-id pub-id-type="pmid">30755603</pub-id><pub-id pub-id-type="pmcid">PMC6372661</pub-id></mixed-citation></ref><ref id="B203"><label>203</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thompson-Souza</surname><given-names>GA</given-names></name><name name-style="western"><surname>Santos</surname><given-names>GMP</given-names></name><name name-style="western"><surname>Silva</surname><given-names>JC</given-names></name><name name-style="western"><surname>Muniz</surname><given-names>VS</given-names></name><name name-style="western"><surname>Braga</surname><given-names>Y</given-names></name><name name-style="western"><surname>Figueiredo</surname><given-names>RT</given-names></name><etal/></person-group>. <article-title>Histoplasma capsulatum-induced extracellular DNA trap release in human neutrophils</article-title>. <source>Cell Microbiol</source> (<year>2020</year>) <volume>22</volume>:<fpage>e13195</fpage>. doi: <pub-id pub-id-type="doi">10.1111/cmi.13195</pub-id><pub-id pub-id-type="pmid">32083807</pub-id></mixed-citation></ref><ref id="B204"><label>204</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Puerta-Arias</surname><given-names>JD</given-names></name><name name-style="western"><surname>Mejia</surname><given-names>SP</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>A</given-names></name></person-group>. <article-title>The role of the interleukin-17 axis and neutrophils in the pathogenesis of endemic and systemic mycoses</article-title>. <source>Front Cell Infect Microbiol</source> (<year>2020</year>) <volume>10</volume>:<elocation-id>595301</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2020.595301</pub-id><pub-id pub-id-type="pmid">33425780</pub-id><pub-id pub-id-type="pmcid">PMC7793882</pub-id></mixed-citation></ref><ref id="B205"><label>205</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Luca</surname><given-names>A</given-names></name><name name-style="western"><surname>Zelante</surname><given-names>T</given-names></name><name name-style="western"><surname>D&#8217;angelo</surname><given-names>C</given-names></name><name name-style="western"><surname>Zagarella</surname><given-names>S</given-names></name><name name-style="western"><surname>Fallarino</surname><given-names>F</given-names></name><name name-style="western"><surname>Spreca</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>IL-22 defines a novel immune pathway of antifungal resistance</article-title>. <source>Mucosal Immunol</source> (<year>2010</year>) <volume>3</volume>:<page-range>361&#8211;73</page-range>. doi: <pub-id pub-id-type="doi">10.1038/mi.2010.22</pub-id><pub-id pub-id-type="pmid">20445503</pub-id></mixed-citation></ref><ref id="B206"><label>206</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aggor</surname><given-names>FEY</given-names></name><name name-style="western"><surname>Break</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Trevejo-Nunez</surname><given-names>G</given-names></name><name name-style="western"><surname>Whibley</surname><given-names>N</given-names></name><name name-style="western"><surname>Coleman</surname><given-names>BM</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>RD</given-names></name><etal/></person-group>. <article-title>Oral epithelial IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis</article-title>. <source>Sci Immunol</source> (<year>2020</year>) <volume>5</volume>(<issue>48</issue>):<elocation-id>eaba0570</elocation-id>. doi: <pub-id pub-id-type="doi">10.1126/sciimmunol.aba0570</pub-id><pub-id pub-id-type="pmid">32503875</pub-id><pub-id pub-id-type="pmcid">PMC7340112</pub-id></mixed-citation></ref><ref id="B207"><label>207</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swidergall</surname><given-names>M</given-names></name><name name-style="western"><surname>Ernst</surname><given-names>JF</given-names></name></person-group>. <article-title>Interplay between candida albicans and the antimicrobial peptide armory</article-title>. <source>Eukaryot Cell</source> (<year>2014</year>) <volume>13</volume>:<page-range>950&#8211;7</page-range>. doi: <pub-id pub-id-type="doi">10.1128/EC.00093-14</pub-id><pub-id pub-id-type="pmcid">PMC4135787</pub-id><pub-id pub-id-type="pmid">24951441</pub-id></mixed-citation></ref><ref id="B208"><label>208</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murdock</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Falkowski</surname><given-names>NR</given-names></name><name name-style="western"><surname>Shreiner</surname><given-names>AB</given-names></name><name name-style="western"><surname>Sadighi Akha</surname><given-names>AA</given-names></name><name name-style="western"><surname>Mcdonald</surname><given-names>RA</given-names></name><name name-style="western"><surname>White</surname><given-names>ES</given-names></name><etal/></person-group>. <article-title>Interleukin-17 drives pulmonary eosinophilia following repeated exposure to aspergillus fumigatus conidia</article-title>. <source>Infect Immun</source> (<year>2012</year>) <volume>80</volume>:<page-range>1424&#8211;36</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.05529-11</pub-id><pub-id pub-id-type="pmcid">PMC3318426</pub-id><pub-id pub-id-type="pmid">22252873</pub-id></mixed-citation></ref><ref id="B209"><label>209</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Netea</surname><given-names>MG</given-names></name><name name-style="western"><surname>Joosten</surname><given-names>L</given-names></name><name name-style="western"><surname>van der Meer</surname><given-names>JWM</given-names></name><name name-style="western"><surname>Kullberg</surname><given-names>B-J</given-names></name><name name-style="western"><surname>Van De Veerdonk</surname><given-names>FL</given-names></name></person-group>. <article-title>Immune defence against candida fungal infections</article-title>. <source>Nat Rev Immunol</source> (<year>2015</year>) <volume>15</volume>:<page-range>630&#8211;42</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nri3897</pub-id><pub-id pub-id-type="pmid">26388329</pub-id></mixed-citation></ref><ref id="B210"><label>210</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kroetz</surname><given-names>DN</given-names></name><name name-style="western"><surname>Deepe</surname><given-names>GS</given-names></name></person-group>. <article-title>The role of cytokines and chemokines in histoplasma capsulatum infection</article-title>. <source>Cytokine</source> (<year>2012</year>) <volume>58</volume>:<page-range>112&#8211;7</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.cyto.2011.07.430</pub-id><pub-id pub-id-type="pmcid">PMC3227768</pub-id><pub-id pub-id-type="pmid">21871816</pub-id></mixed-citation></ref><ref id="B211"><label>211</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Castro-Lopez</surname><given-names>N</given-names></name><name name-style="western"><surname>Hung</surname><given-names>CY</given-names></name></person-group>. <article-title>Immune response to coccidioidomycosis and the development of a vaccine</article-title>. <source>Microorganisms</source> (<year>2017</year>) <volume>5</volume>:<fpage>13</fpage>. doi: <pub-id pub-id-type="doi">10.3390/microorganisms5010013</pub-id><pub-id pub-id-type="pmcid">PMC5374390</pub-id><pub-id pub-id-type="pmid">28300772</pub-id></mixed-citation></ref><ref id="B212"><label>212</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kak</surname><given-names>G</given-names></name><name name-style="western"><surname>Raza</surname><given-names>M</given-names></name><name name-style="western"><surname>Tiwari</surname><given-names>BK</given-names></name></person-group>. <article-title>Interferon-gamma (IFN-&#947;): Exploring its implications in infectious diseases</article-title>. <source>Biomol Concepts</source> (<year>2018</year>) <volume>9</volume>:<fpage>64</fpage>&#8211;<lpage>79</lpage>. doi: <pub-id pub-id-type="doi">10.1515/bmc-2018-0007</pub-id><pub-id pub-id-type="pmid">29856726</pub-id></mixed-citation></ref><ref id="B213"><label>213</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Speakman</surname><given-names>EA</given-names></name><name name-style="western"><surname>Dambuza</surname><given-names>IM</given-names></name><name name-style="western"><surname>Salazar</surname><given-names>F</given-names></name><name name-style="western"><surname>Brown</surname><given-names>GD</given-names></name></person-group>. <article-title>T Cell antifungal immunity and the role of c-type lectin receptors</article-title>. <source>Trends Immunol</source> (<year>2020</year>) <volume>41</volume>:<fpage>61</fpage>&#8211;<lpage>76</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.it.2019.11.007</pub-id><pub-id pub-id-type="pmid">31813764</pub-id><pub-id pub-id-type="pmcid">PMC7427322</pub-id></mixed-citation></ref><ref id="B214"><label>214</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vignesh</surname><given-names>KS</given-names></name><name name-style="western"><surname>Figueroa</surname><given-names>J</given-names></name><name name-style="western"><surname>Porollo</surname><given-names>A</given-names></name><name name-style="western"><surname>Caruso</surname><given-names>JA</given-names></name><name name-style="western"><surname>Deepe</surname><given-names>JGS</given-names></name></person-group>. <article-title>Granulocyte macrophage-colony stimulating factor induced zn sequestration enhances macrophage superoxide and limits intracellular pathogen survival</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>39</volume>:<fpage>697</fpage>&#8211;<lpage>710</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2013.09.006</pub-id><pub-id pub-id-type="pmid">24138881</pub-id><pub-id pub-id-type="pmcid">PMC3841917</pub-id></mixed-citation></ref><ref id="B215"><label>215</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deepe</surname><given-names>GS</given-names></name><name name-style="western"><surname>Gibbons</surname><given-names>R</given-names></name><name name-style="western"><surname>Woodward</surname><given-names>E</given-names></name></person-group>. <article-title>Neutralization of endogenous granulocyte-macrophage colony-stimulating factor subverts the protective immune response to histoplasma capsulatum</article-title>. <source>J Immunol</source> (<year>1999</year>) <volume>163</volume>:<page-range>4985&#8211;93</page-range>.<pub-id pub-id-type="pmid">10528203</pub-id></mixed-citation></ref><ref id="B216"><label>216</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herring</surname><given-names>AC</given-names></name><name name-style="western"><surname>Falkowski</surname><given-names>NR</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G-H</given-names></name><name name-style="western"><surname>Mcdonald</surname><given-names>RA</given-names></name><name name-style="western"><surname>Toews</surname><given-names>GB</given-names></name><name name-style="western"><surname>Huffnagle</surname><given-names>GB</given-names></name></person-group>. <article-title>Transient neutralization of tumor necrosis factor alpha can produce a chronic fungal infection in an immunocompetent host: potential role of immature dendritic cells</article-title>. <source>Infect Immun</source> (<year>2005</year>) <volume>73</volume>:<fpage>39</fpage>&#8211;<lpage>49</lpage>. doi: <pub-id pub-id-type="doi">10.1128/IAI.73.1.39-49.2005</pub-id><pub-id pub-id-type="pmid">15618139</pub-id><pub-id pub-id-type="pmcid">PMC538928</pub-id></mixed-citation></ref><ref id="B217"><label>217</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rocha</surname><given-names>F</given-names></name><name name-style="western"><surname>Alves</surname><given-names>A</given-names></name><name name-style="western"><surname>Rocha</surname><given-names>MFG</given-names></name><name name-style="western"><surname>Cordeiro</surname><given-names>RA</given-names></name><name name-style="western"><surname>Brilhante</surname><given-names>RSN</given-names></name><name name-style="western"><surname>Pinto</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Tumor necrosis factor prevents candida albicans biofilm formation</article-title>. <source>Sci Rep</source> (<year>2017</year>) <volume>7</volume>:<fpage>1206</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-017-01400-4</pub-id><pub-id pub-id-type="pmid">28446778</pub-id><pub-id pub-id-type="pmcid">PMC5430817</pub-id></mixed-citation></ref><ref id="B218"><label>218</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>LL</given-names></name><name name-style="western"><surname>Spurrell</surname><given-names>JC</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JF</given-names></name><name name-style="western"><surname>Neely</surname><given-names>GG</given-names></name><name name-style="western"><surname>Epelman</surname><given-names>S</given-names></name><name name-style="western"><surname>Krensky</surname><given-names>AM</given-names></name><etal/></person-group>. <article-title>CD8 T cell-mediated killing of cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15</article-title>. <source>J Immunol</source> (<year>2002</year>) <volume>169</volume>:<page-range>5787&#8211;95</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.169.10.5787</pub-id><pub-id pub-id-type="pmid">12421959</pub-id></mixed-citation></ref><ref id="B219"><label>219</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dotiwala</surname><given-names>F</given-names></name><name name-style="western"><surname>Lieberman</surname><given-names>J</given-names></name></person-group>. <article-title>Granulysin: killer lymphocyte safeguard against microbes</article-title>. <source>Curr Opin Immunol</source> (<year>2019</year>) <volume>60</volume>:<fpage>19</fpage>&#8211;<lpage>29</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.coi.2019.04.013</pub-id><pub-id pub-id-type="pmid">31112765</pub-id><pub-id pub-id-type="pmcid">PMC6800608</pub-id></mixed-citation></ref><ref id="B220"><label>220</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Voskoboinik</surname><given-names>I</given-names></name><name name-style="western"><surname>Whisstock</surname><given-names>JC</given-names></name><name name-style="western"><surname>Trapani</surname><given-names>JA</given-names></name></person-group>. <article-title>Perforin and granzymes: function, dysfunction and human pathology</article-title>. <source>Nat Rev Immunol</source> (<year>2015</year>) <volume>15</volume>:<fpage>388</fpage>&#8211;<lpage>400</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nri3839</pub-id><pub-id pub-id-type="pmid">25998963</pub-id></mixed-citation></ref><ref id="B221"><label>221</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vitenshtein</surname><given-names>A</given-names></name><name name-style="western"><surname>Charpak-Amikam</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yamin</surname><given-names>R</given-names></name><name name-style="western"><surname>Bauman</surname><given-names>Y</given-names></name><name name-style="western"><surname>Isaacson</surname><given-names>B</given-names></name><name name-style="western"><surname>Stein</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>NK cell recognition of candida glabrata through binding of NKp46 and NCR1 to fungal ligands Epa1, Epa6, and Epa7</article-title>. <source>Cell Host Microbe</source> (<year>2016</year>) <volume>20</volume>:<page-range>527&#8211;34</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2016.09.008</pub-id><pub-id pub-id-type="pmcid">PMC5492882</pub-id><pub-id pub-id-type="pmid">27736647</pub-id></mixed-citation></ref><ref id="B222"><label>222</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>SS</given-names></name><name name-style="western"><surname>Ogbomo</surname><given-names>H</given-names></name><name name-style="western"><surname>Mansour</surname><given-names>MK</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>RF</given-names></name><name name-style="western"><surname>Szabo</surname><given-names>L</given-names></name><name name-style="western"><surname>Munro</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of cryptococcus and candida</article-title>. <source>Nat Commun</source> (<year>2018</year>) <volume>9</volume>:<fpage>751</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-018-03014-4</pub-id><pub-id pub-id-type="pmid">29467448</pub-id><pub-id pub-id-type="pmcid">PMC5821813</pub-id></mixed-citation></ref><ref id="B223"><label>223</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>CF</given-names></name><name name-style="western"><surname>Ma</surname><given-names>LL</given-names></name><name name-style="western"><surname>Jones</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Gill</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Krensky</surname><given-names>AM</given-names></name><name name-style="western"><surname>Kubes</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Cytotoxic CD4+ T cells use granulysin to kill cryptococcus neoformans, and activation of this pathway is defective in HIV patients</article-title>. <source>Blood</source> (<year>2007</year>) <volume>109</volume>:<page-range>2049&#8211;57</page-range>. doi: <pub-id pub-id-type="doi">10.1182/blood-2006-03-009720</pub-id><pub-id pub-id-type="pmid">17038537</pub-id></mixed-citation></ref><ref id="B224"><label>224</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaech</surname><given-names>SM</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>R</given-names></name></person-group>. <article-title>Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells</article-title>. <source>Nat Immunol</source> (<year>2001</year>) <volume>2</volume>:<page-range>415&#8211;22</page-range>. doi: <pub-id pub-id-type="doi">10.1038/87720</pub-id><pub-id pub-id-type="pmcid">PMC3760150</pub-id><pub-id pub-id-type="pmid">11323695</pub-id></mixed-citation></ref><ref id="B225"><label>225</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>HK</given-names></name><name name-style="western"><surname>Mcdonald</surname><given-names>B</given-names></name><name name-style="western"><surname>Kaech</surname><given-names>SM</given-names></name></person-group>. <article-title>The architectural design of CD8+ T cell responses in acute and chronic infection: Parallel structures with divergent fates</article-title>. <source>J Exp Med</source> (<year>2021</year>) <volume>218</volume>(<issue>4</issue>):<elocation-id>e20201730</elocation-id>. doi: <pub-id pub-id-type="doi">10.1084/jem.20201730</pub-id><pub-id pub-id-type="pmid">33755719</pub-id><pub-id pub-id-type="pmcid">PMC7992501</pub-id></mixed-citation></ref><ref id="B226"><label>226</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Portuondo</surname><given-names>DL</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>LS</given-names></name><name name-style="western"><surname>Urbaczek</surname><given-names>AC</given-names></name><name name-style="western"><surname>Batista-Duharte</surname><given-names>A</given-names></name><name name-style="western"><surname>Carlos</surname><given-names>IZ</given-names></name></person-group>. <article-title>Adjuvants and delivery systems for antifungal vaccines: current state and future developments</article-title>. <source>Med Mycol</source> (<year>2015</year>) <volume>53</volume>:<fpage>69</fpage>&#8211;<lpage>89</lpage>. doi: <pub-id pub-id-type="doi">10.1093/mmy/myu045</pub-id><pub-id pub-id-type="pmid">25362733</pub-id></mixed-citation></ref><ref id="B227"><label>227</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>LVN</given-names></name><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name><name name-style="western"><surname>Specht</surname><given-names>CA</given-names></name><name name-style="western"><surname>Levitz</surname><given-names>SM</given-names></name></person-group>. <article-title>Vaccines for human fungal diseases: close but still a long way to go</article-title>. <source>NPJ Vaccines</source> (<year>2021</year>) <volume>6</volume>:<fpage>33</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41541-021-00294-8</pub-id><pub-id pub-id-type="pmid">33658522</pub-id><pub-id pub-id-type="pmcid">PMC7930017</pub-id></mixed-citation></ref><ref id="B228"><label>228</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borriello</surname><given-names>F</given-names></name><name name-style="western"><surname>Poli</surname><given-names>V</given-names></name><name name-style="western"><surname>Shrock</surname><given-names>E</given-names></name><name name-style="western"><surname>Spreafico</surname><given-names>R</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Pishesha</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity</article-title>. <source>Cell</source> (<year>2022</year>) <volume>185</volume>:<fpage>614</fpage>&#8211;<lpage>629 e621</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2022.01.009</pub-id><pub-id pub-id-type="pmid">35148840</pub-id><pub-id pub-id-type="pmcid">PMC8857056</pub-id></mixed-citation></ref><ref id="B229"><label>229</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>JC</given-names></name><name name-style="western"><surname>Bevan</surname><given-names>MJ</given-names></name></person-group>. <article-title>Defective CD8 T cell memory following acute infection without CD4 T cell help</article-title>. <source>Science</source> (<year>2003</year>) <volume>300</volume>:<page-range>339&#8211;42</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.1083317</pub-id><pub-id pub-id-type="pmcid">PMC2778341</pub-id><pub-id pub-id-type="pmid">12690202</pub-id></mixed-citation></ref><ref id="B230"><label>230</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hor</surname><given-names>JL</given-names></name><name name-style="western"><surname>Whitney</surname><given-names>PG</given-names></name><name name-style="western"><surname>Zaid</surname><given-names>A</given-names></name><name name-style="western"><surname>Brooks</surname><given-names>AG</given-names></name><name name-style="western"><surname>Heath</surname><given-names>WR</given-names></name><name name-style="western"><surname>Mueller</surname><given-names>SN</given-names></name></person-group>. <article-title>Spatiotemporally distinct interactions with dendritic cell subsets facilitates CD4+ and CD8+ T cell activation to localized viral infection</article-title>. <source>Immunity</source> (<year>2015</year>) <volume>43</volume>:<page-range>554&#8211;65</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2015.07.020</pub-id><pub-id pub-id-type="pmid">26297566</pub-id></mixed-citation></ref><ref id="B231"><label>231</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahrends</surname><given-names>T</given-names></name><name name-style="western"><surname>Spanjaard</surname><given-names>A</given-names></name><name name-style="western"><surname>Pilzecker</surname><given-names>B</given-names></name><name name-style="western"><surname>Babala</surname><given-names>N</given-names></name><name name-style="western"><surname>Bovens</surname><given-names>A</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>CD4(+) T cell help confers a cytotoxic T cell effector program including coinhibitory receptor downregulation and increased tissue invasiveness</article-title>. <source>Immunity</source> (<year>2017</year>) <volume>47</volume>:<fpage>848</fpage>&#8211;<lpage>861 e845</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2017.10.009</pub-id><pub-id pub-id-type="pmid">29126798</pub-id></mixed-citation></ref><ref id="B232"><label>232</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakanishi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lu</surname><given-names>B</given-names></name><name name-style="western"><surname>Gerard</surname><given-names>C</given-names></name><name name-style="western"><surname>Iwasaki</surname><given-names>A</given-names></name></person-group>. <article-title>CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help</article-title>. <source>Nature</source> (<year>2009</year>) <volume>462</volume>:<page-range>510&#8211;3</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nature08511</pub-id><pub-id pub-id-type="pmcid">PMC2789415</pub-id><pub-id pub-id-type="pmid">19898495</pub-id></mixed-citation></ref><ref id="B233"><label>233</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Redeker</surname><given-names>A</given-names></name><name name-style="western"><surname>Welten</surname><given-names>SP</given-names></name><name name-style="western"><surname>Baert</surname><given-names>MR</given-names></name><name name-style="western"><surname>Vloemans</surname><given-names>SA</given-names></name><name name-style="western"><surname>Tiemessen</surname><given-names>MM</given-names></name><name name-style="western"><surname>Staal</surname><given-names>FJ</given-names></name><etal/></person-group>. <article-title>The quantity of autocrine IL-2 governs the expansion potential of CD8+ T cells</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>195</volume>:<page-range>4792&#8211;801</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1501083</pub-id><pub-id pub-id-type="pmid">26453748</pub-id></mixed-citation></ref><ref id="B234"><label>234</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eickhoff</surname><given-names>S</given-names></name><name name-style="western"><surname>Brewitz</surname><given-names>A</given-names></name><name name-style="western"><surname>Gerner</surname><given-names>MY</given-names></name><name name-style="western"><surname>Klauschen</surname><given-names>F</given-names></name><name name-style="western"><surname>Komander</surname><given-names>K</given-names></name><name name-style="western"><surname>Hemmi</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Robust anti-viral immunity requires multiple distinct T cell-dendritic cell interactions</article-title>. <source>Cell</source> (<year>2015</year>) <volume>162</volume>:<page-range>1322&#8211;37</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2015.08.004</pub-id><pub-id pub-id-type="pmcid">PMC4567961</pub-id><pub-id pub-id-type="pmid">26296422</pub-id></mixed-citation></ref><ref id="B235"><label>235</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaech</surname><given-names>SM</given-names></name><name name-style="western"><surname>Tan</surname><given-names>JT</given-names></name><name name-style="western"><surname>Wherry</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Konieczny</surname><given-names>BT</given-names></name><name name-style="western"><surname>Surh</surname><given-names>CD</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>R</given-names></name></person-group>. <article-title>Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells</article-title>. <source>Nat Immunol</source> (<year>2003</year>) <volume>4</volume>:<page-range>1191&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni1009</pub-id><pub-id pub-id-type="pmid">14625547</pub-id></mixed-citation></ref><ref id="B236"><label>236</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahrends</surname><given-names>T</given-names></name><name name-style="western"><surname>Busselaar</surname><given-names>J</given-names></name><name name-style="western"><surname>Severson</surname><given-names>TM</given-names></name><name name-style="western"><surname>Babala</surname><given-names>N</given-names></name><name name-style="western"><surname>De Vries</surname><given-names>E</given-names></name><name name-style="western"><surname>Bovens</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>CD4(+) T cell help creates memory CD8(+) T cells with innate and help-independent recall capacities</article-title>. <source>Nat Commun</source> (<year>2019</year>) <volume>10</volume>:<fpage>5531</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-019-13438-1</pub-id><pub-id pub-id-type="pmid">31797935</pub-id><pub-id pub-id-type="pmcid">PMC6892909</pub-id></mixed-citation></ref><ref id="B237"><label>237</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woodland</surname><given-names>DL</given-names></name><name name-style="western"><surname>Kohlmeier</surname><given-names>JE</given-names></name></person-group>. <article-title>Migration, maintenance and recall of memory T cells in peripheral tissues</article-title>. <source>Nat Rev Immunol</source> (<year>2009</year>) <volume>9</volume>:<page-range>153&#8211;61</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nri2496</pub-id><pub-id pub-id-type="pmid">19240755</pub-id></mixed-citation></ref><ref id="B238"><label>238</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaech</surname><given-names>SM</given-names></name><name name-style="western"><surname>Wherry</surname><given-names>EJ</given-names></name></person-group>. <article-title>Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection</article-title>. <source>Immunity</source> (<year>2007</year>) <volume>27</volume>:<fpage>393</fpage>&#8211;<lpage>405</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2007.08.007</pub-id><pub-id pub-id-type="pmid">17892848</pub-id><pub-id pub-id-type="pmcid">PMC3431921</pub-id></mixed-citation></ref><ref id="B239"><label>239</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seder</surname><given-names>RA</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>R</given-names></name></person-group>. <article-title>Similarities and differences in CD4+ and CD8+ effector and memory T cell generation</article-title>. <source>Nat Immunol</source> (<year>2003</year>) <volume>4</volume>:<page-range>835&#8211;42</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni969</pub-id><pub-id pub-id-type="pmid">12942084</pub-id></mixed-citation></ref><ref id="B240"><label>240</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sallusto</surname><given-names>F</given-names></name><name name-style="western"><surname>Geginat</surname><given-names>J</given-names></name><name name-style="western"><surname>Lanzavecchia</surname><given-names>A</given-names></name></person-group>. <article-title>Central memory and effector memory T cell subsets: function, generation, and maintenance</article-title>. <source>Annu Rev Immunol</source> (<year>2004</year>) <volume>22</volume>:<page-range>745&#8211;63</page-range>. doi: <pub-id pub-id-type="doi">10.1146/annurev.immunol.22.012703.104702</pub-id><pub-id pub-id-type="pmid">15032595</pub-id></mixed-citation></ref><ref id="B241"><label>241</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaech</surname><given-names>SM</given-names></name><name name-style="western"><surname>Wherry</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>R</given-names></name></person-group>. <article-title>Effector and memory T-cell differentiation: implications for vaccine development</article-title>. <source>Nat Rev Immunol</source> (<year>2002</year>) <volume>2</volume>:<page-range>251&#8211;62</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nri778</pub-id><pub-id pub-id-type="pmid">12001996</pub-id></mixed-citation></ref><ref id="B242"><label>242</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>JT</given-names></name><name name-style="western"><surname>Palanivel</surname><given-names>VR</given-names></name><name name-style="western"><surname>Kinjyo</surname><given-names>I</given-names></name><name name-style="western"><surname>Schambach</surname><given-names>F</given-names></name><name name-style="western"><surname>Intlekofer</surname><given-names>AM</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Asymmetric T lymphocyte division in the initiation of adaptive immune responses</article-title>. <source>Science</source> (<year>2007</year>) <volume>315</volume>:<page-range>1687&#8211;91</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.1139393</pub-id><pub-id pub-id-type="pmid">17332376</pub-id></mixed-citation></ref><ref id="B243"><label>243</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stemberger</surname><given-names>C</given-names></name><name name-style="western"><surname>Neuenhahn</surname><given-names>M</given-names></name><name name-style="western"><surname>Gebhardt</surname><given-names>FE</given-names></name><name name-style="western"><surname>Schiemann</surname><given-names>M</given-names></name><name name-style="western"><surname>Buchholz</surname><given-names>VR</given-names></name><name name-style="western"><surname>Busch</surname><given-names>DH</given-names></name></person-group>. <article-title>Stem cell-like plasticity of naive and distinct memory CD8+ T cell subsets</article-title>. <source>Semin Immunol</source> (<year>2009</year>) <volume>21</volume>:<page-range>62&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.smim.2009.02.004</pub-id><pub-id pub-id-type="pmid">19269852</pub-id></mixed-citation></ref><ref id="B244"><label>244</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fuertes Marraco</surname><given-names>SA</given-names></name><name name-style="western"><surname>Soneson</surname><given-names>C</given-names></name><name name-style="western"><surname>Cagnon</surname><given-names>L</given-names></name><name name-style="western"><surname>Gannon</surname><given-names>PO</given-names></name><name name-style="western"><surname>Allard</surname><given-names>M</given-names></name><name name-style="western"><surname>Abed Maillard</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Long-lasting stem cell-like memory CD8+ T cells with a naive-like profile upon yellow fever vaccination</article-title>. <source>Sci Transl Med</source> (<year>2015</year>) <volume>7</volume>:<fpage>282ra248</fpage>. doi: <pub-id pub-id-type="doi">10.1126/scitranslmed.aaa3700</pub-id><pub-id pub-id-type="pmid">25855494</pub-id></mixed-citation></ref><ref id="B245"><label>245</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Surh</surname><given-names>CD</given-names></name><name name-style="western"><surname>Sprent</surname><given-names>J</given-names></name></person-group>. <article-title>Homeostasis of naive and memory T cells</article-title>. <source>Immunity</source> (<year>2008</year>) <volume>29</volume>:<page-range>848&#8211;62</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2008.11.002</pub-id><pub-id pub-id-type="pmid">19100699</pub-id></mixed-citation></ref><ref id="B246"><label>246</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raeber</surname><given-names>ME</given-names></name><name name-style="western"><surname>Zurbuchen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Impellizzieri</surname><given-names>D</given-names></name><name name-style="western"><surname>Boyman</surname><given-names>O</given-names></name></person-group>. <article-title>The role of cytokines in T-cell memory in health and disease</article-title>. <source>Immunol Rev</source> (<year>2018</year>) <volume>283</volume>:<page-range>176&#8211;93</page-range>. doi: <pub-id pub-id-type="doi">10.1111/imr.12644</pub-id><pub-id pub-id-type="pmid">29664568</pub-id></mixed-citation></ref><ref id="B247"><label>247</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masopust</surname><given-names>D</given-names></name><name name-style="western"><surname>Kaech</surname><given-names>SM</given-names></name><name name-style="western"><surname>Wherry</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>R</given-names></name></person-group>. <article-title>The role of programming in memory T-cell development</article-title>. <source>Curr Opin Immunol</source> (<year>2004</year>) <volume>16</volume>:<page-range>217&#8211;25</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.coi.2004.02.005</pub-id><pub-id pub-id-type="pmid">15023416</pub-id></mixed-citation></ref><ref id="B248"><label>248</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>MD</given-names></name><name name-style="western"><surname>Badovinac</surname><given-names>VP</given-names></name></person-group>. <article-title>Defining memory CD8 T cell</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>2692</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.02692</pub-id><pub-id pub-id-type="pmid">30515169</pub-id><pub-id pub-id-type="pmcid">PMC6255921</pub-id></mixed-citation></ref><ref id="B249"><label>249</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muroyama</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wherry</surname><given-names>EJ</given-names></name></person-group>. <article-title>Memory T-cell heterogeneity and terminology</article-title>. <source>Cold Spring Harb Perspect Biol</source> (<year>2021</year>) <volume>13</volume>(<issue>10</issue>):<elocation-id>a037929</elocation-id>. doi: <pub-id pub-id-type="doi">10.1101/cshperspect.a037929</pub-id><pub-id pub-id-type="pmid">33782027</pub-id><pub-id pub-id-type="pmcid">PMC8485749</pub-id></mixed-citation></ref><ref id="B250"><label>250</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reiner</surname><given-names>SL</given-names></name><name name-style="western"><surname>Sallusto</surname><given-names>F</given-names></name><name name-style="western"><surname>Lanzavecchia</surname><given-names>A</given-names></name></person-group>. <article-title>Division of labor with a workforce of one: Challenges in specifying effector and memory T cell fate</article-title>. <source>Science</source> (<year>2007</year>) <volume>317</volume>:<page-range>622&#8211;5</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.1143775</pub-id><pub-id pub-id-type="pmid">17673652</pub-id></mixed-citation></ref><ref id="B251"><label>251</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gerlach</surname><given-names>C</given-names></name><name name-style="western"><surname>Van Heijst</surname><given-names>JWJ</given-names></name><name name-style="western"><surname>Swart</surname><given-names>E</given-names></name><name name-style="western"><surname>Sie</surname><given-names>D</given-names></name><name name-style="western"><surname>Armstrong</surname><given-names>N</given-names></name><name name-style="western"><surname>Kerkhoven</surname><given-names>RM</given-names></name><etal/></person-group>. <article-title>One naive T cell, multiple fates in CD8+ T cell differentiation</article-title>. <source>J Exp Med</source> (<year>2010</year>) <volume>207</volume>:<page-range>1235&#8211;46</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.20091175</pub-id><pub-id pub-id-type="pmcid">PMC2882844</pub-id><pub-id pub-id-type="pmid">20479114</pub-id></mixed-citation></ref><ref id="B252"><label>252</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bresser</surname><given-names>K</given-names></name><name name-style="western"><surname>Kok</surname><given-names>L</given-names></name><name name-style="western"><surname>Swain</surname><given-names>AC</given-names></name><name name-style="western"><surname>King</surname><given-names>LA</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>L</given-names></name><name name-style="western"><surname>Weber</surname><given-names>TS</given-names></name><etal/></person-group>. <article-title>Replicative history marks transcriptional and functional disparity in the CD8(+) T cell memory pool</article-title>. <source>Nat Immunol</source> (<year>2022</year>) <volume>23</volume>(<issue>5</issue>):<page-range>791&#8211;801</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41590-022-01171-9</pub-id><pub-id pub-id-type="pmcid">PMC7612726</pub-id><pub-id pub-id-type="pmid">35393592</pub-id></mixed-citation></ref><ref id="B253"><label>253</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmed</surname><given-names>R</given-names></name><name name-style="western"><surname>Bevan</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Reiner</surname><given-names>SL</given-names></name><name name-style="western"><surname>Fearon</surname><given-names>DT</given-names></name></person-group>. <article-title>The precursors of memory: models and controversies</article-title>. <source>Nat Rev Immunol</source> (<year>2009</year>) <volume>9</volume>:<page-range>662&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nri2619</pub-id><pub-id pub-id-type="pmid">19680250</pub-id></mixed-citation></ref><ref id="B254"><label>254</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaech</surname><given-names>SM</given-names></name><name name-style="western"><surname>Cui</surname><given-names>W</given-names></name></person-group>. <article-title>Transcriptional control of effector and memory CD8+ T cell differentiation</article-title>. <source>Nat Rev Immunol</source> (<year>2012</year>) <volume>12</volume>:<page-range>749&#8211;61</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nri3307</pub-id><pub-id pub-id-type="pmcid">PMC4137483</pub-id><pub-id pub-id-type="pmid">23080391</pub-id></mixed-citation></ref><ref id="B255"><label>255</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>JT</given-names></name><name name-style="western"><surname>Wherry</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Goldrath</surname><given-names>AW</given-names></name></person-group>. <article-title>Molecular regulation of effector and memory T cell differentiation</article-title>. <source>Nat Immunol</source> (<year>2014</year>) <volume>15</volume>:<page-range>1104&#8211;15</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni.3031</pub-id><pub-id pub-id-type="pmcid">PMC4386685</pub-id><pub-id pub-id-type="pmid">25396352</pub-id></mixed-citation></ref><ref id="B256"><label>256</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hope</surname><given-names>JL</given-names></name><name name-style="western"><surname>Stairiker</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Bae</surname><given-names>EA</given-names></name><name name-style="western"><surname>Otero</surname><given-names>DC</given-names></name><name name-style="western"><surname>Bradley</surname><given-names>LM</given-names></name></person-group>. <article-title>Striking a balance-cellular and molecular drivers of memory T cell development and responses to chronic stimulation</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>1595</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2019.01595</pub-id><pub-id pub-id-type="pmid">31379821</pub-id><pub-id pub-id-type="pmcid">PMC6650570</pub-id></mixed-citation></ref><ref id="B257"><label>257</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sallusto</surname><given-names>F</given-names></name><name name-style="western"><surname>Lenig</surname><given-names>D</given-names></name><name name-style="western"><surname>F&#246;rster</surname><given-names>R</given-names></name><name name-style="western"><surname>Lipp</surname><given-names>M</given-names></name><name name-style="western"><surname>Lanzavecchia</surname><given-names>A</given-names></name></person-group>. <article-title>Two subsets of memory T lymphocytes with distinct homing potentials and effector functions</article-title>. <source>Nature</source> (<year>1999</year>) <volume>401</volume>:<page-range>708&#8211;12</page-range>. doi: <pub-id pub-id-type="doi">10.1038/44385</pub-id><pub-id pub-id-type="pmid">10537110</pub-id></mixed-citation></ref><ref id="B258"><label>258</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lanzavecchia</surname><given-names>A</given-names></name><name name-style="western"><surname>Sallusto</surname><given-names>F</given-names></name></person-group>. <article-title>Understanding the generation and function of memory T cell subsets</article-title>. <source>Curr Opin Immunol</source> (<year>2005</year>) <volume>17</volume>:<page-range>326&#8211;32</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.coi.2005.04.010</pub-id><pub-id pub-id-type="pmid">15886125</pub-id></mixed-citation></ref><ref id="B259"><label>259</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geginat</surname><given-names>J</given-names></name><name name-style="western"><surname>Lanzavecchia</surname><given-names>A</given-names></name><name name-style="western"><surname>Sallusto</surname><given-names>F</given-names></name></person-group>. <article-title>Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines</article-title>. <source>Blood</source> (<year>2003</year>) <volume>101</volume>:<page-range>4260&#8211;6</page-range>. doi: <pub-id pub-id-type="doi">10.1182/blood-2002-11-3577</pub-id><pub-id pub-id-type="pmid">12576317</pub-id></mixed-citation></ref><ref id="B260"><label>260</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leibundgut-Landmann</surname><given-names>S</given-names></name></person-group>. <article-title>Tissue-resident memory T cells in antifungal immunity</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>0</volume>:<elocation-id>1976</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.693055</pub-id><pub-id pub-id-type="pmcid">PMC8185520</pub-id><pub-id pub-id-type="pmid">34113356</pub-id></mixed-citation></ref><ref id="B261"><label>261</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szabo</surname><given-names>PA</given-names></name><name name-style="western"><surname>Miron</surname><given-names>M</given-names></name><name name-style="western"><surname>Farber</surname><given-names>DL</given-names></name></person-group>. <article-title>Location, location, location: Tissue resident memory T cells in mice and humans</article-title>. <source>Sci Immunol</source> (<year>2019</year>) <volume>4</volume>(<issue>34</issue>):<elocation-id>eaas9673</elocation-id>. doi: <pub-id pub-id-type="doi">10.1126/sciimmunol.aas9673</pub-id><pub-id pub-id-type="pmid">30952804</pub-id><pub-id pub-id-type="pmcid">PMC6778482</pub-id></mixed-citation></ref><ref id="B262"><label>262</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mackay</surname><given-names>LK</given-names></name><name name-style="western"><surname>Braun</surname><given-names>A</given-names></name><name name-style="western"><surname>Macleod</surname><given-names>BL</given-names></name><name name-style="western"><surname>Collins</surname><given-names>N</given-names></name><name name-style="western"><surname>Tebartz</surname><given-names>C</given-names></name><name name-style="western"><surname>Bedoui</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>194</volume>:<page-range>2059&#8211;63</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1402256</pub-id><pub-id pub-id-type="pmid">25624457</pub-id></mixed-citation></ref><ref id="B263"><label>263</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Casey</surname><given-names>KA</given-names></name><name name-style="western"><surname>Fraser</surname><given-names>KA</given-names></name><name name-style="western"><surname>Schenkel</surname><given-names>JM</given-names></name><name name-style="western"><surname>Moran</surname><given-names>A</given-names></name><name name-style="western"><surname>Abt</surname><given-names>MC</given-names></name><name name-style="western"><surname>Beura</surname><given-names>LK</given-names></name><etal/></person-group>. <article-title>Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues</article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>188</volume>:<page-range>4866&#8211;75</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1200402</pub-id><pub-id pub-id-type="pmcid">PMC3345065</pub-id><pub-id pub-id-type="pmid">22504644</pub-id></mixed-citation></ref><ref id="B264"><label>264</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirai</surname><given-names>T</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zenke</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Chaudhri</surname><given-names>VK</given-names></name><name name-style="western"><surname>de la Cruz Diaz</surname><given-names>JS</given-names></name><etal/></person-group>. <article-title>Competition for active TGFbeta cytokine allows for selective retention of antigen-specific tissue- resident memory T cells in the epidermal niche</article-title>. <source>Immunity</source> (<year>2021</year>) <volume>54</volume>:<fpage>84</fpage>&#8211;<lpage>98 e85</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2020.10.022</pub-id><pub-id pub-id-type="pmid">33212014</pub-id><pub-id pub-id-type="pmcid">PMC7856016</pub-id></mixed-citation></ref><ref id="B265"><label>265</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sasson</surname><given-names>SC</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>CL</given-names></name><name name-style="western"><surname>Christo</surname><given-names>SN</given-names></name><name name-style="western"><surname>Klenerman</surname><given-names>P</given-names></name><name name-style="western"><surname>Mackay</surname><given-names>LK</given-names></name></person-group>. <article-title>Local heroes or villains: tissue-resident memory T cells in human health and disease</article-title>. <source>Cell Mol Immunol</source> (<year>2020</year>) <volume>17</volume>:<page-range>113&#8211;22</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41423-019-0359-1</pub-id><pub-id pub-id-type="pmcid">PMC7000672</pub-id><pub-id pub-id-type="pmid">31969685</pub-id></mixed-citation></ref><ref id="B266"><label>266</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lugli</surname><given-names>E</given-names></name><name name-style="western"><surname>Dominguez</surname><given-names>MH</given-names></name><name name-style="western"><surname>Gattinoni</surname><given-names>L</given-names></name><name name-style="western"><surname>Chattopadhyay</surname><given-names>PK</given-names></name><name name-style="western"><surname>Bolton</surname><given-names>DL</given-names></name><name name-style="western"><surname>Song</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Superior T memory stem cell persistence supports long-lived T cell memory</article-title>. <source>J Clin Invest</source> (<year>2013</year>) <volume>123</volume>:<fpage>594</fpage>. doi: <pub-id pub-id-type="doi">10.1172/JCI66327</pub-id><pub-id pub-id-type="pmid">23281401</pub-id><pub-id pub-id-type="pmcid">PMC3561805</pub-id></mixed-citation></ref><ref id="B267"><label>267</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graef</surname><given-names>P</given-names></name><name name-style="western"><surname>Buchholz</surname><given-names>VR</given-names></name><name name-style="western"><surname>Stemberger</surname><given-names>C</given-names></name><name name-style="western"><surname>Flossdorf</surname><given-names>M</given-names></name><name name-style="western"><surname>Henkel</surname><given-names>L</given-names></name><name name-style="western"><surname>Schiemann</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Serial transfer of single-Cell-Derived immunocompetence reveals stemness of CD8+ central memory T cells</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>41</volume>:<page-range>116&#8211;26</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2014.05.018</pub-id><pub-id pub-id-type="pmid">25035956</pub-id></mixed-citation></ref><ref id="B268"><label>268</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Joshi</surname><given-names>NS</given-names></name><name name-style="western"><surname>Cui</surname><given-names>W</given-names></name><name name-style="western"><surname>Chandele</surname><given-names>A</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HK</given-names></name><name name-style="western"><surname>Urso</surname><given-names>DR</given-names></name><name name-style="western"><surname>Hagman</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates <italic toggle="yes">via</italic> the graded expression of T-bet transcription factor</article-title>. <source>Immunity</source> (<year>2007</year>) <volume>27</volume>:<page-range>281&#8211;95</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2007.07.010</pub-id><pub-id pub-id-type="pmcid">PMC2034442</pub-id><pub-id pub-id-type="pmid">17723218</pub-id></mixed-citation></ref><ref id="B269"><label>269</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nayar</surname><given-names>R</given-names></name><name name-style="western"><surname>Schutten</surname><given-names>E</given-names></name><name name-style="western"><surname>Bautista</surname><given-names>B</given-names></name><name name-style="western"><surname>Daniels</surname><given-names>K</given-names></name><name name-style="western"><surname>Prince</surname><given-names>AL</given-names></name><name name-style="western"><surname>Enos</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Graded levels of IRF4 regulate CD8+ T cell differentiation and expansion, but not attrition, in response to acute virus infection</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>192</volume>:<page-range>5881&#8211;93</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1303187</pub-id><pub-id pub-id-type="pmcid">PMC4080788</pub-id><pub-id pub-id-type="pmid">24835398</pub-id></mixed-citation></ref><ref id="B270"><label>270</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jameson</surname><given-names>SC</given-names></name><name name-style="western"><surname>Masopust</surname><given-names>D</given-names></name></person-group>. <article-title>Understanding subset diversity in T cell memory</article-title>. <source>Immunity</source> (<year>2018</year>) <volume>48</volume>:<page-range>214&#8211;26</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2018.02.010</pub-id><pub-id pub-id-type="pmcid">PMC5863745</pub-id><pub-id pub-id-type="pmid">29466754</pub-id></mixed-citation></ref><ref id="B271"><label>271</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wherry</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Barber</surname><given-names>DL</given-names></name><name name-style="western"><surname>Kaech</surname><given-names>SM</given-names></name><name name-style="western"><surname>Blattman</surname><given-names>JN</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>R</given-names></name></person-group>. <article-title>Antigen-independent memory CD8 T cells do not develop during chronic viral infection</article-title>. <source>Proc Natl Acad Sci U.S.A.</source> (<year>2004</year>) <volume>101</volume>:<page-range>16004&#8211;9</page-range>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0407192101</pub-id><pub-id pub-id-type="pmcid">PMC524220</pub-id><pub-id pub-id-type="pmid">15505208</pub-id></mixed-citation></ref><ref id="B272"><label>272</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Utzschneider</surname><given-names>DT</given-names></name><name name-style="western"><surname>Alfei</surname><given-names>F</given-names></name><name name-style="western"><surname>Roelli</surname><given-names>P</given-names></name><name name-style="western"><surname>Barras</surname><given-names>D</given-names></name><name name-style="western"><surname>Chennupati</surname><given-names>V</given-names></name><name name-style="western"><surname>Darbre</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>High antigen levels induce an exhausted phenotype in a chronic infection without impairing T cell expansion and survival</article-title>. <source>J Exp Med</source> (<year>2016</year>) <volume>213</volume>:<page-range>1819&#8211;34</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.20150598</pub-id><pub-id pub-id-type="pmcid">PMC4995073</pub-id><pub-id pub-id-type="pmid">27455951</pub-id></mixed-citation></ref><ref id="B273"><label>273</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wirth</surname><given-names>TC</given-names></name><name name-style="western"><surname>Xue</surname><given-names>HH</given-names></name><name name-style="western"><surname>Rai</surname><given-names>D</given-names></name><name name-style="western"><surname>Sabel</surname><given-names>JT</given-names></name><name name-style="western"><surname>Bair</surname><given-names>T</given-names></name><name name-style="western"><surname>Harty</surname><given-names>JT</given-names></name><etal/></person-group>. <article-title>Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8(+) T cell differentiation</article-title>. <source>Immunity</source> (<year>2010</year>) <volume>33</volume>:<page-range>128&#8211;40</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2010.06.014</pub-id><pub-id pub-id-type="pmcid">PMC2912220</pub-id><pub-id pub-id-type="pmid">20619696</pub-id></mixed-citation></ref><ref id="B274"><label>274</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Angelosanto</surname><given-names>JM</given-names></name><name name-style="western"><surname>Blackburn</surname><given-names>SD</given-names></name><name name-style="western"><surname>Crawford</surname><given-names>A</given-names></name><name name-style="western"><surname>Wherry</surname><given-names>EJ</given-names></name></person-group>. <article-title>Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection</article-title>. <source>J Virol</source> (<year>2012</year>) <volume>86</volume>:<page-range>8161&#8211;70</page-range>. doi: <pub-id pub-id-type="doi">10.1128/JVI.00889-12</pub-id><pub-id pub-id-type="pmcid">PMC3421680</pub-id><pub-id pub-id-type="pmid">22623779</pub-id></mixed-citation></ref><ref id="B275"><label>275</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daniels</surname><given-names>MA</given-names></name><name name-style="western"><surname>Teixeiro</surname><given-names>E</given-names></name></person-group>. <article-title>TCR signaling in T cell memory</article-title>. <source>Front Immunol</source> (<year>2015</year>) <volume>6</volume>:<elocation-id>617</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2015.00617</pub-id><pub-id pub-id-type="pmid">26697013</pub-id><pub-id pub-id-type="pmcid">PMC4674549</pub-id></mixed-citation></ref><ref id="B276"><label>276</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wuthrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Warner</surname><given-names>T</given-names></name><name name-style="western"><surname>Klein</surname><given-names>BS</given-names></name></person-group>. <article-title>CD28 is required for optimal induction, but not maintenance, of vaccine-induced immunity to blastomyces dermatitidis</article-title>. <source>Infect Immun</source> (<year>2005</year>) <volume>73</volume>:<page-range>7436&#8211;41</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.73.11.7436-7441.2005</pub-id><pub-id pub-id-type="pmcid">PMC1273838</pub-id><pub-id pub-id-type="pmid">16239544</pub-id></mixed-citation></ref><ref id="B277"><label>277</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Flies</surname><given-names>DB</given-names></name></person-group>. <article-title>Molecular mechanisms of T cell co-stimulation and co-inhibition</article-title>. <source>Nat Rev Immunol</source> (<year>2013</year>) <volume>13</volume>:<page-range>227&#8211;42</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nri3405</pub-id><pub-id pub-id-type="pmcid">PMC3786574</pub-id><pub-id pub-id-type="pmid">23470321</pub-id></mixed-citation></ref><ref id="B278"><label>278</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Humphreys</surname><given-names>IR</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>L</given-names></name><name name-style="western"><surname>Walzl</surname><given-names>G</given-names></name><name name-style="western"><surname>Rae</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Dougan</surname><given-names>G</given-names></name><name name-style="western"><surname>Hill</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>OX40 ligation on activated T cells enhances the control of cryptococcus neoformans and reduces pulmonary eosinophilia</article-title>. <source>J Immunol</source> (<year>2003</year>) <volume>170</volume>:<page-range>6125&#8211;32</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.170.12.6125</pub-id><pub-id pub-id-type="pmid">12794142</pub-id></mixed-citation></ref><ref id="B279"><label>279</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wuthrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Fisette</surname><given-names>PL</given-names></name><name name-style="western"><surname>Filutowicz</surname><given-names>HI</given-names></name><name name-style="western"><surname>Klein</surname><given-names>BS</given-names></name></person-group>. <article-title>Differential requirements of T cell subsets for CD40 costimulation in immunity to blastomyces dermatitidis</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>176</volume>:<page-range>5538&#8211;47</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.176.9.5538</pub-id><pub-id pub-id-type="pmid">16622023</pub-id></mixed-citation></ref><ref id="B280"><label>280</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Q</given-names></name><name name-style="western"><surname>Gault</surname><given-names>RA</given-names></name><name name-style="western"><surname>Kozel</surname><given-names>TR</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>WJ</given-names></name></person-group>. <article-title>Immunomodulation with CD40 stimulation and interleukin-2 protects mice from disseminated cryptococcosis</article-title>. <source>Infect Immun</source> (<year>2006</year>) <volume>74</volume>:<page-range>2161&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.74.4.2161-2168.2006</pub-id><pub-id pub-id-type="pmcid">PMC1418893</pub-id><pub-id pub-id-type="pmid">16552046</pub-id></mixed-citation></ref><ref id="B281"><label>281</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>GH</given-names></name><name name-style="western"><surname>Osterholzer</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Choe</surname><given-names>MY</given-names></name><name name-style="western"><surname>Mcdonald</surname><given-names>RA</given-names></name><name name-style="western"><surname>Olszewski</surname><given-names>MA</given-names></name><name name-style="western"><surname>Huffnagle</surname><given-names>GB</given-names></name><etal/></person-group>. <article-title>Dual roles of CD40 on microbial containment and the development of immunopathology in response to persistent fungal infection in the lung</article-title>. <source>Am J Pathol</source> (<year>2010</year>) <volume>177</volume>:<page-range>2459&#8211;71</page-range>. doi: <pub-id pub-id-type="doi">10.2353/ajpath.2010.100141</pub-id><pub-id pub-id-type="pmcid">PMC2966803</pub-id><pub-id pub-id-type="pmid">20864680</pub-id></mixed-citation></ref><ref id="B282"><label>282</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Felonato</surname><given-names>M</given-names></name><name name-style="western"><surname>Pina</surname><given-names>A</given-names></name><name name-style="western"><surname>Bernardino</surname><given-names>S</given-names></name><name name-style="western"><surname>Loures</surname><given-names>FV</given-names></name><name name-style="western"><surname>De Araujo</surname><given-names>EF</given-names></name><name name-style="western"><surname>Calich</surname><given-names>VL</given-names></name></person-group>. <article-title>CD28 exerts protective and detrimental effects in a pulmonary model of paracoccidioidomycosis</article-title>. <source>Infect Immun</source> (<year>2010</year>) <volume>78</volume>:<page-range>4922&#8211;35</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.00297-10</pub-id><pub-id pub-id-type="pmcid">PMC2976317</pub-id><pub-id pub-id-type="pmid">20713624</pub-id></mixed-citation></ref><ref id="B283"><label>283</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bouguermouh</surname><given-names>S</given-names></name><name name-style="western"><surname>Fortin</surname><given-names>G</given-names></name><name name-style="western"><surname>Baba</surname><given-names>N</given-names></name><name name-style="western"><surname>Rubio</surname><given-names>M</given-names></name><name name-style="western"><surname>Sarfati</surname><given-names>M</given-names></name></person-group>. <article-title>CD28 co-stimulation down regulates Th17 development</article-title>. <source>PloS One</source> (<year>2009</year>) <volume>4</volume>:<elocation-id>e5087</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0005087</pub-id><pub-id pub-id-type="pmid">19333372</pub-id><pub-id pub-id-type="pmcid">PMC2658739</pub-id></mixed-citation></ref><ref id="B284"><label>284</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Revu</surname><given-names>S</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Henkel</surname><given-names>M</given-names></name><name name-style="western"><surname>Rittenhouse</surname><given-names>N</given-names></name><name name-style="western"><surname>Menk</surname><given-names>A</given-names></name><name name-style="western"><surname>Delgoffe</surname><given-names>GM</given-names></name><etal/></person-group>. <article-title>IL-23 and IL-1beta drive human Th17 cell differentiation and metabolic reprogramming in absence of CD28 costimulation</article-title>. <source>Cell Rep</source> (<year>2018</year>) <volume>22</volume>:<page-range>2642&#8211;53</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2018.02.044</pub-id><pub-id pub-id-type="pmcid">PMC5884137</pub-id><pub-id pub-id-type="pmid">29514093</pub-id></mixed-citation></ref><ref id="B285"><label>285</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>C</given-names></name></person-group>. <article-title>Cytokine regulation and function in T cells</article-title>. <source>Annu Rev Immunol</source> (<year>2021</year>) <volume>39</volume>:<fpage>51</fpage>&#8211;<lpage>76</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev-immunol-061020-053702</pub-id><pub-id pub-id-type="pmid">33428453</pub-id></mixed-citation></ref><ref id="B286"><label>286</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cavassani</surname><given-names>KA</given-names></name><name name-style="western"><surname>Campanelli</surname><given-names>AP</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>AP</given-names></name><name name-style="western"><surname>Vancim</surname><given-names>JO</given-names></name><name name-style="western"><surname>Vitali</surname><given-names>LH</given-names></name><name name-style="western"><surname>Mamede</surname><given-names>RC</given-names></name><etal/></person-group>. <article-title>Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>177</volume>:<page-range>5811&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.177.9.5811</pub-id><pub-id pub-id-type="pmid">17056505</pub-id></mixed-citation></ref><ref id="B287"><label>287</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romani</surname><given-names>L</given-names></name></person-group>. <article-title>Immunity to fungal infections</article-title>. <source>Nat Rev Immunol</source> (<year>2011</year>) <volume>11</volume>:<page-range>275&#8211;88</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nri2939</pub-id><pub-id pub-id-type="pmid">21394104</pub-id></mixed-citation></ref><ref id="B288"><label>288</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murdock</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Teitz-Tennenbaum</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>GH</given-names></name><name name-style="western"><surname>Dils</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Malachowski</surname><given-names>AN</given-names></name><name name-style="western"><surname>Curtis</surname><given-names>JL</given-names></name><etal/></person-group>. <article-title>Early or late IL-10 blockade enhances Th1 and Th17 effector responses and promotes fungal clearance in mice with cryptococcal lung infection</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>193</volume>:<page-range>4107&#8211;16</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1400650</pub-id><pub-id pub-id-type="pmcid">PMC4193595</pub-id><pub-id pub-id-type="pmid">25225664</pub-id></mixed-citation></ref><ref id="B289"><label>289</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Break</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Oikonomou</surname><given-names>V</given-names></name><name name-style="western"><surname>Dutzan</surname><given-names>N</given-names></name><name name-style="western"><surname>Desai</surname><given-names>JV</given-names></name><name name-style="western"><surname>Swidergall</surname><given-names>M</given-names></name><name name-style="western"><surname>Freiwald</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Aberrant type 1 immunity drives susceptibility to mucosal fungal infections</article-title>. <source>Science</source> (<year>2021</year>) <volume>371</volume>(<issue>6526</issue>):<elocation-id>eaay5731</elocation-id>. doi: <pub-id pub-id-type="doi">10.1126/science.aay5731</pub-id><pub-id pub-id-type="pmid">33446526</pub-id><pub-id pub-id-type="pmcid">PMC8326743</pub-id></mixed-citation></ref><ref id="B290"><label>290</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montano</surname><given-names>DE</given-names></name><name name-style="western"><surname>Voigt</surname><given-names>K</given-names></name></person-group>. <article-title>Host immune defense upon fungal infections with mucorales: Pathogen-immune cell interactions as drivers of inflammatory responses</article-title>. <source>J Fungi</source> (<year>2020</year>) <volume>6</volume>(<issue>3</issue>):<elocation-id>173</elocation-id>. doi: <pub-id pub-id-type="doi">10.3390/jof6030173</pub-id><pub-id pub-id-type="pmcid">PMC7557740</pub-id><pub-id pub-id-type="pmid">32957440</pub-id></mixed-citation></ref><ref id="B291"><label>291</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deepe</surname><given-names>GS</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Gibbons</surname><given-names>RS</given-names></name></person-group>. <article-title>T Cells require tumor necrosis factor-alpha to provide protective immunity in mice infected with histoplasma capsulatum</article-title>. <source>J Infect Dis</source> (<year>2006</year>) <volume>193</volume>:<page-range>322&#8211;30</page-range>. doi: <pub-id pub-id-type="doi">10.1086/498981</pub-id><pub-id pub-id-type="pmcid">PMC1390767</pub-id><pub-id pub-id-type="pmid">16362898</pub-id></mixed-citation></ref><ref id="B292"><label>292</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romani</surname><given-names>L</given-names></name></person-group>. <article-title>Innate and acquired cellular immunity to fungi</article-title>. <source>Mol Principles Fungal Pathogene</source> (<year>2006</year>), <page-range>471&#8211;86</page-range>. doi: <pub-id pub-id-type="doi">10.1128/9781555815776.ch32</pub-id></mixed-citation></ref><ref id="B293"><label>293</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romani</surname><given-names>L</given-names></name></person-group>. <article-title>Cell mediated immunity to fungi: a reassessment</article-title>. <source>Med Mycol</source> (<year>2008</year>) <volume>46</volume>:<page-range>515&#8211;29</page-range>. doi: <pub-id pub-id-type="doi">10.1080/13693780801971450</pub-id><pub-id pub-id-type="pmid">19180748</pub-id></mixed-citation></ref><ref id="B294"><label>294</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leibundgut-Landmann</surname><given-names>S</given-names></name><name name-style="western"><surname>Wuthrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Hohl</surname><given-names>TM</given-names></name></person-group>. <article-title>Immunity to fungi</article-title>. <source>Curr Opin Immunol</source> (<year>2012</year>) <volume>24</volume>:<page-range>449&#8211;58</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.coi.2012.04.007</pub-id><pub-id pub-id-type="pmcid">PMC3538869</pub-id><pub-id pub-id-type="pmid">22613091</pub-id></mixed-citation></ref><ref id="B295"><label>295</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azuma</surname><given-names>M</given-names></name></person-group>. <article-title>Co-Signal molecules in T-cell activation: Historical overview and perspective</article-title>. <source>Adv Exp Med Biol</source> (<year>2019</year>) <volume>1189</volume>:<fpage>3</fpage>&#8211;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-981-32-9717-3_1</pub-id><pub-id pub-id-type="pmid">31758529</pub-id></mixed-citation></ref><ref id="B296"><label>296</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morris</surname><given-names>AB</given-names></name><name name-style="western"><surname>Adams</surname><given-names>LE</given-names></name><name name-style="western"><surname>Ford</surname><given-names>ML</given-names></name></person-group>. <article-title>Influence of T cell coinhibitory molecules on CD8+ recall responses</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>1810</volume>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.01810</pub-id><pub-id pub-id-type="pmcid">PMC6092517</pub-id><pub-id pub-id-type="pmid">30135685</pub-id></mixed-citation></ref><ref id="B297"><label>297</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roussey</surname><given-names>JA</given-names></name><name name-style="western"><surname>Viglianti</surname><given-names>SP</given-names></name><name name-style="western"><surname>Teitz-Tennenbaum</surname><given-names>S</given-names></name><name name-style="western"><surname>Olszewski</surname><given-names>MA</given-names></name><name name-style="western"><surname>Osterholzer</surname><given-names>JJ</given-names></name></person-group>. <article-title>Anti&#8211;PD-1 antibody treatment promotes clearance of persistent cryptococcal lung infection in mice</article-title>. <source>J Immunol</source> (<year>2017</year>) <volume>199</volume>:<page-range>3535&#8211;46</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1700840</pub-id><pub-id pub-id-type="pmcid">PMC5687305</pub-id><pub-id pub-id-type="pmid">29038249</pub-id></mixed-citation></ref><ref id="B298"><label>298</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shwetank</surname></name><name name-style="western"><surname>Abdelsamed</surname><given-names>HA</given-names></name><name name-style="western"><surname>Frost</surname><given-names>EL</given-names></name><name name-style="western"><surname>Schmitz</surname><given-names>HM</given-names></name><name name-style="western"><surname>Mockus</surname><given-names>TE</given-names></name><name name-style="western"><surname>Youngblood</surname><given-names>BA</given-names></name><etal/></person-group>. <article-title>Maintenance of PD-1 on brain-resident memory CD8 T cells is antigen independent</article-title>. <source>Immunol Cell Biol</source> (<year>2017</year>) <volume>95</volume>:<page-range>953&#8211;9</page-range>. doi: <pub-id pub-id-type="doi">10.1038/icb.2017.62</pub-id><pub-id pub-id-type="pmcid">PMC5698165</pub-id><pub-id pub-id-type="pmid">28829048</pub-id></mixed-citation></ref><ref id="B299"><label>299</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>SL</given-names></name><name name-style="western"><surname>Zaid</surname><given-names>A</given-names></name><name name-style="western"><surname>Hor</surname><given-names>JL</given-names></name><name name-style="western"><surname>Christo</surname><given-names>SN</given-names></name><name name-style="western"><surname>Prier</surname><given-names>JE</given-names></name><name name-style="western"><surname>Davies</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Local proliferation maintains a stable pool of tissue-resident memory T cells after antiviral recall responses</article-title>. <source>Nat Immunol</source> (<year>2018</year>) <volume>19</volume>:<page-range>183&#8211;91</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41590-017-0027-5</pub-id><pub-id pub-id-type="pmid">29311695</pub-id></mixed-citation></ref><ref id="B300"><label>300</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>KC</given-names></name><name name-style="western"><surname>Burnham</surname><given-names>CA</given-names></name><name name-style="western"><surname>Compton</surname><given-names>SM</given-names></name><name name-style="western"><surname>Rasche</surname><given-names>DP</given-names></name><name name-style="western"><surname>Mazuski</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Mcdonough</surname><given-names>JS</given-names></name><etal/></person-group>. <article-title>Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis</article-title>. <source>Crit Care</source> (<year>2013</year>) <volume>17</volume>:<fpage>R85</fpage>. doi: <pub-id pub-id-type="doi">10.1186/cc12711</pub-id><pub-id pub-id-type="pmid">23663657</pub-id><pub-id pub-id-type="pmcid">PMC3706819</pub-id></mixed-citation></ref><ref id="B301"><label>301</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gartshteyn</surname><given-names>Y</given-names></name><name name-style="western"><surname>Askanase</surname><given-names>AD</given-names></name><name name-style="western"><surname>Mor</surname><given-names>A</given-names></name></person-group>. <article-title>SLAM associated protein signaling in T cells: Tilting the balance toward autoimmunity</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>654839</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.654839</pub-id><pub-id pub-id-type="pmid">33936082</pub-id><pub-id pub-id-type="pmcid">PMC8086963</pub-id></mixed-citation></ref><ref id="B302"><label>302</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kohn</surname><given-names>EM</given-names></name><name name-style="western"><surname>Dos Santos Dias</surname><given-names>L</given-names></name><name name-style="western"><surname>Dobson</surname><given-names>HE</given-names></name><name name-style="western"><surname>He</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Klein</surname><given-names>BS</given-names></name><etal/></person-group>. <article-title>SLAMF1 is dispensable for vaccine-induced T cell development but required for resistance to fungal infection</article-title>. <source>J Immunol</source> (<year>2022</year>) <volume>208</volume>:<page-range>1417&#8211;23</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.2100819</pub-id><pub-id pub-id-type="pmcid">PMC8917092</pub-id><pub-id pub-id-type="pmid">35217584</pub-id></mixed-citation></ref><ref id="B303"><label>303</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cyster</surname><given-names>JG</given-names></name><name name-style="western"><surname>Shotton</surname><given-names>DM</given-names></name><name name-style="western"><surname>Williams</surname><given-names>AF</given-names></name></person-group>. <article-title>The dimensions of the T lymphocyte glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation</article-title>. <source>EMBO J</source> (<year>1991</year>) <volume>10</volume>:<fpage>893</fpage>&#8211;<lpage>902</lpage>. doi: <pub-id pub-id-type="doi">10.1002/j.1460-2075.1991.tb08022.x</pub-id><pub-id pub-id-type="pmid">1706994</pub-id><pub-id pub-id-type="pmcid">PMC452732</pub-id></mixed-citation></ref><ref id="B304"><label>304</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ostberg</surname><given-names>JR</given-names></name><name name-style="western"><surname>Barth</surname><given-names>RK</given-names></name><name name-style="western"><surname>Frelinger</surname><given-names>JG</given-names></name></person-group>. <article-title>The Roman god janus: A paradigm for the function of CD43</article-title>. <source>Immunol Today</source> (<year>1998</year>) <volume>19</volume>:<page-range>546&#8211;50</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0167-5699(98)01343-7</pub-id><pub-id pub-id-type="pmid">9864944</pub-id></mixed-citation></ref><ref id="B305"><label>305</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Onami</surname><given-names>TM</given-names></name><name name-style="western"><surname>Harrington</surname><given-names>LE</given-names></name><name name-style="western"><surname>Williams</surname><given-names>MA</given-names></name><name name-style="western"><surname>Galvan</surname><given-names>M</given-names></name><name name-style="western"><surname>Larsen</surname><given-names>CP</given-names></name><name name-style="western"><surname>Pearson</surname><given-names>TC</given-names></name><etal/></person-group>. <article-title>Dynamic regulation of T cell immunity by CD43</article-title>. <source>J Immunol</source> (<year>2002</year>) <volume>168</volume>:<page-range>6022&#8211;31</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.168.12.6022</pub-id><pub-id pub-id-type="pmid">12055210</pub-id></mixed-citation></ref><ref id="B306"><label>306</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manjunath</surname><given-names>N</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>RS</given-names></name><name name-style="western"><surname>Staunton</surname><given-names>DE</given-names></name><name name-style="western"><surname>Pasqualini</surname><given-names>R</given-names></name><name name-style="western"><surname>Ardman</surname><given-names>B</given-names></name></person-group>. <article-title>Targeted disruption of CD43 gene enhances T lymphocyte adhesion</article-title>. <source>J Immunol</source> (<year>1993</year>) <volume>151</volume>:<page-range>1528&#8211;34</page-range>.<pub-id pub-id-type="pmid">8335945</pub-id></mixed-citation></ref><ref id="B307"><label>307</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manjunath</surname><given-names>N</given-names></name><name name-style="western"><surname>Correa</surname><given-names>M</given-names></name><name name-style="western"><surname>Ardman</surname><given-names>M</given-names></name><name name-style="western"><surname>Ardman</surname><given-names>B</given-names></name></person-group>. <article-title>Negative regulation of T-cell adhesion and activation by CD43</article-title>. <source>Nature</source> (<year>1995</year>) <volume>377</volume>:<page-range>535&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.1038/377535a0</pub-id><pub-id pub-id-type="pmid">7566153</pub-id></mixed-citation></ref><ref id="B308"><label>308</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pedraza-Alva</surname><given-names>G</given-names></name><name name-style="western"><surname>Merida</surname><given-names>LB</given-names></name><name name-style="western"><surname>Del Rio</surname><given-names>R</given-names></name><name name-style="western"><surname>Fierro</surname><given-names>NA</given-names></name><name name-style="western"><surname>Cruz-Munoz</surname><given-names>ME</given-names></name><name name-style="western"><surname>Olivares</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>CD43 regulates the threshold for T cell activation by targeting cbl functions</article-title>. <source>IUBMB Life</source> (<year>2011</year>) <volume>63</volume>:<page-range>940&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.1002/iub.554</pub-id><pub-id pub-id-type="pmcid">PMC3742379</pub-id><pub-id pub-id-type="pmid">21905200</pub-id></mixed-citation></ref><ref id="B309"><label>309</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mudalagiriyappa</surname><given-names>SD</given-names></name><name name-style="western"><surname>George S</surname><given-names>D</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Nanjappa</surname><given-names>SG</given-names></name></person-group>. <article-title>Sialophorin is an essential host element for vaccine immunity against pulmonary fungal infections</article-title>. <source>bioRxiv</source> (<year>2022</year>). doi: <pub-id pub-id-type="doi">10.1101/2022.03.31.486552</pub-id></mixed-citation></ref><ref id="B310"><label>310</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pulendran</surname><given-names>B</given-names></name><name name-style="western"><surname>Arunachalam</surname><given-names>PS</given-names></name><name name-style="western"><surname>O&#8217;hagan</surname><given-names>DT</given-names></name></person-group>. <article-title>Emerging concepts in the science of vaccine adjuvants</article-title>. <source>Nat Rev Drug Discov</source> (<year>2021</year>) <volume>20</volume>:<page-range>454&#8211;75</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41573-021-00163-y</pub-id><pub-id pub-id-type="pmcid">PMC8023785</pub-id><pub-id pub-id-type="pmid">33824489</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>